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Abstract
This  thesis  presents  a  number  of  studies  in  the  general  subject  of
bioinformatics  and  functional  genomics.  The  studies  were  made  in
collaboration with experimental scientists of the London Pain Consortium
(LPC), an initiative that has promoted collaborations between experimental
and computational scientists to further understanding of pain. The studies
are mainly concerned with the molecular biology of pain and deal with data
gathered  from  high  throughput  technologies  aiming  to  assess  the
transcriptional  changes  involved  in  well  induced  pain  states,  both  from
animal  models  of  pain  and  human  patients.  We  have  analysed  next
generation sequencing data (NGS data) in order to assess the transcriptional
changes in rodent’s dorsal root ganglions under well induced pain states. We
have also developed a customised computational pipeline to analyse RNA-
sequencing  data  in  order  to  identify  novel  Long  non-coding  RNAs
(LncRNAs),  which  may  function  as  mediators  of  neuropathic  pain.  Our
analyses detected hundreds  of  novel  LncRNAs significantly dysregulated
between sham-operated animals and animal models of pain. In addition, in
order  to  gain  valuable  insights  into  neuropathic  pain,  including  both  its
molecular  signature,  somatosensory  profiles  and  clusters  of  individuals
related  to  pain  severity,  we  analysed  clinical  data  together  with  data
obtained from quality of life pain-questionnaires. Based on this study, we
were able to identify distinct pain modalities associated with the intensity of
neuropathic  pain.  Our  results  will  be  useful  for  the  understanding  of
neuropathic pain and its future treatment. 
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Introduction
This thesis  presents a number of studies in the general subject of
Bioinformatics and Functional Genomics.  The studies presented were made
in collaboration with experimental scientists of the London Pain Consortium
(LPC), an initiative that has promoted collaborations between experimental
and computational scientists to to further our understanding of pain.
The  work  presented  in  this  thesis  is  mainly  concerned  with  the
molecular  biology  of  pain  and  deals  with  data  gathered  from  high
throughput  technologies  aiming  to  assess  the  transcriptional  changes
involved in well induced pain states, both from animal models of pain and
human patients. The ultimate aim is to gather valuable insights that will help
us  understand  pain  and  more  specifically  neuropathic  pain  and  produce
efficient drugs to control it. In order to do so we have used RNA-sequencing
data of tissues involved in the nervous system, clinical markers and self-
completed pain questionnaires. 
Profiling technologies have been used extensively in the context of
pain research to identify Differentially Expressed (DE) genes under well-
induced pain states, usually using animal models. In addition advancements
in next generation sequencing and particularly in RNA-sequencing (RNA-
seq) have enabled us to comprehensively assess transcriptional changes of
animal models under specific pain models. Thus, we are now able to detect
alterations  in  expression  for  both  annotated  and  un-annotated  genomic
regions and to identify Long Non-Coding RNAs (LncRNAs), which may
contribute to neuropathic pain.
In this  thesis  we present  a  study the primary  aim of  which is  to
identify pain-related genes and transcriptional patterns of pain, novel pain-
related genes encoding for LncRNAs, which may contribute to neuropathic
pain  and  to  analyse  their  biological  pathways  using  functional  genomic
approaches. Moreover we will analyse both molecular and clinical data in
12
order to gather more insights regarding the different qualities of neuropathic
pain and to further understanding of its molecular signature.
Pain
Pain has played a crucial role in human evolution as its sensation
protects the body from serious injury. The ability to detect and respond to
such stimuli is crucial for surviving (Basbaum et al., 2009). In other words
the  sensation  of  pain  gives  to  the  organism  an  early  warning  about  a
potentially  damaging  stimulus  (Woolf  and  Salter,  2000).  In  1968  in  his
paper “Psychological aspects of pain” (Merskey, 1968) H. Merskey gave the
following broad definition of pain: “an operational definition of pain should
be  adopted  as  follows:  ‘An  unpleasant  experience  which  we  primarily
associate  with  tissue  damage  or  described  in  terms  of  such  damage,  or
both’”.  As the International Association for the Study of Pain rephrases it:
"Pain is  an unpleasant  sensory and emotional  experience associated with
actual or potential tissue damage, or described in terms of such damage."
Pain it  is  not  homogenous however,  it  can  be due to  an external
stimuli  or  due  to  a  malfunction  of  the  nervous  system.  In  general  pain
involves higher level emotional components and it qualitatively differs from
the body’s response to a potentially damaging stimuli. IASP classifies pain
according to  its  features  or  more  specifically  by the  region of  the  body
involved,  the  system  whose  dysfunction  may  be  causing  the  pain,  the
duration and pattern of occurrence, the intensity and the aetiology. But other
scientists  argue  that  pain  can  be  classified  into  three  main  categories:
physiological,  inflammatory  and  neuropathic  (Woolf  and  Salter,  2000).
Physiological pain is nociceptive pain, it is activated by a noxious stimuli.
Inflammatory pain is pain due to the response of the immune system and
inflammation  and  neuropathic  pain  is  pain  due  to  damage  or  disease
affecting the nervous system. Both the peripheral and the central nervous
system are involved in pain. Pain can be acute, due to an intense stimuli
when detection coding and modulation of noxious stimuli generates pain or
persistent – chronic pain. Persistent pain involves increased plasticity of the
13
pain  transmission  pathway leading to  hypersensitivity,  i.e.  the  peripheral
and/or central nervous system enhancing pain signals. Neuropathic pain is
indeed  the  verbalization  of  such  maladaptive  neuronal  plasticity,  in  the
context of trauma or lesions to the somatosensory nervous system  (Costigan
et al., 2009). As mentioned above pain can be initiated, and physiological
pain generally is, by a noxious external stimuli.  The process of detecting
encoding  and  processing  such  a  stimuli  is  nociception.  This  process  is
carried out by the nervous system and it involves the encoding of a broad
range of mechanical, chemical and thermal stimuli. The nerve fibres which
detect such stimuli  are called nociceptors and lie in the periphery of the
nervous system (Basbaum et al., 2009). Nociceptors transmit information to
neurons in the spinal cord which in turn transmit information to the cortex
via their projections and create the sensation of pain  (Gold and Gebhart,
2010).  Thus  nociception  is  the  detection  of  thermal,  mechanical  and
chemical  stimuli  from  high  threshold  nerves  on  the  peripheral  nervous
system,  on  the  other  hand  the  sensation  of  pain  per  se involves  higher
functions of the brain in order to process this information. 
The cell bodies of nociceptors innervating the body are located in the
Dorsal Root Ganglia (DRG), and those of nociceptors innervating the face
are  in  the  trigeminal  ganglion.  In  general,  axons  of  nociceptors  are
connecting target organs to the spinal cord. Contrary to the typical neuron,
nociceptors  can  facilitate  bidirectional  transmission  of  information,  as
proteins expressed in DRG or trigeminal ganglion are transferred from the
dendrite to the axon and vice versa.
Nociceptors are classified into two major classes: medium diameter
myelinated (Aδ) afferents that mediate highly-localised, acute, fast pain and
small  diameter  un-myelinated  “C” fibres  that  mediate  diffused and slow
pain. More specifically these classes are divided in subclasses. For Αδ fibres
type  I  do  respond  to  mechanical  and  chemical  stimuli  but  are  not  that
sensitive to heat stimuli and type II have low threshold in heat stimuli but
are not sensitive to mechanical stimuli. Most C fibres can detect mechanical
and  heat  stimuli,  while  other  are  sensitive  to  heat  and  have  very  high
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mechanical  thresholds  and  only  lower  their  mechanical  threshold  as  a
response  to  inflammation  when injured.   These  different  and specialised
types project on different laminae of the dorsal horn of the spinal cord. Αδ
fibres innervate laminae I and V, where laminae V receives both noxious
and innocuous stimuli. C fibres innervate laminae I and II.
Pain at the molecular level
At the molecular level, pain is mediated by proteins that translate
signal  detection  to  electrical  current  in  order  to  communicate  with  the
central nervous system. Various molecules are involved in signal detection
and  transduction.  The  specialisation  of  nociceptors  is  mirrored  in  the
molecular  level.  C  fibres  can  be  peptidergic,  producing  neuropeptides,
substance  P,  Calcitonin  Gene  Related  Peptide  (CGRP)  and  expressing
neurotrophic  tyrosine  kinase  TrkA,  or  non-peptidergic  (Basbaum  et  al.,
2009).  Non-peptidergic  c  fibres  express  the  transmembrane  receptor
tyrosine  kinase  C-ret  (Rearranged  during  Transfection)  neurotrophin,  G
protein  coupled  receptors,  neurterin  and  artemin  and  purinergic  receptor
15
Figure 1: Distinct types of nociceptors and Aβ fibers responding to light 
touch project on different laminae of the spinal cord. Image courtesy of 
(Basbaum et al., 2009) 
subtypes.  Certain  families  of  proteins  are  also  differentially  expressed
between these specialised nociceptors and mediate distinct qualities of pain,
ASICs respond to acidic  environment,  TRPV1 channels respond to heat,
TRPM8 to cold and TRPA1 to chemical stimuli.  
Regarding  detection  of  noxious  mechanical  stimuli  Transient
Receptor  Potential  (TRP)  channels  are  thought  to  activate  nociceptors.
TRPA1 functions as a detector of mechanical stimuli, TRPV4 is involved in
pain hypersensitivity after injury and TRPV2 can respond to noxious heat
and mechanical stimuli. Also KCNK potassium channels, like KCNK2 and
KCNK4 and also KCNK18 act as regulators of the duration and excitability
of action potentials. ASIC, acid sensitive channels, are also thought to be
implicated  in  detecting  mechanical  stimuli  (Basbaum  et  al.,  2009).  In
addition mechanically activated ion channels are thought to be critical in
initiating touch sensation and transducing mechanical stimuli. Piezo2, which
is a mechanically activated ion channel expressed Merkel cells of  the dorsal
root ganglion has been found to be the major transducer for touch sensation
(Ranade et al., 2014). Moreover, not yet identified mechanically activated
ion channels, are likely to transduce noxious mechanical stimuli (Ranade et
al., 2014).
After nociceptors detect pain the signal need to be transduced to the
central  nervous system.  Voltage gated  ion  channels  are  essential  for  this
process. Sodium and potassium channels generate action potentials in order
to transmit signals to dorsal  horn.  Sodium channels transmit information
from the periphery to the dorsal horn and potassium channels act as breaks
on excitability. Calcium channels release neurotransmitters and play a key
role in transmitting neuronal sensation either to generate pain or neurogenic
inflammation,  thus  they  are  highly  relevant  to  neuropathic  pain.  These
voltage  gated  ion  channels  are  crucial  in  modulating  the  excitability  of
nociceptors and transmitting pain from the peripheral nervous system.  
Several  studies  have  highlighted  the  importance  of  voltage  gated
sodium and potassium channels in pain. The Nav1.7 voltage gated sodium
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channel (Koenig et al., 2015), encoded by the Scn9a gene, and Kcna2 (Zhao
et al., 2013) gene that encodes a voltage gated potassium channel, are both
known to be implicated in pain and also have known antisense LncRNAs
regulating their expression. Recently we have published a study regarding
the role of Nav1.7 – Scn9a, where loss-of-function mutations in that gene
cause congenital  insensitivity to pain in humans and mice  (Minett  et  al.,
2015). On the other hand, gain of function mutations of the Scn9a gene lead
to  hyper-excitability  and  intense  burning  sensations  related  to  the
erythromelalgia,  paroxysmal  pain  disorder  syndromes  and  small  fibre
neuropathy  (Bennett and Woods, 2014; Estacion et al., 2008; Fertleman et
al., 2006).
Regarding persistent pain, a group of cells and signalling molecules
driving  peripheral  sensitisation,  like  non-neuronal  cells  related  to
inflammation which are recruited and infiltrate areas of tissue damage, play
a crucial role. This is often called inflammatory soup  (Calvo et al., 2012)
and acts as mediator of peripheral sensitisation. Activated nociceptors and
those non-neuronal immune cells express various signalling molecules like
substance p, CGRP, bradykinin, neurotrophins, cytokines and chemokines
(White  and  Wilson,  2008).  Certain  nociceptors,  are  activated  from these
endogenous  chemokines  and cytokines  and express  TRPA1,  TRPV1 and
ASIC  channels.  In  addition  NGF,  a  well  known  nerve  growth  factor
implicated  in  embryonic  development  of  neurons,  is  also  an  important
endogenous factor  of  this  inflammatory soup. It  is  expressed after  nerve
injury  and  acts  on  peptidergic  C  fibres  mediating  mechanical
hypersensitivity after nerve injury.
Moreover,  a  set  of  manually  curated  genes  that  are  validated  in
transgenic knockout mice to be involved in pain are available in the Pain
Genes  database  (Lacroix-Fralish  et  al.,  2007).  This  set  of  430  genes
represents  a  comprehensive  repertoire  of  the  significant  transcriptional
changes involved in pain. Genes are included if they found to be statistically
significant differentially expressed between mutant mice (showing increased
injury  or  stimulus  induced  hypersensitivity  or  stress  or  drug  induced
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inhibition  of  nociception)  and  wild  type  controls.  Functional  genomics
examination of these genes in the context of the biological process they are
involved in produced the “wheel of pain”, showing over-represented Gene
Ontologies terms that describe biological processes of pain 
(Lötsch et al., 2013). 
Gene Ontology (GO) is a hierarchy of terms, represented as a direct
acyclic  graph,  where  each  node  is  a  clearly  defined  term  related  to
biological  process,  cellular  component  or  molecular  function.  Genes  are
assigned to GO terms by manual literature curation. In terms of biological
processes  pain  is  found to be associated at  the molecular  level  to  terms
stemming  from  response  to  external  stimulus.  The  12  more  highly
associated terms of the genes validated to be implicated in pain (pain genes)
are behaviour, response to wounding, response to organic substance, cellular
ion  homeostasis,  ion  transport,  synaptic  transmission,  G-protein  coupled
receptor  protein  signalling  pathway,  intracellular  signal  transduction,
positive  regulation  of  biological  process,  regulation  of  system  process
(multicellular), anatomical structure development, regulation of localization
(figure  2).  Moreover  cognition  emerges  as  an  over-represented  process,
connected with memory via learning, representing the higher brain function
component of pain. 
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Figure 2: Sub-graph of 
significantly over-represented
GO terms in pain genes. 
Image courtesy of 
(Lötsch et al., 2013)
Neuropathic Pain
As the International Association for the Study of Pain (IASP) defines
it,  Neuropathic  Pain  is  “pain  initiated  or  caused by a  primary  lesion  or
dysfunction in the nervous system.” (Treede et al., 2008). Thus the diagnosis
of neuropathic pain necessitates the identification of an underlying disease
or  lesion  on  the  somatosensory  system,  which  in  turn  gives  rise  to
neuropathic  pain  as  a  symptom.  Although neuropathic  pain  affects  more
than  5%  of  the  population  there  is  no  adequate  treatment  available.
Neuropathic  pain  causes  severe  dysfunctions  and  disabilities  to  patients.
These come as an effect of various sensory abnormalities associated with
neuropathic pain. These sensory abnormalities include persistent pain and
paraesthesia,  allodynia,  hyperalgesia  and  loss  of  sensation  (Calvo  et  al.,
2012). Paraesthesia is the sensation of tickling, pricking or burning pain like
“pins and needles” with no apparent cause, allodynia is pain evoked by a
normally non-painful stimuli like brushing, hyperalgesia is the abnormally
increased sensitivity to normally painful stimuli (Calvo et al., 2012).
Neuropathic  pain  is  a  symptom  of  an  underlying  neuropathy;  a
neuronal injury that is usually associated with “a trauma, infection, toxins or
metabolic  agents”  (Calvo  et  al.,  2012).  In  all  of  the  above  cases  the
organism’s response to the injury involves a robust immune response. Under
pain conditions, immune cells, macrophages and monocytes are recruited to
participate in the inflammatory response. These immune cells infiltrate the
nerve itself,  therefore,  neuropathic  pain has an inflammatory component,
which contributes to the maintenance of pain.
Tools for assessing neuropathic pain
In order for the optimal treatment to be delivered, neuropathic pain
must be correctly diagnosed. This can be a difficult task as this kind of pain
is due to highly heterogeneous clinical conditions.  Due to this heterogeneity
of  causes  and  clinical  symptoms  there  is  an  emerging  need  to  classify
patients of neuropathic pain accordingly and provide them with the most
effective treatment. For the accurate diagnosis of neuropathic pain numerous
subjective pain questionnaires have been developed. As the developers of
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The Neuropathic Pain Symptom Inventory (NPSI) questionnaire state “In
this context, we thought it would be of interest to develop and validate a
specific  self-completed  questionnaire  for  the  assessment  of  the  different
symptoms of neuropathic pain. Ideally, such a questionnaire could represent
a  useful  and exploitable  tool  for  large cohorts  of  patients  in  multicentre
studies and give information comparable to that provided by quantitative
evaluation,  as  regards  the  nature  and  intensity  of  the  various  painful
symptoms. ” (Bouhassira et al., 2004) .
Moreover a compendium of clinical assays has been systematically
used to  asses  neuropathic  pain  and/or  identify  the  underlying  disease  or
lesion  causing  it.  Standard  neurophysiological  assays  can  identify  and
quantify neuropathy. Laser evoked potentials, which specifically stimulate
pain  afferents,  are  used  as  diagnostic  tools  for  central  and  peripheral
neuropathic pain. Also punch skin biopsy can quantify the extent of skin
innervation and more specifically Aδ and C nerve fibres by measuring the
density of intra-epidermal nerve fibres (IENFD) (Cruccu and Truini, 2009). 
Other clinical tests include the Quantitative Sensory Testing (QST) a
test designed to measure response to controlled sensory stimuli. Usually Von
Frey filaments, i.e.  nylon filaments that will buckle elastically at a specific
force  measured  in  grams,  vibrameters,  i.e.  plates  vibrating  in  specific
frequencies, weighted needles and thermodes, i.e. a probe that can heat or
cool skin, are used in order to quantitatively assess thermal and mechanical
allodynia and hyperalgesia.
Although these tools can effectively assess pain, they cannot always
distinguish nociceptive from neuropathic pain. For that reason, several self
reported pain questionnaires and calendars have been introduced and used
extensively in pain studies aiming to screening neuropathic pain and assess
its intensity. The most well known of them which have been widely used by
medical doctors and researchers all over the world are DN4 (Bouhassira et
al., 2005), TCSS (Bril and Perkins, 2002), the 7-Day pain diary and  NPSI
(Bouhassira et al., 2004).
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Animal models of pain
In order to study neuropathic pain, to define its causes and develop
drugs,  several animal models have been developed.  Pain involves higher
brain functions and is subjective in both humans and other animals and as
we  discuss  below  the  measurement  and  assessment  of  pain  remain  a
challenge (Mogil et al., 2010). But at the molecular level, the interrogation
of certain molecular changes involved in nociception or in processes related
to  chronic  pain  are  well  conserved  (Khuong  and  Neely,  2013)  not  only
between  mammals,  for  example  mutations  in  TrkA causing  congenital
insensitivity  to  pain  in  human  were  first  discovered  in  Ntrk1-knockout
mouse  (Mogil,  2009),  but  also  between  distant  species  like  drosophila,
mouse and human (Neely et al., 2010). We should note that animal models
of pain are exactly models of pain, they model conditions and create pain
phenotypes  similar  but  not  identical  to  pain  experienced  due  to  diverse
origins.  Thus  when  using  these  models  we  should  be  very  careful  in
translating  molecular  findings  into  clinical  drugs.  Regarding  neuropathic
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Figure 3: Main rodent models of neuropathic pain. SNL involves the 
ligation of L5 and L6 spinal nerves, CCI involves a loose ligation of 
the sciatic nerve, PSNI involves the ligation of about half of the 
sciatic nerve and SNI involves the ligation of the tibial and peroneal 
branches while leaving the sural nerve intact or other combination of 
two ligated and one intact branch. Image courtesy of (Calvo et al., 
2012b) 
pain, animal models can produce neuropathic pain-like hypersensitivity or
other neuropathic pain-like behavioural.  
Most  of  them  involve  rodents,  usually  mice  and  rats,  and  emulate
neuropathy by inducing  nerve injury usually through a surgical process,
although  chemical  lesion  models  are  also  used.  These  models  aim  to
produce  a  reproducible  pain-behaviour  that  could  be  quantified  by
behavioural  tests.  The  well-induced  pain  states  measured  to  quantify
neuropathic  pain  are  heat-hyperalgesia,  mechano-hyperalgesia,  mechano-
allodynia  and  cold-allodynia  (Bennett  et  al.,  2003).  The  most  common
animal models of pain include the Chronic Constriction Injury (CCI), the
Partial  Sciatic  Ligation  (PSL),  the  Spinal  Nerve Ligation  (SNL),  Spared
Nerve Injury (SNI) and the Spinal Nerve Transection (SNT). In our study
we will mainly use data derived from mice and rats that have undergone the
SNT and SNI pain models and humans with diabetic neuropathy which is
related  to  neuropathy  and  neuropathic  pain.  An  overview  of  the  main
models of neuropathic pain evoked by peripheral nerve injury can be seen in
figure 3.
The  usage  of  animal  models  has  been  pivotal  for  our  further
understanding  of  pain.  As  described  above  by  inducing  sensory
abnormalities  in  animals  several  human  conditions  leading  to  pain  and
neuropathic  pain  can  be  modelled.  Thus  a  series  of  physiopathological
phenomena can be modelled by a diverse array of animal models, which
have been developed to model the diverse aetiology and manifestations of
neuropathic  pain  observed  in  humans.  Moreover  different  models  and
consequently  different  behavioural  assays  model  different  types  of  pain,
namely  acute  nociceptive  pain,  spontaneous  pain,  hypersensitivity  and
allodynia due to peripheral or central nerve injury, drug induces or disease
induced pain (Jaggi et al., 2011).    
As described above there is an ensemble of neurophysiological tools,
clinical protocols and self-completed questionnaires that can be used in a
research or clinical context in order to assess and quantify pain. Nonetheless
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these do not answer any reductionist question about possible causes of pain
in the molecular level, a question very relevant for scientific research, or
they do not identify any objective biomarker that could be used in order to
identify pain in the molecular level (Mogil, 2009). 
Animal models of pain can overcome limitations of experiments on
humans as research subjects in the field of pain. Usage of animals, which
have  undergone  some  invasive  or  pharmacological  process  in  order  to
facilitate  a  well  induced pain  state  has  been  essential  for  pain  research.
Additionally  well  replicated  controlled  experiments,  stratified  for  several
factors are much more feasible when using non-human animal models of
pain.  Moreover  we can harvest  tissue and carry  out  molecular  assays  in
order to understand transcriptional or translational changes in pain states,
where usually harvesting pain-relevant tissue involves dissection. 
Several  tests  have  been  introduced  to  measure  for  different
dimensions  of  pain.  Most  of  those methods involve the application of  a
noxious stimuli to a body part of the animal, usually a hind-limp, and then
the recording of a simple pain related behaviour that can be scored, usually
limp withdrawals. Of course behavioural tests can be much more complex
in order to score persistent pain, those tests involve long term recording of
normal behaviours like mating, looking for food, guarding, biting etc. Most
of the tests measure spinal reflexes or simple natural behaviours and are not
always relevant to pain per se (Mogil, 2009). Additionally, most of the tests
are  biased  towards  the  measure  of  hypersensitivity,  i.e.  allodynia  and
hyperalgesia,  because  they  record  and  score  evoked  responses  when  in
reality many patients with chronic pain suffer paroxysmal pain. As a matter
of fact, in this study we used Von Frey filaments which measure induced
hypersensitivity or allodynia after a pain model of peripheral neuropathy.
We  should  state  here  that  in  animal  models  of  pain  we  cannot
directly measure pain. Instead we can measure several behavioural aspects
indicating pain. On the other hand this is also the case for humans, as we
also rely on behavioural tests or questionnaires exploiting the advantage of
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linguistic  communication  between humans.  J.  Mogil  has  discussed  these
aspects of animal models of pain, presenting the advantages and drawbacks,
but generally highlighting the necessity of animal models in the research of
pain (Mogil, 2009; Mogil et al., 2010). In the current study we used rodent
models of pain, namely rats and mice.
 The Spinal Nerve Transection (SNT) Neuropathic Pain Model
As mentioned above one of the main models for neuropathic pain is
the  Spinal  Nerve  Transection  model.  According  to  that  specific  model
protocol  a  well-induced  pain  behaviour  is  imposed  on  the  animal  by  a
surgical injury to the Lumbar 5 or 6 of the Dorsal Root Ganglion. The injury
consists  of a  tight  ligation and transection of  the L5 or L6 spinal  nerve
(Bridges et al., 2001), figure 3. Thus the SNT model is a model of peripheral
neuropathy  which  leads  to  long-lasting  mechanical  and  thermal
hypersensitivity  as  well  as  to  hyperalgesia  (Bennett  et  al.,  2003).  As  a
control group it is possible to use animals which undergo only sham surgery.
In this case the spinal nerve is being exposed but not ligated. 
The Spared Nerve Injury (SNI) pain model
SNI is another well known model of pain that has been proposed in
order  to  achieve  a  well  induced  and  reproducible  neuropathic  pain
phenotype.  The  goal  is  to  produce  a  pain  model  which  results  in
reproducible  sensory  abnormalities  including  allodynia,  hyperalgesia  and
spontaneous bursts of pain  (Jaggi et al., 2011)  in a period of time broad
enough to allow extensive behavioural, clinical and molecular assays to be
implemented.  SNI  is  a  relatively  modern  model  of  neuropathic  pain,
proposed in 2000 by Decosterd and Woolf (Decosterd and Woolf, 2000). In
this  model  two  of  the  sciatic  nerves  are  axotomised  and  one  is  left
untouched, i.e. spared, thus the model's name Spared Nerve Injury. In order
for the model to be implemented correctly huge caution is needed in order to
not  injure  the  untouched  nerve.  Different  combinations  exist,  tibial  and
common peroneal axotomised and sural  spared or the other way around.
Sparing  the  tibial  branch  (figure  4)  produces  consistent  and  robust
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mechanical  allodynia  without  increasing  heat  sensibility  (Shields  et  al.,
2003). 
Gene Expression
The Central Dogma
As Francis  Crick  states  in  his  seminal  paper  “Central  Dogma of
Molecular Biology” (Crick, 1970) the flow of genetic information could be
formulated as follows: DNA is transcribed to RNA which is consequently
translated to Proteins. Similarly, in F. Crick’s words, “The central dogma of
molecular  biology  deals  with  the  detailed  residue-by-residue  transfer  of
sequential information. It states that such information cannot be transferred
back from protein to either protein or nucleic acid.”.
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Figure 4: SNI pain model, the common peroneal and sural nerve branches 
are axotomised. The tibial nerve is spared.
The  central  dogma  of  molecular  biology  describes  the  flow  of
genetic information within a biological system as follows: DNA replicates
itself, DNA is transcribed to RNA, then RNA is translated to protein. The
unit of heredity that codes for a protein is defined as a gene. Yet a very small
percentage of a genome actually codes for proteins. In this study we will
also  study  sequences  which  are  transcribed  but  not  translated  into
polypeptides. More specifically we will deal with a subclass of non-coding
RNA. The vertebrate's genome is transcribed into a large repertoire of non-
coding RNAs. Most of them are small and this class of small RNA includes
the small  nuclear/  nucleolar RNA (sn/snoRNA), the miRNA, siRNA and
piRNA all of which generally regulate expression activity. There are also the
classes  of  ribosomal  RNA (rRNA) and transfer  RNA (tRNA).  The class
which we will study more in depth is that of long non-coding RNAs, these
are non-coding RNAs which are more than 200bp long.
Long Non-coding RNAs (LncRNAs)
Although LncRNAs is a topic that attracts a lot of focus in current
research  there  is  not  a  general  and  unambiguous  way  of  defining  and
identifying  them  (Kapusta  and  Feschotte,  2014).  Recent  papers  have
proposed bioinformatics strategies to identify transcripts of LncRNAs but
they use slightly different definitions and properties for them. One of the
main properties of LncRNAs is that they are mainly defined by a set  of
negative traits  (Ulitsky and Bartel, 2013) like non-coding for proteins and
not belonging in other families of small non protein coding RNAs. 
Long  non-coding  RNAs  can  be  intergenic,  antisense  i.e.  on  the
opposite strand of protein coding gene models overlapping any exon, sense
overlapping i.e. overlapping introns and exons of a protein coding gene and
producing a non-coding transcript, intronic i.e. completely nested within an
intron of a protein coding gene or divergent i.e. when its transcription is
initiated by a bidirectional promoter common with a protein coding gene in
very close genomic proximity.  
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In  the  rest  of  our  study we refer  to  Long Non-Coding  RNAs as
LncRNAs, and we specifically focus on intergenic ones, namely between
known  protein  coding  gene  models,  and  antisense  ones,  namely  on  the
opposite  strand  of  known  gene  models.  Thus  we  classified  LncRNAs
according  to  their  genomic  context  while  acknowledging  that  LncRNAs
could also be classified by non-mutually exclusive criteria according to their
chromatin  content,  subcellular  localization,  structures  and  function.  We
should  also  note  that  different  studies  propose  slightly  different  names,
which describe the same classes of LncRNAs (Harrow et al., 2012; Ponting
et al.,  2009; Ulitsky and Bartel,  2013, 2013). Using the genomic context
classes, presented in the comprehensive review papers “Volatile evolution of
long noncoding RNA repertoires, mechanisms and biological implications”,
“Evolution  and  Functions  of  Long  Noncoding  RNAs”,  “lincRNAs:
Genomics, Evolution and Mechanisms” we focus on what are consistently
described as intergenic and antisense LncRNAs (Figure 5).
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Figure 5: Classification of LncRNAs according to genomic context. (Kapusta and Feschotte, 2014)
The main characteristic of the LncRNAs is that they are usually 5'
capped, non-protein coding, polyadenylated transcripts of more than 200bp
long.  They  are  usually  multi-exonic  even  though  they  do  not  code  for
proteins. Various studies, including the GENCODE annotation comprising
of manually curated and predicted gene models, show that they usually have
two  exons  (Harrow  et  al.,  2012;  Ilott  and  Ponting,  2013;  Marques  and
Ponting, 2014; Ponting et al., 2009; Young et al., 2012), which are slightly
longer than those of protein coding genes. In mammalian genomes several
studies  have  predicted  vast  quantities  of  LncRNAs  and  pervasive
transcription,  1%  of  human's  genome  codes  for  the  exonic  parts  of
LncRNAs  alone,  although  different  methods  and  criteria  produce  highly
divergent catalogues of LncRNAs. Some catalogues are thought to have a
significant percentage of putative LncRNAs produced by computational or
experimental artefacts, namely pseudogenes, mRNA precursors, sequencing
noise  in  the  form  of  scattered  mono-exonic  transcripts  or  genomic
contamination (Ponting et al., 2009). 
Less  than  10%  of  the  human  genome  encodes  for  mRNAs  and
spliced non-coding RNAs, out of this only 1% encodes for proteins, leaving
about  9% transcribed  into  non-coding  transcripts  but  with  yet  unknown
function  (Ponting et al., 2009), it is also thought that at some point every
single genomic base of most mammalian organisms would be transcribed
(Marques  and  Ponting,  2014).  In  addition  about  30% of  protein  coding
genes have a natural antisense transcript in the opposite DNA strand. It is
such the extent of non-exonic, non-canonical transcription that in our dataset
only about 20% if RNA-seq reads were mapped to annotated exons.
LncRNAs  are  thought  to  have  different  roles  in  regulating  gene
expression (Marques and Ponting, 2014) although due to the general lack of
conservation most of them are thought to be non-functional  (Ulitsky and
Bartel,  2013).  The  functional  ones  can  regulate  expression  in  cis,  i.e.
regulating neighbouring genes, or in trans, i.e. regulating distal genes.  In
addition some of the non-functional ones may regulate gene expression by
just being transcribed in the first place, where the transcription itself can
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interfere with chromatin changes or with the transcriptional machinery itself
which in turn regulate gene expression. In that case the transcription itself
regulates expression and not its product (Ulitsky and Bartel, 2013). 
In terms of sequence conservation they are under modest negative
selection with a very low average selective constraint. On the other hand,
although they are not usually conserved across species, they show syntenic
conservation  as  they  can  be  found  in  genomically  equivalent  positions
across different species. Usually less than 5% of their sequence is conserved
(Marques and Ponting, 2014) and that leads to the hypothesis that even a
very small  fraction of sequence can be enough to retain function for the
functional ones. 
In terms of expression levels they are notoriously lowly expressed,
they can have a median expression 10 fold lower than that of protein coding
genes (Ilott and Ponting, 2013; Marques and Ponting, 2014; Ponting et al.,
2009;  Ulitsky  and  Bartel,  2013).  In  addition  they  have  very  diverged
expression patterns, their expression is highly cell type and developmental
stage specific, thus it is hypothesized that they contribute to the diverged
pattern of transcriptional changes emerged (Marques and Ponting, 2014). 
Given all  these features,  it  is inherently difficult  to identify novel
LncRNAs.  Very  indicative,  different  studies  have  described  sets  of
LncRNAs with very low overlap. For example GENCODE’s (Harrow et al.,
2012) human annotation, which has the most annotated LncRNAs, shows
very modest overlap with other  studies.  Namely 42% of the GENCODE
LncRNAs intersect with the database lncRNAdb (Amaral et al., 2011) and
39% with the catalogue published by Cabili (Cabili et al., 2011). 
Young  et  al  (Young  et  al.,  2012)  predicted  119  LncRNAs  in
drosophila  while  the  modEncode  project  (Brown  et  al.,  2014)  collected
evidence  for  3504  transcribed  regions.  From  those  datasets  only  246
LncRNAs gene models  could  be constructed.  This  is  a  result  of  several
technical difficulties such as the very low expression of the transcripts, lack
of data for the Transcription Start Site (TSS), poor genome annotation, high
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tissue specificity of the transcript etc. In human GENCODE v13 (Harrow et
al., 2012), the reference human annotation from the ENCODE/ENSEMBL
team,  predicted  12393 LncRNAs while  Cabili  et  al  (Cabili  et  al.,  2011)
predicted 8263. Only 4343 LncRNAs are common in these sets, this lack of
agreement again arises from some of the barriers presented above.
In  addition  there  is  limited  overlap  and significant  differences  in
gene models annotated by ENSEMBL/GENCODE (Yates et al., 2016) and
RefSeq  (Pruitt et al., 2014) consortia. For these reasons there is group of
studies  which  have  focused  only  in  LncRNAs  showing  some  splicing
activity  in  order  to  control  for  RNA-sequencing  noise  or  genomic
contamination, or in certain sub classes of LncRNAs, i.e. only lincRNAs
(Marques and Ponting, 2014; Ulitsky and Bartel, 2013). In addition, as there
are no sequence or genomic characteristics that can be directly used  to infer
function, a divergent expression profile and transcriptional changes under
certain conditions, cell types or developmental stages are good indicators of
functional LncRNAs (Ponting et al., 2009) .  
The review of Ponting and Illott (Ilott and Ponting, 2013) presents a
comprehensive analysis of the main methods for predicting long non-coding
RNAs  using  RNA  sequencing.  The  classic  workflow  for  predicting
LncRNAs  is  described  as  follows:  After  RNA  extraction  and  library
preparation  comes  sequencing  by  synthesis.  During  sequencing,  strand
information can be either retained or not, while reads can be paired-end or
single-end.  Then  reads  are  aligned  to  a  reference  genome.  In  order  to
remove protein coding transcripts all the known, annotated genomic regions
which are included in one or more reference gene sets are excluded. This is
followed  by  the  identification  and  assignment  of  reads  to  what  we  call
islands of expression, namely genomic regions outside gene models which
accumulate  reads  over  a  certain  threshold,  or  Transcriptionally  Active
Regions  (TARs)  (Gerstein  et  al.,  2014).  We should  note  here  that  these
islands  of  expression  could  be  either  non-coding  RNAs,  yet  unknown
protein coding genes, erroneously mapped reads to the genome, sequencing
artefacts  or  genomic  contamination.  Thus  every  pipeline  for  identifying
32
LncRNAs from RNA-sequencing uses a lot of filtering downstream of the
identification  of  TARs  or  islands  of  expression.  The  next  step  involves
selecting transcripts by their size, usually more than 200bp length. As we do
not have annotated gene models it  is only possible to identify Islands of
Expression that are likely to represent novel exons, or groups of novel exons
in close proximity so as to retain a certain coverage threshold. Subsequently
the sequences of the above transcript set are fed into algorithms that assess
their coding potential. 
Another way to reconstruct gene models is to perform a complete
transcriptome assembly and then to discard transcripts derived from known
protein coding gene models. There are tools like Cufflinks (Trapnell et al.,
2012), Scripture  (Guttman et al., 2010) and StringTie  (Pertea et al., 2015)
which  use  a  splice  graph  to  identify  transcripts  and  can  reconstruct  the
whole  transcriptome  relying  on  RNA-sequencing  data  and  a  genome
assembly (Ilott and Ponting, 2013). StringTie was released in 2015, after the
completion of most  of the study presented in  this  thesis  and despite  the
existence  of  the  two  other  methods,  most  of  the  studies  aiming  to  the
identification  of  LncRNAs  have  developed  some  computational  pipeline
tailor made to the exact task of the identification of LncRNAs  (Xu et al.,
2016).  Although  Cufflinks  has  been  used  in  a  lot  of  studies  aiming  to
identify novel isoforms, it does not produce an annotation which is suitable
for count based RNA-seq analysis at the gene level. As a matter of fact, its
transcriptome reconstruction step produces a set of transcripts with FPKM
scores assigned to them and calculates DE based on those scores. Thus its
output can only be analysed by Cuffdiff (Trapnell et al., 2012).
In general, these tools focus on extending the known annotations, so
they can identify un-annotated isoforms. Then, they produce a set of full-
length transcripts,  but they are computationally expensive as they do not
focus only on identifying novel LncRNAs. All these are not drawbacks of
those methods, but rather direct consequences stemming from the original
aim of reconstructing the whole transcriptome and not just identifying novel
LncRNAs. There are also tools that can de-novo assemble RNA-seq reads to
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perform a whole transcriptome reconstruction, but these de-novo assemblers
are  not  well  suited  for  identifying  LncRNAs  as  they  are  very  lowly
expressed (Ilott and Ponting, 2013).
Recently  numerous  studies  reported  pervasive  transcription  to  be
prominent at similar levels in most species (Gerstein et al.,  2014). As an
example  32% in  Human,  36.9%  in  Worm  and  34.5% in  fly  sequenced
genomes  were  transcribed  into  transcriptionally  active  regions  of  no-
canonical transcription excluding all classes of annotated non-coding RNAs,
mRNAs and pseudogenes. The authors call the Islands of Expression where
non-canonical,  non-protein  coding,  transcription  takes  place
Transcriptionally Active Regions (TARs). That is an accurate description of
the regions able to be identified using RNA-seq for analysing non annotated
parts of a genome.
In our study we used the term Islands of Expression for these regions
and we found that 30% of our RNA-seq reads were mapped to yet unknown
parts of the genome. Regarding annotated genes, 21857 ENSEMBL genes
were expressed in mouse DRG, associated with 86525 transcripts,  out of
which 42685 (49.33%) were non-coding transcripts  of various classes on
non-coding RNAs. 
 Several thorough studies aiming at the identification of LncRNAs
give us insights about the details of the relevant bioinformatics pipelines and
produce  an  indirect  but  comprehensive  set  of  properties  which  define
LncRNAs. For example in studies including the “Integrative annotation of
human  large  intergenic  noncoding  RNAs  reveals  global  properties  and
specific subclasses”(Cabili et al., 2011) and “Identification and Properties of
1,119  Candidate  LincRNA  loci  in  Drosophila  melanogaster  genome”
(Young et al., 2012), the main defining feature of LincRNAs is that they are
long transcripts of more than 200bp and 1kb on average, with very small or
no coding potential. They are on average shorter than coding gene models,
simpler and with fewer exons, but most of them are multi-exonic. They are
expressed in  lower levels than protein-coding genes.  Additionally  studies
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like the “Comparative analysis of the transcriptome across distant species”
(Gerstein  et  al.,  2014)  present  a  comprehensive  pipeline  for  identifying
transcriptionally  active  regions  and  predicting  LncRNAs from chromatin
signatures. Another approach is to use supervised predictions i.e. to build
classifiers which integrate all those different features to distinguish actual
LncRNAs from false positives. However these approaches can only detect
about 10% of actually present transcripts in Human (Gerstein et al., 2014).
These  results  suggests  that  whole  new classes  of  LncRNAs might  exist.
Moreover  studies  like  the  “Diversity  and  dynamics  of  the  Drosophila
transcriptome”  (Brown  et  al.,  2014)  present  us  with  methods  for
reconstructing LncRNAs gene models.
Although,  as  discussed  above,  databases  and  annotated  sets  of
LncRNAs have been disseminated for various species, like Human, Mouse,
Fly and Worm, those classes of annotated LncRNAs may dramatically differ
from  the  novel  islands  of  expression,  or  TARs,  identified.  This  finding
suggests that there might be a huge repertoire of functions and expression
profiles in non-coding RNAs yet to be discovered.
Functional repertoires of LncRNAs
As we previously  discussed certain  features  of  LncRNAs suggest
that  most  of  them are  non-functional.  Also  it  is  hypothesized  that  cells
transcribe  regularly  and  then  control  expression  mostly  post-
transcriptionally.  From  an  evolutionary  perspective  there  is  no  point  of
spending energy in order to stop transcription of DNA as protein abundance
or abundance of non-coding RNAs can be post-transcriptionally regulated or
non-functional  transcripts  can  degrade  rapidly  without  any  consequence
(Ulitsky and Bartel, 2013).  Nevertheless a set of functional LncRNAs with
diverse  functions  and even more  diverse  ways of  functioning have been
identified. Recent studies  (Ponting et al.,  2009; Ulitsky and Bartel,  2013)
have  highlighted  the  diverged  repertoire  of  mechanisms  through  which
LncRNAs can regulate gene expression directly or indirectly, in cis or in in-
trans. Most of the functional LncRNAs are multi-exonic but two of the most
well known ones are long mono-exonic transcripts. Malat1 is involved in
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the organization of nuclear speckle domains and Neat1 is essential for para-
speckle  formation,  its  expression  is  also  induced  in  mouse  brains  after
infection from Japanese encephalitis virus. Hotair  is transcribed from the
HOXC  gene  complex  but  regulates  and  silences  the  expression  of  the
HOXD genes which lie on a different chromosome. All those LncRNAs are
examples of functional in-trans transcriptional regulators.
Some  very  well  known  LncRNAs  are  found  to  regulate  gene
expression in-cis. Evf2 regulates Dlx5 and Dlx6 genes involved in neuronal
differentiation.  Xist  is  essential  in  the  inactivation  of  X chromosome in
eutherian mammals. It functions in a similar fashion to Kcnq1ot1, Air and
Nespas which are necessary for the epigenetic gene silencing of imprinted
genes  in  their  clusters  which  have  close  proximity.  They  are  all  long
transcripts with very little splicing and long exons. LINoCR activates the
LYZ gene by its transcription. Its transcription per se activates an upstream
enhancer by unbinding CTCF from a local insulator. PTENP1, which has
derived from accumulated mutations after a duplication event of the PTEN
known onco-gene, regulates the expression of PTEN and loss of function
mutations are associated with cancer. Pbcas4, which is conserved in rodents,
is predicted to act as a competing endogenous RNA where it antagonises
with certain mRNAs for binding to specific miRNAs. SRG1 acts through
transcriptional  interference.  Its  transcription  through  the  promoter  of  the
SER3 gene suppresses the ability of the promoter to initiate transcription of
the protein coding gene. Moreover a set of LncRNAs upstream of the fbp1
gene when transcribed change the chromatin structure and allow for  the
transcription of the fbp1. 
In addition a set of protein binding LncRNAs  bind to transcription
factors, like LncRNAs upstream of the CCND1 gene and upstream of the
DHFR gene, and suppress expression of protein coding genes.   
A special class of LncRNAs is the antisense LncRNAs, which lie on
the  opposite  strand  of  protein  coding  genes.  Antisense  LncRNAs  can
overlap some of the genomic regions of the gene model on the opposite
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strand to various extents and they can regulate its transcription. Progression
of transcription of a pair of protein coding gene and antisense LncRNA can
be convergent or divergent.  Furthermore LncRNAs can be regulated by a
bidirectional  promoter,  i.e  a  common  promoter  with  the  sense  protein
coding  gene  in  divergent  transcription.  Or  they  can  be  regulated  by  a
polymerase II  complex which transcribes the LncRNA convergently with
the protein coding gene on the opposite strand (Albrecht and Ørom, 2016).
In  terms  of  regulatory  characteristics,  transcription  of  a  LncRNA can
activate the transcription of a protein coding gene on the opposite strand
(Albrecht and Ørom, 2016) or it can silence by producing a ncRNA which
acts as a competing endogenous RNA for the protein coding gene’s mRNA
(Han and Jan, 2013).
Known pain-related LncRNAs
Recently  a  number  of  studies  have  been  published  regarding  the
functional repertoires of LncRNAs in the context of pain. In 2013 Zhao et al
(Zhao et al., 2013) identified a natural Kcna2 antisense LncRNA in DRG
neurons. This natural antisense transcripts has been identified in rat, mouse,
monkey and human and suppresses  the expression of the Kcna2 gene,  a
voltage gated potassium channel. The antisense LncRNA is upregulated in
peripheral nerve injury that causes neuropathic pain. On the other hand the
protein  coding Kcna2 is  downregulated  after  nerve  injury  in  mice.  That
distinct opposite expression pattern and the fact that most of the antisense
Kcna2 overlaps most of the region of the protein coding gene suggest that
the  LncRNA  regulates  in  cis  the  expression  of  Kcna2.  This  KCNA2
antisense  LncRNA is  the  only  known  LncRNA  that  is  proven  to  be
functionally  involved  in  neuropathic  pain.  It  is  expressed  only  in  DRG
tissue, in rat, mouse, monkey and human. It is also very lowly expressed,
compared  to  Kcna2  mRNA.  The  main  factor  that  induces  the  Kcna2
antisense  LncRNA after  nerve  injury  is  the  MZF1  transcription  factor,
belonging to the family of zinc finger proteins  (Marie Lutz et al., 2014).
This LncRNA can be an endogenous trigger in neuropathic pain as nerve
injury induces its expression, which in turn reduces the expression of Kcna2
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mRNA resulting in an increase of ectopic activity in large and medium DRG
neurons (Marie Lutz et al., 2014).
In 2016 Wu et al (Wu et al., 2016), analysed the whole transcriptome
of rat’s DRG after the SNL pain model. The identified a huge amount of
significantly DE genes (about 30%) and also they identified 944 non-coding
RNA significantly  DE.  These  ncRNAs  are  mainly  intergenic  RNAs and
antisense RNAs.
In 2015 Jiang et al  (Jiang et al., 2015) identified 511 differentially
expressed LncRNAs in the spinal cord of mice after the spinal nerve ligation
neuropathic  pain  model.  35  of  those  LncRNAs  had  neighbouring  or
overlapping significantly differentially expressed protein coding genes.
In  2015  Koenig  et  al  (Koenig  et  al.,  2015) identified  a  natural
SCN9A antisense transcript in DRG conserved in human and mice.  This
antisense  LncRNA is  expressed  in  similar  tissues  like  SCN9A,  a  gene
coding for one part of the Nav1.7 sodium channel.  The antisense LncRNA
has  long  overlapping  regions  with  the  protein  coding  gene  and  down-
regulates the gene on the opposite strand. However the authors report that
there is no significant DE of the gene nor the antisense LncRNA in animal
models of pain.
Overview of computational pipelines for identifying LncRNAs
As more and more studies for LncRNAs are getting published and
more  LncRNAs  are  being  identified  there  is  an  emerging  need  for  data
repositories and standardized computational pipelines regarding LncRNAs.
Currently  there  are  24  distinct,  published  annotation  pipelines  for  the
identification  of  LncRNAs  (Xu  et  al.,  2016).  The  majority  of  them are
independent studies, focused on a specific organism or a specific biological
process  and  dealing  only  with  one  kind  of  high  throughput  molecular
biology data. There are also pipelines developed as part of more complex
gene annotation consortia like NONCODE  (Xie et al., 2014), LNCipedia,
GENCODE (Harrow et al., 2012). 15 out of those 24 annotation resources
use RNA-seq as the main data  source.  More specifically  the majority  of
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them use  ab initio assembly, where reads are first mapped to a reference
genome, paired end-reads, a minimum length threshold of 200bp, a filter
which  filters  out  mono-exonic  transcripts,  a  coverage  threshold  and  a
method  to  assess  coding  potential.  Some  studies  do  incorporate  other
sources  of  data  like  ChIP-sec  and/or  epigenetic  signals.  In  terms  of
databases  there are  15 distinct  publicly available  databases  of  LncRNAs
which  are  populated  by  data  annotated  mainly  for  the  computational
pipeline briefly presented above. Xu  (Xu et al., 2016) and Illot and Ponting
(Ilott  and  Ponting,  2013) have  published  very  comprehensive  reviews
regarding those computational resources.  In this study, in chapter Methods
for identifying LncRNAs and analyse RNA-sequencing data we present a
computational  pipeline  that  identifies  novel  LncRNAs  using  RNA-
sequencing data. The main advantage of the proposed pipeline is that it has
been specifically developed for the identification of novel LncRNAs and not
all novel isoforms. Thus its is efficient and not computationally expensive
and  more  importantly  it  does  not  rely  on  the  FPKM  metric  to  assess
transcription  strength,  but  it  rather  produces  predicted  gene  models  of
LncRNAs  suitable  for  downstream  analysis  with  the  proper  framework
regarding calculation of differential expression.
RNA-Sequencing
RNA-seq  is  a  next-generation  sequencing,  or  sequencing  by
synthesis method. It is used both for Differential Expression (DE) analysis
and  to  identify  unknown  genes  or  non-coding  genomic  regions  i.e.
transcribed  loci  that  do  non  encode  for  proteins  (Trapnell  et  al.,  2010;
Weikard  et  al.,  2013).  Due  to  recent  developments  in  next  generation
sequencing and particularly in RNA sequencing, we are now able to identify
genes and previously un-annotated transcripts,  such as LncRNAs, and to
estimate their expression levels at the same time (Cabili et al., 2011; Young
et  al.,  2012).  These  Long  non-coding  transcripts,  which  might  have  a
regulatory role in gene expression, are the focus of much recent research
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which aims to identify them in different species and infer their functional
role.
Briefly RNA-seq involves the conversion of RNA, in whole or an
enriched  subset  of  RNA,  to  a  library  of  complementary  DNA (cDNA)
fragments with specific strings of nucleotides, i.e.  adaptors, attached at both
ends. Then these fragments are amplified and each molecule is sequenced
by synthesizing the complementary sequence from one end in single-end
protocol or from both ends in paired-end protocol. This is a high-throughput
process which generates numerous short reads with lengths varying from 50
to 400 bp (Wang et al., 2009). 
Following the amplification and sequencing steps RNA-seq involves
the  de novo or  ab initio assembly of multiple short reads of cDNA. The
transcriptome can be assembled and analysed by sequencing those double
stranded cDNA fragments reversely transcribed from RNA in the case of the
de  novo assembly,  or  reads  could  be  mapped  onto  known  genome
assemblies in the case of the ab initio assembly also known as a map-first
strategy.  Ab  initio assembly  can  reduce  the  computational  burden  of
transcriptome  reconstruction  and  it  can  produce  more  accurate  results.  
Thus,  one  of  the  obvious  advantages  of  this  high  throughput
sequencing technology, by contrast to micro-array probes, is that it does not
depend on an  a priori knowledge about the transcriptome and thus makes
possible both the identification of yet unknown gene models or the de novo
genome assembly for organisms with yet unknown genomes (R. Li et al.,
2009;  Mak,  2011).   Most  RNA-seq  studies  rely  on  ab  initio analysis
methods, where reads are first mapped on a known genome assembly.   
RNA-seq  analysis  usually  involves  counting  and  mapping  of  the
numerous short reads. Hence it is considered a count-based method. When
used for  detecting  fold changes  in  expression of  RNA between different
conditions  RNA-seq  can  quantify  changes  over  8000  fold  with  low
background noise. It can detect different isoforms, splicing events and lowly
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expressed  transcripts  (Wang  et  al.,  2009).  An  overview  of  the  RNA-
sequencing procedure is provided in Figure 6. 
RNA isolation and library construction
In order to carry out RNA sequencing we need to extract RNA from
tissues of interest  and produce a sequencing library.  Library construction
involves several steps and manipulations and is generally considered to be
the  step  in  RNA-seq  which  introduces  most  of  the  undesired  variance
(Seqc/Maqc-Iii Consortium, 2014). 
The two most common methods are phenol extraction and column
purification, but a lot of labs have developed hybrid protocols combining
these two methods.  A hybrid method of combined phenol  extraction and
column purification can be used with excellent results (Bartus et al., 2016).
According to this  method two steps of RNA isolation and extraction are
carried out, resulting in sufficient yield of high quality pure RNA. Tissue is
first  homogenized and then mixed with chloroform following the phenol
extraction  method.  After  centrifuging,  the  rest  of  the  aqueous  liquid
containing the nucleic acids, which stays on the top of the tube, should be
removed. This solution is then subjected to the column purification method.
RNA is then extracted and all samples are subjected to on-column digestion
in order to prevent genomic contamination i.e. presence of DNA in the RNA
samples. 
The concentration of RNA in the samples is first measured using a
nanodrop and if quantity and quality of samples is found to be good the
sample is sequenced. Then  a  sequencing  library  of  complementary  DNA
(cDNA) is constructed using a stranded or un-stranded protocol. The strand-
specific (deoxy-UTP strand-marking protocol) dUTP protocol (figure 7) is
the  leading  protocol  for  strand-specific  synthesis  of  cDNA.  The  main
features of the dUTP strand specific protocol are the incorporation of deoxy
- UTP when synthesizing the second strand and the subsequent destruction
of the remaining uridine - containing (dNTP) strand in the library. Thus after
synthesizing the first  strand of cDNA, dNTP is  removed and the second
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strand cDNA is then synthesized using dUTP. In this way the polarity of the
transcripts  is  revealed  (Parkhomchuk et al.,  2009).  In dUTP protocol the
reads  produced have  reversed  strandedness/direction,  thus  this  should  be
taken into account for downstream analysis. Namely strandedness of reads
should be reversed before counting.
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Figure 6:  Overview of RNA-sequencing 
Total RNA or mRNA (blue line) is purified and ribosomal RNA is depleted or 
poly-adenylated RNA is selected.  The selected fraction of RNA is fragmented 
and then reverse transcribed into cDNA and amplified. Afterwards, sequence 
adaptors (blue rectangulars) are attached to fragments, the protocol could be 
stranded or un-stranded. The library of cDNA is PCR-amplified and then 
sequencing starts from one end or both ends. 
Potentials and drawbacks
Despite its obvious benefits, RNA-seq has some drawbacks which
can  create  noisy  results.  Most  of  the  noise  is  usually  introduced  in  the
library  preparation  step  but  there  are  also  significant  bioinformatic
challenges. First, the reads cannot always be unambiguously mapped to a
certain  genomic  region  due  to  repetitive  sequences  or  erroneous  base
calling. On the other hand, some reads cannot be mapped at all because of
certain differences in the sequence between the sample and the reference
genome.  This  problem  can  become  more  severe  in  less  well-annotated
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Figure 7: Overview of the dUTP strand specific protocol (Parkhomchuk et 
al., 2009)
genomes, like the rat genome, with a lot of unknown SNPs and with a poor
estimation of the genomic variation in general. Gapped aligners like Top-
Hat 2 and STAR (Dobin et al., 2013; Trapnell et al., 2012)  can overcome
this particular problem by allowing sub-strings of the read to be optimally
mapped on the genome. This approach can facilitate either reads falling into
splicing junctions or reads having differences in certain bases compared to
the reference genome assembly. 
Another  problem,  which  could  lead  to  overestimation  of  the
expression of genes is that if a few genes in the sample are too abundant
then  they  could  use  all  the  available  reads  of  the  given  read  depth.  In
addition small variances in the counts of lowly expressed genes, i.e. genes
with low counts can produce very high log fold changes and gene counts
cannot be directly comparable if they are the product of unequal sequencing
libraries.  These  problems  have  led  to  the  development  of  several
normalisation methods that usually shrink the fold changes in some way.
These methods usually scale the counts of each gene or genomic region by
an estimation of the specific library size and estimate log fold changes by
moderating  them according  to  the  general  trend  of  changes  observed  in
genes of similar expression strength. 
We should note here that there are various methods for the analysis
of  RNA-sequencing  data.  One  is  the  normalised  count  based  approach
(Anders et al., 2015; Love et al., 2014) where read counts represent relative
transcript  abundance for  the scope of downstream differential  expression
analysis and another is an approach where read counts are normalised by the
transcript length, the read length and the library size, i.e. total number of
mapped reads, and transformed into a score named Fragments Per Kilobase
of exon per Million mapped reads (FPKM) or Reads Per Kilobase of exon
per  Million  mapped  reads  (RPKM),  representing  expression  strength
(Trapnell et al., 2012).
Additionally,  some  early  studies  showed  that  for  RNA-seq  read
depth  is  much  more  important  than  biological  or  technical  replicates
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(Seqc/Maqc-Iii Consortium, 2014). Recently, more advanced data analysis
approaches  show  that  biological  replication  gives  us  significantly  more
experimental power than increasing the read depth above a threshold (Liu et
al., 2014). Additionally biological replicates drastically reduce intra-sample
variation  and  marginalise  systematic  biases  (Seqc/Maqc-Iii  Consortium,
2014). A comprehensive assessment of RNA-seq also reveals that most of
the biases are not due to specific sequence characteristics, like the transcript
length or the GC content of a particular genomic region. Rather, most of the
data  variability  is  attributable  to  library  preparation  (Seqc/Maqc-Iii
Consortium, 2014; Xu et al., 2016). 
Combining  this  with  the  sources  of  technical  variation  presented
above,  we  can  conclude  that  RNA-seq  cannot  be  considered  a  robust
method for estimating absolute transcript abundances, but rather a method
for  quantifying  relative  abundance  differences,  namely  Differential
Expression (Łabaj and Kreil, 2016; Rapaport et al., 2013). Moreover RNA-
seq is considerably better  than microarrays when it  is carried out with a
sequence depth of 50 million reads or more.  A recent review (Perkins et al.,
2014) comparing  RNA-sequencing  to  exon  arrays,  when  assessing
transcriptional changes in the context of the SNT  pain model in rat, showed
that, although both methods agree in the genes they found to be significantly
differentially expressed, RNA-sequencing clearly outperforms exon arrays.
It  has  much  better  sensitivity  in  detecting  lowly  expressed  genes,  an
attribute  which is  increased by increasing the read  depth;  a  significantly
higher dynamic range of fold changes and the ability to interrogate a much
larger proportion of the genome and also to detect novel genes. All these
desirable features can be extended by increasing the read depth and adding
biological  and  technical  replicates.  Although,  in  terms  of  consistency
between  experiments  carried  out  in  different  labs,  RNA-sequencing  is
inferior  to  microarrays  if  we  consider  only  genes  with  higher  log  fold
changes (Seqc/Maqc-Iii Consortium, 2014). In addition, interestingly one of
the most widely used RNA-seq data analysis pipelines, mostly due to its
simplicity and ease of use, the “tophat 2 + cufflinks” pipeline is found to
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show  the  worst  consistency  amongst  all  other  RNA-  seq  pipelines  and
microarrays. This pipeline is heavily relying on the transcription strength
FPKM / RPKM score paradigm. In general  the count  based approach is
better  suited  for  differential  expression  analysis  while  the  FPKM/RPKM
approach can be used to estimate absolute transcript abundance in a tissue or
cell line (Anders et al., 2015; Love et al., 2014; Seqc/Maqc-Iii Consortium,
2014).
Statistical  analysis  of  RNA-seq  data  is  not  trivial  and  requires
biological replicates, normalization and gene filtering. These findings also
suggest that DE results should be prioritized not solely by p.value but also
by the size of the effect, namely by fold changes between samples. Other
bioinformatic challenges arise from the sheer amount of data RNA-seq can
produce and also due to the increasing complexity of the gene models to
which reads should be assigned. 
Analysing RNA-sequencing data
This  study involves analysis  of  RNA-seq datasets  associated with
pain  and  particularly  neuropathic  pain.  In  this  section  we  will  briefly
describe the main steps for analysing RNA-seq count data. This paragraph
will give an overview, of steps which will be covered in more detail in the
following chapters.
After mapping raw reads to a reference genome using an aligner we
can  acquire  counts  for  specific  features.  A feature  is  represented  by  a
genomic interval, a chromosome, a start and end position and the strand.
Usually features are protein coding gene models and non coding transcripts
like  gene  models  of  novel  LncRNAs.  Genomic  features,  like  genes,  are
comprised  of  exons,  introns  and  untranslated  regions  (UTRs).  Different
combinations of these, produce numerous transcripts arising from the same
gene. As exons are the features of a gene model that are part of the mature
RNA, after  the introns  have  been removed during  splicing,  we calculate
relative gene abundance by calculating the number of RNA-seq reads (or
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pairs  of  reads  when dealing  with  paired-end sequencing)  overlapping its
respective exons.
The aim of the study involving RNA-sequencing data analysis also
dictates what might be the best method for assigning a distinct numerical
score to those gene models in order to quantify transcript abundance. As we
briefly discussed above, there are two broad families of methods. One is
more appropriate for identifying absolute expression strength and the other
is  more  appropriate  as  a  first  step  in  an  analysis  aiming  to  identify
significant  changes  in  relative  transcript  abundance,   i.e.  differential
expression. 
The  first  method  calculates  a  score,  usually  normalised  reads  or
ffragments  per  kilobase of  transcript  per  million mapped reads  using  all
available  reads,  which  ideally  should  represent  the  number  of  cDNA
fragments found in a sample, while the second method retains only reads
which carry information in order to accurately assess statistical significance
and log fold change between different conditions using a table of counts. We
used the latter read-filtering and count-based approach as we were interested
in  identifying  genes  significantly  differentially  expressed  between
conditions of interest and not in performing an absolute quantification of
expression strength, an elusive task as we discussed above. 
Counting RNA-seq reads for DE analysis
A count-based RNA-seq analysis  involves two steps.  First,  in  the
counting step a table of counts is calculated, which stores the raw number of
sequencing  fragments  (single  reads  or  pairs  of  reads)  that  overlap  each
feature of an annotation for each sample. Then, reads are normalised and
statistical analysis quantifies the expression differences between conditions
of interest and assesses whether differences in the amount of reads between
different conditions reach statistical significance.  
Counting  reads  for  DE  analysis  needs  specific  approaches  as
repetitive  sequences,  wrong  base  calling,  overlapping  and  nested  gene
annotations are  making the assignment of RNA-seq reads on features an
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inherently non-trivial  task  (Anders  et  al.,  2015).  For example if  a  set  of
reads can be assigned on the same time in two overlapping or adjacent loci
we cannot  efficiently  compute  differential  expression  analysis  as  we are
counting the same signal twice and in the case of relatively short transcripts,
like most LncRNAs, a very small number of reads could give an artificially
high FPKM score. Moreover, if we have two or more loci with identical
sub-strings of sequences, like in the case of paralogous genes, then we need
to identify which one is actually differentially expressed. Additionally, the
varying quality of the reference genome and the varying complexity and
quality  of  the  annotation  set  can  lead  in  significant  biases  if  we  allow
ambiguously mapped reads to contribute to the estimation of the relative
expression abundance. In the case of computationally predicted annotations,
like  sets  of  novel  LncRNAs,  it  is  preferred  to  use  a  more  conservative
approach in counting features to overcome biases arising from the putative
inferior quality of a computationally predicted annotation. That is why we
used a conservative count-based approach, where reads assigned to a feature
are being counted only once, but in combination with a strategy to retain
some ambiguously mapped reads.
There are three approaches for counting features as the first step for
a differential expression analysis (figure 8). The first method, which is the
most conservative one, considers only the union of the un-ambiguously /
uniquely  mapped reads  assigned on the  group of  exons of  an  annotated
feature.  All  reads  mapping  to  more  than  one  feature  are  discarded.  The
second, “intersection strict” approach only considers reads fully contained
in an exon, but in the case of reads mapping to more than one feature it
assigns  the  read  only  to  the  feature  which  fully  contains  it.  The  third,
“intersection not empty” method first  calculates a disjoint  version of the
annotation consisting of only non-overlapping features while keeping track
of all features originally found in the annotation. Then, when a read overlaps
one  of  those  non-overlapping  features,  which  represent  an  original
annotation feature, is being counted. Only reads that are fully contained in
two originally overlapping features are discarded as ambiguous. Thus reads
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that could be, even partly, assigned on a diverged part of two features with
otherwise similar sequences they can be uniquely counted. This means that
even if a fraction of a read overlaps two features, if there is another fraction
of the read that uniquely overlaps a fraction of one of the two features then
it would be assigned to the feature it uniquely overlaps partially. Because
the  third  strategy  allows  for  some  ambiguously  mapped  reads  to  being
counted (only once) to the feature they are the most likely to have derived
from,  it  is  better  suited  to  the  differential  expression  analysis  of
computationally predicted features. 
Subsequently  an  RNA-sequencing analysis  will  typically  look for
significant differences in the expression levels of genes (features) between
conditions  of  interest.  The attributes  of  count  data  including  its  discrete
nature, non-normality and dependence between the variance and the mean,
must be taken into account. Natural variance within groups or conditions,
technical biases,  very lowly or very highly expressed genes and differences
in library sizes can significantly affect the relative expression of a feature
across  conditions.  Moreover  high  dynamic  range  and  outliers,  given  a
limited number of replicates, produce additional challenges. 
Most  of  the methods for  analysing  RNA-sequencing data  address
these  problems  by  not  treating  each  gene  separately  but  instead  by
borrowing information  and constructing assumptions  for  gene expression
using different genes in the same experiment (Anders and Huber, 2010).
Identification  of  significantly  DE genes  involves  normalization  to
the  library  size,  data  transformations,  an  estimate of  dispersion  of  genes
between and within  conditions  and performing statistical  inference using
hypothesis testing.
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Figure 8: Count modes of RNA-seq reads, 
different strategies assign different reads to 
gene A and gene B. Image courtesy of (S. 
Anders et al., 2015)
Differential Expression analysis for count-based RNA-seq data
Typically, the Table Of Counts (TOC) produced in the counting step
is supplied into an algorithm which then estimates fold changes between
conditions, filters out outlying features with artificially low or high counts
or low or high dispersion, and assesses statistical significance. In this study
we used DESeq2  (Love et al., 2014) the latest and most widely used R /
Bioconductor (Gentleman et al., 2004) method for analysing RNA-seq count
data. DESeq2 and the method we used for counting reads, which is HTSeq
(Anders et al., 2015), are tightly coupled and highly compatible.
DESeq2 estimates  log fold changes  of  genes  and infers statistical
significance of the observed change. To accurately estimate log fold changes
(lfc)  and  to  overcome  biases  introduced  due  to  the  diverge  average
expression and the dependence of variance to the mean, DESeq2 borrows
information  across  all  genes  in  an  experiment.  Then  moderates  the
dispersion of genes through an empirical Bayes shrinkage method based on
the  assumption  that  genes  with similar  average expression  strength  have
similar dispersion. Additionally, it shrinks log fold changes of genes towards
zero  according to  how much information  (counts,  dispersion,  degrees  of
freedom) is available. Furthermore, it filters out outlying genes which show
artificially high or low dispersion or counts. The table of content entries that
report the number of RNA-seq fragments assigned to each gene for each
sample are modelled using the negative binomial distribution. The mean of
the  distribution  is  then  scaled  according  to  a  normalisation  factor
proportional  to  each  sample’s  library  size.  Subsequently,  the  within
conditions variability or dispersion is modelled by a dispersion parameter.
Genes  of  similar  expression  levels,  i.e.  similar  mean  of  the  negative
binomial distributions are assumed to show similar dispersion. First  each
gene  is  treated  independently,  and  dispersion  is  estimated  using  the
maximum  likelihood  criterion.  Then  this  estimation  is  normalised  to
accommodate for dependence on the average gene expression strength by
fitting a smoothed curve. Finally the dispersion estimates for each gene are
shrunk towards the predicted smoothed dispersion curve. The strength of
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normalisation / shrinkage depends on the degrees of freedom, namely the
sample size and the number of replicates and on an estimation of how far
actual dispersions are from the fit. 
As genes with low counts are more sensitive to small variations and
thus  inherently  noisier  than  genes  with  relatively  hight  counts,  DESeq2
shrinks  log  fold  changes  for  those  genes  according  to  the  amount  of
information  available  using an  empirical  Bayesian approach.  Genes  with
low counts or high dispersion in experiments with few degrees of freedom
(small  sample  size,  few  replicates)  undergo  stronger  shrinkage.   These
normalised and transformed log fold changes are then used for hypothesis
testing.    
Hypothesis testing 
To  estimate  differential  expression  between  conditions  we  use  a
Generalized  Linear  Model  (GLM)  formalism.  For  every  transcript
considered,  raw  counts  are  modelled  as  following  a  negative  binomial
distribution, as is standard practise for RNAseq counts. The mean of that
distribution is linked to a linear predictor via a link function, in this case of
logarithmic form. In the simplest form, the GLM contains only one term
reflecting the status of a sample (condition versus control) and the GLM fit
returns a coefficient corresponding to the log2 fold change in expression
between the two types of samples. The use of GLM models also allows for
more complex designs,  where a number of independent variables can be
included in the linear predictor to reflect additional covariates affecting gene
expression.
Then typically we test if the estimated coefficient calculated using
the correct contrast is equal to zero, i.e. the null hypothesis. Usually this
involves classical hypothesis testing. There are a number of tests for
classical hypothesis testing like the Student t-test, Fisher exact test or the
Wald test. Typically these tests compare two distributions and answer the
question whether the values observed are too extreme to belong within a
distribution of reference. The process is as follows: the coefficient estimate,
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the normalised fold change between conditions is divided by its variance
producing z-scores which are then compared to a normal distribution. 
First  we  should  precisely  specify  a  null  hypothesis  (usually  no
change-coefficient  is  zero)  and  an  alternative  (usually  coefficient  is  not
zero). We then use the sample data assuming that the null hypothesis is True
and because of that we can calculate the test statistic using the mean and the
standard variance of the observed data. Consequently, we can calculate the
p.value  for  a  specific  test  by  using  the  known  distribution  of  the  test
statistic. 
The p.value is a statistic that describes: “If the null hypothesis is true
what is the probability that we would observe such extreme measurements”.
Then, typically, we set an arbitrary cut-off threshold which represents the
probability that we would reject the null hypothesis when it is actually true.
This is called type 1 error or false positive. Similarly, type 2 error is when
we do not reject the null hypothesis when it is not true. These errors are
meaningful in the context of specificity for type 1 errors and sensitivity for
type 2 errors. Ideally we would like an optimal trade-off between sensitivity
and specificity.  We should stress attention again to  the fact that  p.values
represent how likely it is to observe our data when we assume that the null
hypothesis  is  true.  Thus  the  actual  probability  of  a  test  to  be  erroneous
cannot be directly inferred by the p.value, but we rather need to take into
account the actual chance of a real effect. In our case the real effect of a
gene to be significantly DE between certain conditions (Nuzzo, 2014). 
As we are dealing with thousands of genes it is reasonable that errors
will be aggregated by the number of tests we perform. For example if we
allow for a probability to reject the null hypothesis when it is actually true to
5%, or we seek for a p.value < 0.05 in order to reject our null hypothesis in
one test, then we can have our null hypothesis being rejected 5 times if we
perform 100 tests. Thus we use only adjusted p.values for multiple testing,
where the simplest way to adjust is to divide the cut-off threshold by the
number  of  tests.  Although  this  produces  a  consistent  threshold  it
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dramatically affects sensitivity, thus more usually we use more sophisticated
methods like the False Discovery Rate (FDR), where we control the total
number of false positives over the whole set of comparisons to be below a
certain threshold. In the current study, in most cases, we rejected the null
hypothesis only when we observed adjusted p.values < 0.05.
Explain complex interactions of many variables
In most of the studies presented in this thesis we are dealing with
large datasets having too many variables and a relatively small number of
samples. In general we are dealing with problems that cannot be analytically
solved with certain systems of equations. Moreover we usually have highly
heterogenous data, where different variables have very different scales and
variances and different types of variables (numeric, categorical, ordinal) co
-exist. Typically we would like to infer, or perform a reductionist approach,
on these datasets in order to either identify the most important attributes that
characterize certain conditions, or to identify coherent sub-populations with
specific properties in our samples. These problems could be formulated into
problems of identifying the most contributing set of coefficients in a linear
model, i.e. finding the most powerful predictors, or finding the combination
of predictors that could effectively explain most of the data’s variance or
optimally classify our samples in a biologically meaningful way.
Principal Components Analysis and varimax rotation
After  normalization  a  dataset  is  ready  to  undergo  some  form  of
reduction  in  dimensionality.  This  is  exactly  the  process  that  reducts  the
variables or combinations of variables with the largest explanatory power. A
standard well known method is the principal components analysis (PCA).
Principal  components  (PC),  i.e.  linear  combinations  of  the  original
variables, which are orthogonal with each other and explain the maximum
possible  variance  of  the  original  data,  are  calculated  and  those  that
cumulatively  explain  more  than  a  certain  fraction  of  the  original  data's
variance are retained. Principal components can be less or at most equal to
the number of original variables. There are several methods to decide the
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optimal number of principal components. One method uses scree plots that
show the number of PCs against  the eigenvalues and one can select  the
number of components that corresponds to an elbow in the graph, i.e. after
that  point  the  rate  of  the  reduction  in  the  eigenvalue’s  values  is  getting
significantly  lower.  Or  one  can  select  the  PCs that  explain  more  than  a
certain  fraction  of  the  original  data’s  variance,  typically  80%  of  the
variance, or just select only principal components with eigenvalues of 1 or
more.  Plots  of  the  two  first  principal  components  are  used  in  order  to
examine how those PCs can effectively partition data and when the only
purpose is this kind of visualisation only two components are used. We used
the latter technique for visualising sample separation based on the two first
principal components of a gene expression matrix. We should note that PCA
is very sensitive to the original distribution of the data’s variance, thus it
requires careful normalisation (scaling) of the data. 
PCA is essentially a singular value decomposition of a data matrix
(Principal Component Analysis, 2002). In PCA,  a covariance matrix is split
into a scalar part (eigenvalues) and a direction part (eigenvectors). Loadings
are  the  eigenvectors,  the  coordinates  of  the  variables  for  each  principal
component  (dimension),  divided  (scaled)  by  the  square  root  of  their
respective eigenvalues. Thus loadings are the most efficient way to observe
the normalized contribution of the original  factors  and variables into the
distinct principal components (“FactoMineR,” n.d.). 
In PCA, principal components, which are essentially projections of
the data on the directions defined by the eigenvectors, are uncorrelated. In
other  words  the  space  of  the  principal  components  is  an  uncorrelated
orthogonal  basis  set  of  the  original  data.  The  eigenvectors  are  in  turn
orthogonal directions. As loadings are the eigenvectors, if we select a certain
number  of  principal  components  we  can  observe  how  different  factors
contribute on their respective loadings. Thus it will be easier if we could
have as sparse components as possible, with some few factors with relative
high values and with a lot of factors with zero or near zero values.  In this
study we used the varimax (Kaiser, 1958) rotation in order to rotate the sub-
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space of the orthogonal basis of the loadings and increase their ability to
optimally separate data. Varimax rotation is taking place on the latent space,
the space of loadings and not the space of the original principal directions.
Namely, it rotates the sub-space of the orthogonal basis of the loadings by
multiplying  them  with  a  K  x  K square  orthogonal  matrix  T,  which  is
calculated  as  the  orthogonal  square  matrix  which  can  carry  out  the
orthogonal decomposition of the matrix which holds the first  K (K < nr of
original loadings) loadings. The aim is to make the matrix of the rotated
components as sparse as possible. 
Overview of thesis chapters
The next chapter,  chapter 2: Methods for identifying LncRNAs
and analyse RNA-sequencing data, of this thesis presents an automated
bioinformatics pipeline, aiming to identify novel LncRNAs using RNA-seq
data,  to  calculate  differential  expression,  to  annotate  these  LncRNAs
according to their genomic context and to perform functional enrichment of
the known DE genes. This customised pipeline integrates a strategy for the
identification  of  LncRNAs  which  exploits  the  previously  un-annotated
transcribed areas found applying a coverage threshold to the RNA-seq data,
alongside  with un-annotated  splicing  junctions  de  novo  identified  by  a
gapped aligner.  This  pipeline has  the  advantage  of  producing gene level
annotations of LncRNAs suited for downstream counting and analysing for
differential expression. The next two chapters present results from using this
pipeline
Chapter 3: Transcriptional changes of protein coding genes and
novel LncRNAs in rat’s DRG,  presents a rubric for analysing RNA-seq
data using the customised pipeline presented in chapter 2 and results from
rat dorsal root ganglion (DRG) under the spinal nerve transection (SNT)
pain  model.  This  study  investigates  the  transcriptional  changes  of  both
known genes and novel LncRNAs. 
Chapter 4: Transcriptional changes in DRG of two mouse strains
experiencing high and low induced hypersensitivity,  further investigates
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transcriptional changes under animal models of peripheral neuropathy. In
this  chapter  we  present  results  from  analysing  RNA-seq  data  from two
mouse strains DRGs under the spared nerve injury (SNI) pain model. Those
two strains had significantly different induced hypersensitivity after the pain
surgery  and  we  carried  transcriptional  profiling  investigating  both  novel
predicted LncRNAs and known genes. 
Chapter  5:  Clustering  of  patients  with  diabetic  neuropathy
reveals  distinct  neuropathic  pain  dimensions,  of  this  thesis  presents
another  bioinformatic  approach  for  the  further  understanding  of  painful
neuropathy. This time we present a rubric and results from an exploratory
data analysis of clinical data and data obtained from quality of life – pain
questionnaires from patients suffering from diabetic neuropathy.  Analysis
of  this  data  gave  us  useful  insights  regarding  the  correlation  of  various
questionnaires  with  neuropathic  pain  intensity,  the  correlation  of
neuropathic  pain  intensity  with  clinical  factors  and  the  diverge
somatosensory  clusters  of  diabetic  neuropathy  that  can  be  related  to  the
reported intensity of neuropathic pain. 
Finally, in chapter 6 we provide a brief summary of the conclusions
drawn from the thesis chapters and discuss immediate future work.     
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Methods for identifying LncRNAs and 
analyse RNA-sequencing data
Overview of computational identification and DE of  
LncRNAs 
In  this  study we present  methods  and results  of  a  bioinformatics
pipeline  developed  to  analyse  RNA  sequencing  data,  in  order  to
computationally  identify  novel  LncRNAs,  which  may  be  functionally
important as they are differentially expressed (DE) between conditions of
interest.  As  discussed  in  Introduction,  numerous  studies  have  identified
LncRNAs  using  RNA-sequencing  data.  Almost  all  of  them  have  used
computational  pipelines  made  for  identifying  novel  isoforms  of  known
genes (i.e. pipelines using Cufflinks (Trapnell et al., 2012)) and others have
used  computational  methods  for  a  complete  de  novo or  ab  initio
identification of the transcriptome (i.e. methods using scripture (Guttman et
al., 2010) and stringtie (Pertea et al., 2015)). All these methods can identify
novel LncRNAs but they are either computational expensive and not very
sensitive as they try to reconstruct the complete transcriptome, or they do
not  produce  annotations  compatible  with  count-based  methods  for  DE
analysis,  as  they  just  identify  sets  of  transcripts  and isoforms  using  the
FPKM transcription strength estimation. In this chapter we present a method
tailor-made  for  the  identification  of  LncRNAs.  Our  method  predicts
complete  models  of  sufficiently  expressed  novel  LncRNAs,  using  a
mapping-first  strategy,  which  are  in  suitable  form  for  downstream  DE
analysis. Thus we can identify novel LncRNAs and infer their function by
analysing  their  expression  profile  under  certain  biological  conditions  of
interest.    
In the next chapter we present results from applying this pipeline to
analyse RNA-seq data of rats  under the Spinal Nerve Transection (SNT)
pain model and in the following chapter we present results from RNA-seq
data of mice which underwent the Spared Nerve Injury (SNI) pain model. 
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The aim is to identify putative LncRNAs which may have a certain
functional  role  in  neuropathic  pain.  This  is  inferred  mainly  by  their
expression  pattern  in  pain  relevant  tissues  under  different  biological
conditions  of  interest,  their  genomic  context  and  the  abundance  and
consistency of their expression. We computationally predicted and annotated
loci that express LncRNAs that were differentially expressed (DE) between
conditions  and strains  related  to  neuropathic  pain.  We also  assessed  the
general transcriptional changes under neuropathic pain models by detecting
significantly  DE  known/annotated  genes  and  by  performing  functional
enrichment analysis on those gene sets.
The main  advantage  of  this  customised  pipeline  is  its  integration
with the proper framework for analysing RNA-sequencing data in order to
identify DE genes. Thus we propose an approach that identifies gene models
of  LncRNAs  that  are  suitable  for  further  downstream  analysis,  namely
counting with a method that does not overestimate counts and deals with
ambiguous reads, like HTSeq, and DE analysis with a count-based approach
that does not overestimate log fold changes for lowly expressed transcripts,
like  DESeq2.  That  is  not  trivial,  as  LncRNAs  are  notoriously  lowly
expressed,  which makes DE analysis  difficult  and error prone.  Moreover
summarisation at the gene level is very important, as the identification of
novel transcribed loci / gene models of LncRNAs can give many slightly
different transcripts, some of them overlapping, which can seriously affect
downstream DE analysis. Thus our approach is significantly different to the
approaches described in Introduction in the way that it does not identify a
set of transcripts, using metrics suited to the transcript expression strength
and not to DE analysis, but instead we identify predicted full gene models
suited for further DE analysis. 
More  specifically  this  computational  pipeline  was  designed  in
collaboration  with  experimental  biologists  and  it  can  use  data  from  a
biologically  relevant  RNA-sequencing  experiment  in  order  to  predict
putative LncRNAs, calculate differential expression and perform functional
enrichment.  The  aim  is  not  to  perform  a  complete  and  complicated
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reconstruction  of  the  whole  transcriptome,  but  rather  to  develop  a  fast,
simple and intuitive pipeline that could identify loci, i.e. genomic regions at
the gene level,  of putative LncRNAs which are the most  probable to be
functionally important  and are expressed at  levels that  allow them to be
validated  in  the  wet  lab  in  the  context  of  a  very  specific  biological
experiment. Thus the pipeline gives us the ability to have a more complete
image of transcriptional changes, both in annotated genes and un-annotated
LncRNAs, under specific conditions.
Analysing several RNA-Seq datasets using this pipeline allowed us
to computationally predict putative gene models of LncRNAs using RNA-
seq expression data and de novo annotated splicing junctions. We have also
studied the expression of these LncRNAs in the context of the expression
profile  of  their  antisense  protein  coding  genes  and  genes  functionally
validated in animal models of pain found in “The Pain Genes Database”
(Lacroix-Fralish et al., 2007).
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Methods
The main  task  of  this  computational  pipeline  is  to  identify  novel
LncRNAs  which  could  be  functionally  important  and  thus  differentially
expressed in a biologically relevant experiment. For this purpose we have
used  the  statistical  programming  environment  R  (R  Core  Team,  2015),
several  Bioconductor  packages  (Gentleman  et  al.,  2004) and  customised
unix scripts. A brief overview presenting all the main steps of the pipeline is
in figure 1.
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63Figure 1: Flowchart of computational pipeline
LncRNAs ENSEMBL genes
RNA-Seq and library preparation
The  main  input  of  the  pipeline  is  RNA-seq  data  from a  specific
biological experiment. Although all  RNA-seq datasets could be analysed,
there  are  some  limitations  and  certain  sequencing  specifications  will
definitely produce much more accurate results.
Firstly, data should be obtained for at least two conditions of interest
and  there  should  be  enough  technical  and  biological  replicates.  Recent
reviews  (Seqc/Maqc-Iii  Consortium,  2014) have  shown  that  RNA-seq
results are highly dependent on effects arising in the library preparation step.
Thus in order to obtain an accurate estimation of within samples variance
for every feature of interest we need at least two biological replicates for
each condition and some technical replicates that will control the variance
introduced in the library preparation step. Moreover, in most cases, pooled
samples, i.e. when RNA from a certain number of different samples is put
together  to  create  one data-point,  should be used as an effective way to
marginalise unwanted variance within conditions. When technical replicates
are available (i.e. different libraries from the same biological material) those
are mapped separately to the genome and then the output of the mapping
algorithm, i.e BAM files for each replicate, are merged. When biological
replicates (i.e. different samples from the same condition) are available they
are not merged but used to estimate within samples variance.  
Also, a sequencing depth of more than 50 million reads per sample is
required for the identification of lowly expressed transcripts and paired-end
reads  would  allow  for  a  significant  increase  in  the  accuracy  of  the
identification of expressed loci ,as fragments of cDNA are sequenced from
both  ends  (Ilott  and  Ponting,  2013;  Perkins  et  al.,  2014;  Seqc/Maqc-Iii
Consortium, 2014). As we wish to identify expressed regions outside known
gene  models,  to  reconstruct  those  transcripts  our  results  are  highly
dependent on the read depth, the read length and whether reads are paired-
end or single-ended. Genomic sequences of low complexity, complex gene
models and the way of mapping short reads to the genome which introduces
some inherent uncertainty makes the mapping of shorter single-ended reads
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a more difficult problem that the mapping of longer paired-end reads. As the
pipeline uses the output of a gapped aligner, the ability of that aligner to
accurately align reads to the genome is crucial. Moreover, as we need to use
novel splicing junctions outside known gene models in order to reconstruct
gene models of putative LncRNAs, our results depend on the number and
accuracy of the splicing sites identified by the gapped aligner. Longer reads
have much more probability  to fall  into splicing sites  and a  higher  read
depth  gives  much  more  accuracy  in  detecting  splicing  events  and
contiguously  expressed  regions  according  to  the  number  of  reads  that
overlap them  (Perkins  et  al.,  2014).  For  these  reasons we used reads  of
100bp and longer, paired-end with a read depth of more than 50 million
reads per sample. These sequencing specifications are not extremely high
but are known to produce accurate and reproducible results (Seqc/Maqc-Iii
Consortium, 2014).   
Since there is a finite RNA-seq read depth and since certain fractions
of  RNA are  much   more  abundant,  we  used  enriched  RNA for  certain
fractions of the transcriptome. The main goal is to discard the ribosomal
RNA which would otherwise take up the largest part of our read depth. One
way  is  to  select  only  poly-adenylated  RNA in  order  to  have  samples
enriched in mRNA. The other way is to specifically remove ribosomal RNA
from the sample, this process is called ribodepletion. In order to maximize
the ability to identify novel transcripts it is advisable to use the ribodepleted
fraction of the total RNA for further sequencing. Ribodepletion excludes the
ribosomal RNA but it does not filter all other types of RNA which might be
of biological interest as we are mainly interested on the non-coding part of
the transcriptome.
Finally, in order to be able to identify antisense LncRNAs we needed
a  library  preparation  protocol  which  retains  strandedness.  It  is  also
important to know the direction of transcription in the downstream analysis
in order to validate targets in the wet lab. We used the dUTP protocol (see
chapter Introduction, section RNA-sequencing), which synthesizes both the
forward and reverse strand in the amplification step of library preparation.
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Aligning reads to the genome
As we  used  the  ab  initio /  map first assembly  strategy,  we  first
mapped raw reads stored in FastQ files to the reference genome. For this
purpose we used the STAR aligner (Dobin et al., 2013) in its latest version.
As we were looking for un-annotated parts of the transcriptome, it is crucial
that we used an aligner that could accurately align short to medium reads by
taking  into  account  mismatches,  insertions  and  deletions,  repetitive
sequences  and wrong base  calling  and  at  the  same time  an  aligner  that
performs well in aligning into genomic regions that are not continuous, but
they have been joined together by splicing.  
STAR is an aligner that has been developed and designed with all
these  features  in  mind.  It  makes  use  of  the  Maximum Mappable  Prefix
(MMP) concept, where, instead of aligning the whole sequence of an RNA-
seq read,  takes  the  longest  substring  of  the  read’s  sequence  that  exactly
matches the sequence of one or more substrings of the reference genome’s
sequence, figure 2. The genome’s substring with the maximum length sets
the Maximum Mappable Length (MML). Then the unmapped part of the
read is subjected to the same process of substring mapping. This process is
iterated until no more of the read can be mapped. In this way, if for example
a read falls on a splicing junction, the first seed will map to the donor site
and the second seed to the acceptor site. Finally all seeds that are aligned in
a predefined window, which intuitively defines the maximum intron size,
are clustered and stitched together. By recurring passes of the MMP step,
reads  with  mismatches  can  be  aligned.  Moreover,  paired-end  reads  are
clustered and stitched together as a single sequence in order to preserve the
natural attribute of these reads to represent both ends of the same sequence /
cDNA fragment. 
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 Additionally  STAR  is  very  fast  and  it  can  be  easily  used  in
environments  where  computational  power  is  limited.  Before  the  actual
mapping of reads we generated a genome index using the latest version of
the  organism’s  reference  genome in  FASTA format.  STAR uses  indexed
genomes in order to perform fast non-linear searches for the MMP on the
reference  genome.  Thus,  how  the  genome  is  generated  affects  the
performance  of  the  following  steps.  Namely  a  lot  of  frequent  indices
improve  speed  but  need  more  memory,  while  less,  more  sparse  indices
create a trade off between memory consumption and computational speed.
We created the genome index using the “sparse indices” option in order to
reduce  memory  consumption.  This  makes  a  reasonable  trade-off  to
algorithm’s speed but in most cases it does not significantly affect execution
time. This mapping step is the most computationally expensive step of this
data analysis pipeline but it has to be executed once and its output is used
for  all  subsequent  data  analysis.  In  order  to  keep  things  consistent  we
always used the same resource for the reference genome and for fetching the
sequences  of  the  predicted  LncRNAs.  In  every  case  this  was  the  latest
version of the ENSEMBL genome in FASTA format. 
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Figure 2: The first substring (MMP 1) that matches exactly a substring of 
the reference genome is first mapped to an exon, then a gap is introduced 
and the second substring is being matched on another exon. This read is 
assigned to the exons, i.e. produces a certain coverage, and at the same time
identifies a splicing event. Image courtesy of (Dobin et al., 2013).  
We then created BAM files sorted by the genomic coordinate and tab
separated text files holding the information about splicing junctions. A BAM
files  is  the  compressed,  binary  version  of  the  Sequence/Alignment  Map
(SAM) file. SAM files, which are flat text files, are the main file format for
storing large nucleotide alignments. BAM files are the standard file type for
mapped reads to a reference genome (i.e. nucleotide alignments) in binary
format. We run the aligner with default parameters and we did not filter out
any splicing junctions in that step, as we did this in downstream analysis. 
Subsequently,  we merged  together  technical  replicates.  As  library
preparation and sequencing lane effects can introduce significant variance in
RNA-seq  experiments,  sequencing  of  libraries  from  different  biological
conditions is usually multiplexed in a sufficient number of sequencing lanes
in  order  to  obtain the  desirable  read depth  and marginalize lane-specific
batch effects.
Selecting reads according to overlapping genomic features
As  the  ultimate  aim  is  to  go  from the  representation  of  discrete
RNA-seq reads to estimated gene models for LncRNAs, the first step, after
preprocessing data as presented above, was to select only the reads that can
be of use. Intuitively, we discarded all reads that overlapped with known
protein coding gene models, reads overlapping possible untranslated regions
(UTRs)  that  flank gene  models  or  belonging to  proximal  enhancers  and
promoters and reads that overlapped genomic regions that have a very high
probability to code for a protein even if they are not annotated in the current
organism.
To  do  this  we  used  the  latest  genomic  annotations,  downloaded
programmatically using R from the servers of the University of California,
Santa Cruz (UCSC) (Meyer et al., 2012) and ENSEMBL/GENCODE (Yates
et  al.,  2016).  Using  the  GenomicFeatures  (Lawrence  et  al.,  2013) and
biomaRt  (Durinck  et  al.,  2009)  Bioconductor  (Gentleman  et  al.,  2004)
packages we fetched the following annotation sets from UCSC: Reference
Sequences (RefSeq) genes  (Pruitt et al., 2014) annotation compiled by the
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National Center for Biotechnology Information (NCBI), ENSEMBL genes
annotation compiled by the ENSEMBL/GENCODE project  (Yates  et  al.,
2016) and the XenoRefSeq annotation, which includes all known annotated
gene  model  sequences  from  other  organisms  which  can  be  accurately
aligned to the genome of the organism of the experiment. XenoRefSeq table
has been compiled by NCBI and it consists only of alignments made with
BLAT (Kent, 2002) with more than 15% of the sequence aligned and more
than 40 bases of non-repetitive unmasked DNA. Furthermore only the top
1% of alignments based on identity level and at least 35% base identity of
the  query  were  selected.  From  these  annotations  we  then  selected  and
filtered out any models describing known and predicted long non-coding
RNAs using the respective prefixes “NR” and “XR” for RefSeq annotations
and  models  that  conform  to  the  description  pattern  of  “linc  rna”  or
“antisense  rna”  for  ENSEMBL annotations.  When  dealing  with  poorly
annotated genomes, such as rat, we extended these gene models by 2000bp
from each side in order to avoid un-annotated untranslated regions (UTRs),
proximal promoters and enhancers or not yet annotated exons belonging to
those  genes.  Finally  using  functions  from  the  GenomicRanges  package
(Aboyoun et al., 2013) we calculated  the intergenic areas, i.e. gaps outside
the exons of these annotations, and we selected only the subset of RNA-seq
reads that are falling completely within those gaps outside of the exons of
the known protein coding gene models.
Identify expressed regions outside known gene models
We then used the subset of reads selected above in order to produce
continuously expressed regions. We call these regions islands of expression.
Ideally they should be a close approximation of exons, but due to the way of
mapping reads to the genome which involves some uncertainty, the limited
read  length  and  the  potentially  wrong  base  calling  they  could  be
significantly  different.  RNA-seq  and  essentially  all  next  generation
sequencing methods produce certain coverage (the average number of reads
that covers all bases of a genomic interval normalised by the length of the
region) peaks (figure 3), these peaks usually offer a close approximation of
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exons  but  there  is  also  some  coverage  on  the  intronic  areas  and  as  a
consequence it is almost impossible to find the exact transcription start and
end sites from RNA-seq alone  (Ulitsky and Bartel, 2013).  Essentially, in
every RNA-seq experiment there is a number of reads that will always map
in un-transcribed regions, either intronic or intergenic, but there is a certain
coverage  threshold  that  could  effectively  separate  those  artefacts  from
actually  transcribed  regions.  We  have  developed  a  specific  function  for
performing this step.
Subsequently, we parsed BAM files containing mapped reads of an
RNA-seq experiment into smaller chunks in order to reduce memory usage.
In  order  to  fully  exploit  the  advantages  of  the  paired-end  protocol,  we
parsed these aligned reads as pairs of reads using the readGAlignmentPairs
function from the GenomicAlignments package (Lawrence et al., 2013). In
the context of paired-end reads we do not refer to individual reads but rather
to mated pairs of reads. We then subset the reads that exclusively overlap
regions outside known gene models as described above. 
The next step of the function involves the transformation of these
aligned  reads  into  easily  manipulated  data  types.  We  stored  them  in  a
GrangesList  (Aboyoun et al.,  2013), which is an indexed list of genomic
intervals inheriting all  features from the R class data.table  (Dowle et al.,
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Figure 3: Coverage graph of RNA-seq across an annotated gene model. 
Coverage peaks are observed above exons (thick black rectangular blocks), but 
there are also small coverage “leaks” in introns (thin black line). Also the UTR 
of the gene model (thick black lines at the gene’s edges) is being covered by 
reads. Note that coverage does not stop immediately but rather gradually.
exon intronUTR
coverage
2015),  an indexed table allowing non-linear search and efficient memory
usage for sparse matrices. Then, reads mapped to the forward and reverse
strand were separated and the coverage for each strand was calculated. 
Coverage is calculated by the formula  (read counts x read length /
library  size)   and  naturally  represents  the  average  number  of  reads  that
overlap every base of  a  genomic interval. We then identified continuous
regions above a certain coverage threshold that indicates actual transcription
activity. To do this we eventually transformed the list of genomic ranges into
a list of integers using the “run length encoding” (rle). The “rle” function
encodes the array of the raw number of reads overlapping an interval into
their respective run length, where instead of the raw number of overlapping
reads we used the length of the longest run with a certain value. In that way
we compressed data and also we were able to slice this “rle” vector with a
certain  threshold  in  order  to  acquire  the  longest  possible  region  that  is
covered by a certain number of reads. In our case we would like to find
continuous  regions,  which  can  be  parts/tiles  of  the  non-coding
transcriptome, with at least one read overlapping all their nucleotides with
no gaps.   Thus we used a  cut-off  threshold  of  1  to  slice the  run length
encoded coverage vector. As islands of expression are defined as expressed
regions  outside  known  gene  models,  the  incentive  was  to  identify  and
further process all these expressed regions. Thus we used this deliberately
low cut-off  is as we would like to identify the largest possible extent of
individual islands of expression and produce a close approximation of full
length gene models / loci of LncRNAs. We then finally grouped, trimmed
and  sliced  these,  possibly  elongated,  exons  by  the  de  novo identified
splicing junctions.  
To sum up we first  calculated  the  coverage  using  the  fraction  of
reads  that  did  not  overlap  protein  coding  genes.  That  gave  us  a
representation of the fraction of total RNA that has been sequenced in our
library and which could be derived from LncRNAs. Then we sliced that
transcriptome into regions longer than 100bp, which is the shortest RNA-
seq  read  length  that  we  can  use  in  the  pipeline,  that  had  a  continuous
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coverage of more than 1. Intuitively this represents the fraction of the non-
coding transcriptome comprised of intervals that had their bases covered by
more than one read on average. We call these intervals islands of expression,
see table 1. This cut-off is intentionally very low, as the goal at this step is to
identify  the  whole  fraction  of  the  genome  which  is  transcribed  outside
known  gene  models.  We  consider  as  evidence  of  transcription  the
continuous accumulation of more than 1 read (coverage > 1) for every base
of a genomic interval of 100bp. Thus we we used a continuous run of at
least  100  bases  with  coverage  >  1  and  then  we further  processed  these
regions into putative models of LncRNAs downstream in the pipeline.
Islands of expression
Genomic Context Transcribed areas that do not overlap with gene
models (ENSEMBL, RefSeq, XenoRefSeq)
Length Length > 100bp (1 RNA-seq read mate length)
Expression Threshold Coverage > 1
Table 1: Attributes of Islands of Expression
We repeated this process for both strands and then we transformed
the results again in a GenomicRanges object, which holds genomic intervals
that are sufficiently transcribed in at least one of the BAM files of the RNA-
seq experiment. These objects are indexed and hold information on genomic
72
Figure 4: Genomic Ranges in a GRanges object containing the 
subset of RNA-seq reads / pairs of reads  overlapping with non 
protein-coding regions
intervals by storing the chromosome, start position, end position, strand and
metadata including a name and possibly a coverage score, see figure 4 for a
detailed representation of genomic intervals. At the same time the pipeline
creates detailed logs including the number of reads or pairs of reads selected
and the number of islands of expression, i.e. transcribed genomic intervals,
identified for each BAM file, see table 2. Finally, we created a customised
annotation  of  novel  transcribed  regions  by  collecting  all  those  regions
identified in each BAM file and collapsing the overlapping and book-ended
ones into a single region that spans across all of the collapsed features. In
this  way we incorporated  information  by combining read-depth  from all
samples in an RNA-seq experiment. Thus we have generated a customised
annotation of continuously transcribed regions outside known gene models. 
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Log file for Sample51_BALB.c_SHAM_M.bam
Chunk nr: 1 . Number of reads (pairs) overlapping with intergenic regions:  520048 
Chunk nr: 1 . Number of reads overlapping with islands of expression coverage > 1 & width > 100:  55603 
Integrating chunk nr 1 to bam file Sample51_BALB.c_SHAM_M.bam. Nr of reads overlapping with intergenic
regions: 55603
Chunk nr: 2 . Number of reads (pairs) overlapping with intergenic regions:  188923 
Chunk nr: 2 . Number of reads overlapping with islands of expression coverage > 1 & width > 100:  14757 
Integrating chunk nr 2 to bam file Sample51_BALB.c_SHAM_M.bam. Nr of reads overlapping with intergenic
regions: 70360
Chunk nr: 3 . Number of reads (pairs) overlapping with intergenic regions:  582369 
Chunk nr: 3 . Number of reads overlapping with islands of expression coverage > 1 & width > 100:  63916 
Integrating chunk nr 3 to bam file Sample51_BALB.c_SHAM_M.bam. Nr of reads overlapping with intergenic
regions: 134276
Chunk nr: 4 . Number of reads (pairs) overlapping with intergenic regions:  1444413 
Chunk nr: 4 . Number of reads overlapping with islands of expression coverage > 1 & width > 100:  57571 
Integrating chunk nr 4 to bam file Sample51_BALB.c_SHAM_M.bam. Nr of reads overlapping with intergenic
regions: 191847
Chunk nr: 5 . Number of reads (pairs) overlapping with intergenic regions:  496979 
Chunk nr: 5 . Number of reads overlapping with islands of expression coverage > 1 & width > 100:  54005 
Integrating chunk nr 5 to bam file Sample51_BALB.c_SHAM_M.bam. Nr of reads overlapping with intergenic
regions: 245852
Chunk nr: 6 . Number of reads (pairs) overlapping with intergenic regions:  756139 
Chunk nr: 6 . Number of reads overlapping with islands of expression coverage > 1 & width > 100:  71220 
Integrating chunk nr 6 to bam file Sample51_BALB.c_SHAM_M.bam. Nr of reads overlapping with intergenic
regions: 317072
Chunk nr: 7 . Number of reads (pairs) overlapping with intergenic regions:  601027 
Chunk nr: 7 . Number of reads overlapping with islands of expression coverage > 1 & width > 100:  59339 
Integrating chunk nr 7 to bam file Sample51_BALB.c_SHAM_M.bam. Nr of reads overlapping with intergenic
regions: 376411
Chunk nr: 8 . Number of reads (pairs) overlapping with intergenic regions:  779006 
Chunk nr: 8 . Number of reads overlapping with islands of expression coverage > 1 & width > 100:  73097 
Integrating chunk nr 8 to bam file Sample51_BALB.c_SHAM_M.bam. Nr of reads overlapping with intergenic
regions: 449508
Chunk nr: 9 . Number of reads (pairs) overlapping with intergenic regions:  477328 
Chunk nr: 9 . Number of reads overlapping with islands of expression coverage > 1 & width > 100:  45811 
Integrating chunk nr 9 to bam file Sample51_BALB.c_SHAM_M.bam. Nr of reads overlapping with intergenic
regions: 495319
Table 2: Log file showing all  the rounds of read selection and island of
expression identification. In order for the pipeline to be memory efficient
BAM files are processed in chunks of 4500000 pairs of reads.  For each
chunk of a BAM file the 1st  line shows the total number of pairs of reads
outside known gene models for this particular chunk, the 2nd line shows the
number  of  reads  overlapping  continuous  islands  of  expression  for  this
particular chunk and the 3rd line shows the cumulative total number of reads
overlapping  islands  of  expression  for  this  BAM  file.  In  this  particular
example we can see the log file for Sample51_BALB.c_SHAM_M.bam. In
order to completely parse this particular file and identify expressed regions
outside known gene models  we processed 9 chunks.  At  the  end we had
495319 reads that were overlapping continuously transcribed regions with
coverage more than 1. These islands of expression (produced by 495319
pairs of reads) comprised our customised annotation of putative LncRNAs
for this particular BAM file.
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Reconstruct genes of putative LncRNAs
These islands of expression would include all previously unknown
exons of novel LncRNAs but we still need to trim and group them together
into  transcripts  and  filter  out  those  that  are  below  the  minimum length
threshold of 200bp, see figure 5. Additionally, as RNA-seq, due to its nature
as a collection of short discrete reads, mapped to a genome using a process
which  involves  some uncertainty,  cannot  produce  accurate  start  and end
sites of transcription, we need to trim these islands of expression according
to a scaffold created by the identified splicing junctions. Essentially we used
two sources of information, one is the de novo identified splicing junctions
and the other is the islands of expression outside known protein coding gene
models, which have their nucleotides covered by at least one read for their
full  length.  By combining together  these two sources  of  information  we
acquired a prediction of unknown gene models. If these gene models are
more than 200bp in length and with no coding potential, they are putative
LncRNAs.  In  order  to  reconstruct  these  gene  models  we  filtered  out
spurious  splicing  junctions  and  islands  of  expression  which  were  more
probable to be false positives. 
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Figure 5: Islands of Expression are being grouped together and trimmed by Splicing Junctions into putative LncRNAs.  
We first selected the subset of novel splicing junctions which were
confidently identified. Splicing junctions were stored in tab separated text
files that indicate the genomic interval of the respective intron as well as the
type of the donor and acceptor site,  the read overhangs and read counts.
More specifically we set the maximum overhang of the read mates of pair of
reads  on  the  donor  or  acceptor  site  to  be  (read mate  length)  –  1.  The
maximum overhang of RNA-seq reads to the donor or acceptor site dictates
how  many  bases  of  a  read  are  allowed  to  overlap  either  the  donor  or
acceptor site when a read is spliced and a splicing junction is identified. In
the case of paired-end reads we used as the maximum overhang the length
of one read mate, which in our case is 100b, minus 1. This means that at
maximum a read could be spliced and mapped using 99b on one side. Thus
splicing junctions were identified only when the original mates were spliced
and the sequence of one of the read-mates was mapped on both sites of the
splicing  junction.  Splicing  of  the  fragment  (an  not  the  read-mate  itself)
sequenced  from  both  ends  with  paired-end  reads  would  not  identify  a
splicing junction if the original mates were not spliced. Moreover during the
mapping step we used the default minimum allowed overhang of 3b. This
means that overhangs of 1 and 2 bases were prohibited for the identification
of splicing junctions. 
We  also  imposed  a  cut-off  threshold  of  more  than  2  reads
overlapping a junction to consider it a valid splicing event. This threshold
produces the lowest ratio of mapper-specific junctions (Dobin et al., 2013) ,
thus  splicing  junctions  accumulating  reads  above  this  threshold  are
consistently identified by different aligners and are less likely to be false
positives. 
We parsed  in R, collapsed and sorted all splicing junctions detected.
Subsequently  we  developed  a  function  that  filters  out  spurious  splicing
junctions and groups together islands of expression transforming them into
putative exons by trimming the edges according to the identified splicing
activity. Grouping of islands of expressions and splicing junctions was done
as shown in figure 6. 
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To do this  we exploited a  feature that  relates to the way splicing
junctions are identified. As reads are mapped using the MMP concept and
we  used  the  same  reads  to  identify  islands  of  expression  and  splicing
junctions,  by  definition  the  very  same  reads  whose  aligned  seeds  have
produced  a  certain  coverage  value  over  a  genomic  interval,  have  also
identified novel splicing junctions as they were split into seeds in the first
place. Some islands of expression would overlap the same junction, some
junctions would overlap more than one island of expression and vice versa.
In  that  way  we  defined  co-overlapping  sets  of  junctions  and  islands  of
expression that have been connected by the same RNA-seq reads, see figure
6. After this first grouping, we got a set of splicing junctions and islands of
expression stored in the respective vectors.  Some of them might  overlap
each other, essentially describing parts of the same genomic interval. Thus,
we collapsed overlapping islands of expression and we selected from the
overlapping  splicing  junctions  the  regions  which  are  more  probable  to
represent actual introns. We call the latter regions consensus junctions.    
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Figure 6: 3 islands of expression (I.oe), A, B and C and 14 splicing junctions (SJ) define a set of co-overlapping features. As a matter of fact I.o.e A 
overlaps SJ 1, I.o.e B overlaps SJ 1,2,3,4,5,6 etc. We can create three vectors:
A → SJ 1
B → SJ ,12,3,4,5,6
C → SJ 1,2,3,4,5,6,7,8,9,10,11,12,13,14
These vectors have common features so I.o.e A, B and C can be grouped together alongside with SJ 1-14.
ENSMUG00000085282 is an annotated ENSEMBL LncRNA, the 3 continuous islands of expression A, B and C with coverage > 1 And length > 100b 
gave a good approximation of the maximum transcribed loci. Further downstream processing would trim these elongated transcribed regions 
according to the set of splicing junctions comprised of SJ1 to SJ14. 
To select consensus junctions of high-confidence we calculated the
smallest  set  of  genomic  intervals  that  are  non  overlapping  and  which
together,  reproduce  the  initial  regions  described  in  the  novel  splicing
junctions annotation. This is called a disjoint transformation of the genomic
intervals and by definition it consists only of non overlapping features, or in
other words it splits the ranges into non-overlapping segments keeping track
of  all  the  original  regions.  Then  we  counted  how many  of  the  original
splicing junctions overlap with the disjoint ones and thereby we calculated
the relative frequency of each discrete segment of a set of splicing junctions.
This map of overlaps was used as a “grouping guide”, see figure 7. We note
again that de novo identified splicing junctions are represented in the form
of the genomic intervals of introns.
We  then  grouped  together  all  islands  of  expression  that  are
overlapped by the same set of junctions, using this “grouping guide” as an
index.  In  this  way we produced a  set  of  introns  and a  set  of  islands  of
expression that together can be used to reconstruct a gene model of a novel
LncRNA. Nevertheless, these junctions do not always consistently describe
introns since, some disjoint intron intervals are overlapped by more novel
splicing junctions  than others.  In other  words,  some of  these introns are
more probable to be actual introns and thus are identified more frequently
than others  in the same set.  Therefore we looked for a set  of consensus
introns  in  which  we had higher  confidence.  Moreover,  as  we needed to
generate  an  annotation  of  putative  LncRNAs at  the  gene  level  and then
proceed to differential expression analysis, we had to identify all possible
exons  of  the  novel  LncRNA gene.  Disjoint  introns  with  the  maximum
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Figure 7: Hits of original splicing junctions (queryHits) on the disjoint 
splicing junctions (subjectHits). The character vector “names” defines a list 
of co-overlapping junctions. 
number of overlaps for a specific set of islands of expression and introns /
splicing junctions should represent the most dominant transcript, but there
might be additional junctions and exons belonging to different transcripts
for the same loci and also some junctions could accumulate slightly less
reads  due  to  random effects.  As  we  would  like  to  reconstruct  the  most
complete  gene  models  we  calculated  the  top  counts  and  the  standard
deviation of counts for each set of the disjoint intervals. We always selected
the introns with the most counts and also the introns that have counts equal
or  more  than  round(top(counts)  –  sd(counts)).  These  consensus  introns
represent the high-confidence set of introns for a specific LncRNA model
and we used them to trim the islands of expression accordingly. To do so we
subtracted  the  genomic  intervals  of  these  consensus  introns  from  the
genomic  intervals  of  the  grouped  islands  of  expression.  That  gave  us  a
putative gene model of a novel LncRNA, see figure 8 for an illustration of
the consensus introns / splicing junctions and gene model reconstruction. 
In figure 8, we present an example of how our pipeline identified a
known  LncRNA using  RNA-sequencing  data.  The  consensus  introns  /
junctions gave an accurate representation of the actual splicing events and
the islands of expression gave an almost accurate representation of where
transcription starts and ends. The difference between the tracks of islands of
expression  and the  respective  consensus  introns  gave  as  a  very  accurate
representation of this LncRNA’s gene model. We should note here that the
differences between the gene models for the this LncRNA amongst the two
major  annotation projects,  RefSeq and ENSEMBL/GENCODE, are more
significant than the difference between our prediction and the ENSEMBL
annotation. 
The pipeline stores and exports these putative LncRNAs in the Gene
Transfer Format (GTF), which stores the genomic coordinates of each exon,
their order in the transcript and the genomic intervals of the whole RNA of
the  LncRNA together  with  a  LncRNA name  in  the  form of  chrX:start-
end(strand).  Given  the  reconstructed  transcripts  produced  by  the  above
process we selected only those which had more than 200bp exonic length
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and  we  fetched  their  sequence  from  ENSEMBL genome  assemblies  in
FASTA format. 
Coding potential of the complete models of putative LncRNAs was
calculated using the Coding Potential Calculator (CPC) (Kong et al., 2007),
which  is  essentially  a  Support  Vector  Machine  (SVM)  classifier  which
classifies  transcripts  into  potentially  protein  coding  or  non-coding.  CPC
uses two sources of information for classifying transcripts according to their
coding potential. One is homology of the translated sequences with known
proteins. To do this all the translated FASTA sequences were blasted using a
locally installed BLAST+ (Camacho et al., 2009) suite against a local copy
of the UniRef90 protein database  (Suzek et al., 2007). The more hits the
more likely it is for a transcript to be protein-coding. Then CPC parses the
BLAST+ output and together with sequence linguistic features it trains a
SVM classifier and assigns a score to every transcript. These  biologically
plausible  features  include:  the quality  and coverage  of  a  predicted Open
Reading Frame (ORF), the integrity of the ORF that includes whether an
ORF begins with a start codon and ends with an in-frame stop codon and the
length of ORFs. We filtered out all transcripts with a cpc score > 1. CPC
scores between -1 and 1 are considered to be in the grey zone, while scores
above 1 are considered definitely coding and scores below -1 definitely non
coding.  Moreover  CPC is  more accurate in identifying coding than non-
coding transcripts  (Kong et al.,  2007) and some LncRNAs are known to
produce  small  peptides  (Ulitsky  and Bartel,  2013).  For  these reasons,  in
order  no to discard any putative LncRNAs, we only discarded predicted
transcripts with a CPC score > 1. Finally, the predicted gene models which
were  consistently  and  sufficiently  expressed,  non-coding  and  more  than
200bp in length comprised a set of putative LncRNAs, see table 3.  
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Putative LncRNAs
Annotation Spliced groups of Islands of Expression and introns / novel
SJs
Length > 200bp
Expression > 0 reads across at least all samples of one condition 
Coding Potential < 1 CPC score
Table 3: Attributes of putative LncRNAs
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Figure 8: In this figure we present the known mouse LncRNA ENSMUG00000085282 and how our pipeline reconstructed it. Subtracting the consensus
intron (calculated from the regions most frequently covered by the identified splicing junctions) from the track showing the de novo identified grouped 
islands of expression gives us a close approximation of the real gene model. First we calculated the disjoint transformation of introns. Then we 
counted the overlaps of the original introns / novel splicing junctions on these disjoint regions. This produced the calculated consensus intron. Then we
subtracted these introns in which we have higher confidence from the grouped islands of expression. The only significant difference is that the first 
exon is smaller than in our prediction, but nevertheless the latest RefSeq annotation does not include the first exon at all.
Predicted 
LncRNA
Islands of 
Expression
Identified splicing 
junctions (introns)
ENSEMBL 
and RefSeq
annotation
Calculated consensus 
intron
Calculate DE and associate expression profiles of putative 
LncRNAs and genes 
The reconstructed gene models discussed above were exported in the
form  of  the  standard  Gene  Transfer  Format  (GTF)  file,  which  stores
genomic coordinates for the predicted LncRNAs. The output of this pipeline
is suitable for further count-based DE analysis. A table of counts for the
predicted  LncRNAs  can  be  directly  calculated  as  the  first  step  for  DE
analysis.    
Counts  were  assigned  on  LncRNAs  using  the  python  framework
HTSeq (Anders et al., 2015). We counted the reads overlapping exons and
summarized them at the gene level of the LncRNA. As a strategy for solving
reads  assigned  to  multiple  features  or  to  multiple  exons  of  the  same
LncRNA (i.e. ambiguous reads), we used the IntersectionNotEmpty strategy.
According to this strategy a disjoint version of the annotation of LncRNAs
was calculated and reads were assigned on the non-overlapping regions. In
this way a fraction of the ambiguous reads can be retained and assigned to
the feature they mostly overlap. The total number of ambiguous reads and
their distribution across samples was also used as a metric to asses both the
quality  of  our  annotation  of  predicted  LncRNAs  and  the  quality  of
individual  samples.  Although  the  number  of  multi-mappers,  i.e.  reads
aligned to more than one genomic region, are a trait of the RNA-seq sample
and the genome assembly, the amount of ambiguous reads in the counting
step is a trait  of the annotation and the counting algorithm. Thus a poor
annotation,  which  does  not  effectively  capture  the  actual  transcriptome’s
form,  would  produce  much  more  ambiguous  reads.  Additionally,  if  we
observe, in an otherwise consistent distribution of ambiguous reads across
samples  for  the  same  annotation,  spikes  of  ambiguous  reads  in  certain
samples and if this finding is consistent with spikes in the number of multi-
mappers,  then  we  can  hypothesize  that  those  samples  suffer  from  poor
sequencing quality, RNA-degradation or genomic contamination and should
probably  be  excluded  as  outliers.  Before  any  analysis  we  assessed  the
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quality of samples by measuring the number of ambiguous reads and the
non-unique alignments produced by the multi-mapped reads.
Next,  we  filtered  out  transcripts  which  were  not  sufficiently  or
consistently expressed in our experiment. Typically we removed LncRNAs
which did not reach counts of more than a threshold for at least all samples
of one condition. In this way we removed all predicted loci which showed
both very low and highly inconsistent expression with just some expression
spikes. Then we used DESeq2  (Love et al., 2014) to calculate differential
expression.  DESeq2  estimates  log  fold  changes  of  genes  and  infers
statistical significance of the observed change. The method moderates the
dispersion of genes through empirical Bayes shrinkage based on the average
expression  strength  of  genes  across  all  samples.  The  assumption  is  that
genes with similar average expression have similar dispersion. Additionally,
it shrinks log fold changes of genes towards zero according to how much
information  (counts,  dispersion,  degrees  of  freedom) is  available.  In  this
way,  artificially  high  Log  Fold  Changes  (LFC)  occurring  due  to  the
dispersion effect  on gene models with low reads,  are moderated.  This is
particularly important for predicted LncRNAs, where read counts are very
low and very small changes to the total read counts for a condition could
lead  to  very  high  log  fold  changes.  Then  hypothesis  testing  tests  if  the
coefficient  of  the  fitted  Generalised  Linear  Model  for  each  gene  is
significantly different from zero. We used the Wald test to calculate adjusted
p.values. 
Comparing conditions using Generalized Linear Models (GLMs)
In order to compare conditions and identify DE genes between them
we need a matrix with some quantification of gene expression, usually a
table of counts derived as described in the “Methods” chapter. In general we
start from a matrix Eij, where rows (i)  are the genes/features and columns (j)
are the samples. Then the matrix entries are fitted to a specific distribution,
usually  modelled  after  the  negative  binomial  distribution.  The  negative
binomial distribution fits the nature of the problem well as it is a discrete
probability distribution and it describes the number of successes in a series
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of  independent  Bernouli  trials  before  a  certain  pre-specified  number  of
failures occurs. 
Most  methods  calculate  sample  specific  constants,  which  are
proportional to the total number of mapped reads for the sample (i.e. the
library  size  for  RNA-seq),  and use  them to  normalize  gene  abundances.
Some  other  methods  calculate  gene-specific  normalization  constants  by
exploiting distinct attributes of the gene like nucleotide content or transcript
length.   
Then a Generalized Linear Model is used to explain changes in the
expression matrix for each gene. We should note here that the model is not
linear,  but there is a link function that links the linear predictor to the y
values. This is the attribute that distinguishes GLMs from linear models. 
 First counts are transformed into logarithms and then into a model of the
form:
The y response variable represents the measured quantity of a gene’s
abundance, i.e. counts, for genes  1  to n.  bo,  b1,  b2 etc are the coefficients
which explain changes in variable  y for condition  Xp. The residual term e
represents the error and is the measured variance of the true value and the
predicted value of Y given the fit of the GLM. 
This GLM can be much more elegantly represented in a matrix form 
y = Xb + e:
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As we have a lot of genes this can be written as yij=∑rxjrbir, where xjr  are the
design matrix elements and  bir  the coefficients. In a simple linear model
with  only  two  conditions  the  two  coefficients  are  the  mean  of  the
measurements for one group and the difference between the means of the
two groups. The design matrix for such a model with formula  y ~ condition
would be:
Samples Intercept Condition 2
1 1 0
2 1 0
3 1 0
4 1 0
5 1 1
6 1 1
7 1 1
8 1 1
For the example above, if the formula is a model of the mean then
the  Intercept  covariate  is  the  mean  of  all  samples.  The  Condition  2
covariate  is  the  difference  of  the  estimation  of  the  mean  of  samples
belonging to Condition 2 compared to all samples. In complex models like
the one used for this experiment, which are frequently used when we have
more  than  one  condition  of  interest,  or  if  we  want  to  model  a  nested
interaction or batch effects, we can have formulas of the type y ~ condition
+ type + type:condition. For example in this imaginary dataset described by
the above model we have condition 1 and 2 and type 1 and 2. In such a case
we  have  an  additive  model  of  condition  plus  type,  so  we  can  look  at
variances  related  to  “condition”  by  controlling  variances  introduced  by
“type” and we have also type specific effects of the condition variable using
the  nested  interaction  term  “type:condition”.   A model  with  the  above
formula is very useful when we want to compare condition effects across
different  strains  or  cell  lines  and  also  when  we  have  two  interacting
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conditions.  The  above formula  can  also  be  more  elegantly  written   y  ~
condition * type. 
Given  such  a  model  and  using  the  R’s  formulation  of  GLM  for
hypothesis  testing  we  can  have  the  following  coefficients  of  the  linear
model: intercept,  type 2,  condition 2, type 2: condition 2. Then we need to
define the reference level for each factor, lets say condition 1 for condition
and type 1 for type. In order to carry out the comparison of  “condition 2 vs
condition  1”  for  the  reference  type  only  (type  1),  we use  the  estimated
coefficient “condition 2”. In order to compare “type 2 vs type 1” for the
reference  condition  only  (condition  1),  we  use  the  estimated  coefficient
“type 2”.  The interaction term  “type 2: condition 2”  describes only the
difference between the effect of condition 2 vs condition 1 in type 2, vs the
effect of condition 2 vs condition 1 in type 1. Thus this coefficient, i.e. the
interaction term, represents the difference of differences.
It  is  very  important  to  clarify  that  the  interaction  term  “type  2:
condition 2” does not  describe the whole response in condition 2 for type 2,
but rather how different that is from the effect of condition 2 in the reference
type, i.e. type 1. It describes only the difference in coefficients of condition
2 vs condition 1 for type 2, vs condition 2 vs condition 1 for type 1. This is
exactly  the  difference  of  coefficients  between  type  2  and  type  1  in  the
comparison of condition 2 vs condition 1. It explains only the proportion of
the effect of condition 2 in type 2 that cannot be explained by the general
effect of condition 2. Thus this comparison does not involve the comparison
of normalised abundances but rather the comparison of fold changes. 
We furthermore  assessed  the  expression consistency of  LncRNAs
using  the  Cook’s  distance.  Cook’s  distance  is  the  difference  in  the
coefficient of a linear model explaining the expression of a gene or LncRNA
across samples if we remove a sample and refit the model. We plotted the
log10 of the Cook’s distance for each loci to detect outliers with inconsistent
expression and bar-plots of the average Cook’s distance for all LncRNAs in
a sample to asses quality of samples. 
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Annotation of predicted LncRNAs
Next, we assessed the ability of the predicted LncRNAs’ expression
pattern to separate samples in order to asses whether they carry or not any
biological signal relevant to the respective experimental  conditions using
principal components analysis and hierarchical clustering. 
Finally, we annotated putative LncRNAs with a unique name using
the form chr:start-end(strand). Moreover, we annotated predicted LncRNAs
by the gene names that flank it upstream and downstream and also by the
gene name of any antisense protein coding gene. Then, after we calculated
differential expression of known gene annotations, we used them to identify
correlating and anti-correlating expression profiles of protein coding genes
and antisense or intergenic LncRNAs.
More specifically we reported all antisense LncRNAs, all LncRNAs
which had a known pain gene (Lacroix-Fralish et al., 2007) as their closest
neighbour and all LncRNAs which were antisense of a known pain gene.
Additionally,  we  selected  all  antisense  LncRNAs  which  had  an  anti-
correlated expression profile with the gene on the opposite strand and were
both significantly DE (adjusted p.value < 0.05) for the same comparison.
We also selected and reported all antisense LncRNAs that were significantly
DE on the opposite strand of significantly DE protein coding genes  with an
opposite  log  fold  change  and  all  significantly  DE intergenic  LincRNAs
proximal to significantly DE protein coding genes These sets of LncRNAs
are comprised of predictions that are highly probable of having a functional
role in neuropathic pain.  
As all LincRNA had a highly correlated expression profile with their
most closest protein coding gene and we had no gold standard of known
highly correlated genes and LincRNAs, we used a permutation approach in
order to select the most highly correlated pairs of LincRNAs and protein
coding genes. Pearson correlation was calculated for all samples using the
regularised  log  transformed  normalised  counts  in  order  to  make  counts
directly comparable. We then utilized a permutation/randomisation. First we
generated random numbers from a normal distribution and used them to pair
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features  of  the  datasets  of  LincRNAs  and  their  closest  genes.  We  only
considered  significant  estimations  (p.value  <  0.05)  of  the  Pearson
correlation coefficient regarding the comparison wise error rate. In this way
we calculated the correlation between random pairs of protein-coding genes
and LincRNAs, we considered these as false positives. We then did the same
for the actual pairs  of adjacent protein coding genes and LincRNAs, we
considered these as true positives. As we wanted to reduce false positives as
much as possible, we adjusted the cost of false positives to be 3 times that of
false negatives and we adjusted the optimal cut-off threshold of significant
correlation so as to discard as much as false positives without losing a lot of
true positives. We then assessed the performance of this classifier by the
Receiver  Operator  Characteristic  (ROC)  curve  and  the  respective  Area
Under  the  Curve  (AUC) and calculated  the  optimal  cut-off  value  of  the
correlation coefficient, figure 9.  
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Figure 9: Area under the curve of a classifier built to distinguish 
between correlation calculated form from random pairing and 
correlation of actual pairs of proximal genes and LincRNAs. 
Correlation coefficients above the cut-off were considered significant.
Calculate counts and DE of known genes
Regarding the already annotated and protein coding fraction of the
transcriptome,  we  used  the  same  approach  as  for  LncRNAs.  First,  we
always used the latest annotation of ENSEMBL / GENCODE genes as they
are the most comprehensive ones in terms of the inclusion of all possible
gene types. They have been also found to be significantly better than RefSeq
annotations in terms of the percentage of mapped reads and the number of
features  with  clear  evidence  support  (Seqc/Maqc-Iii  Consortium,  2014).
Although  AceView  (Thierry-Mieg  and  Thierry-Mieg,  2006) outperforms
ENSEMBL annotation in  human,  it  is  not  that  widely used and not  that
convenient to use for DE analysis in automated pipelines. We then assigned
counts  using  HTSeq  with  the  “invert  strandedness”  option  in  order  to
accommodate  for  the  usage  of  dUTP libraries  (see  Introduction,  section
Analysing  RNA-Sequencing  data)  and   the  “Intersection_nonempty”
counting strategy in order to resolve assignment of ambiguous reads and not
lose experimental power. 
Subsequently, we carried out differential expression analysis using
DESeq2. Regarding annotated genes we did not impose any expression filter
but we rather relied on independent gene filtering based on Cook’s distance
as implemented in DESeq2. For performing principal components analysis
and for visualization purposes, where transformed counts that remove the
variance’s  dependence  on  the  mean  and  a  zero-centered  distribution  of
counts  are  highly  desirable,  we  used  either  the  regularized  log
transformation (rld) or the variance stabilizing transformation (vsd). Both
methods borrow information from all samples in the experiment in order to
remove the general trend of variance observed on genes with similar mean
counts. Also, as we usually dealt with complex designs, we used interaction
terms and blocking designs in order to assess group specific responses (see
Introduction, section Analysing RNA-sequencing experiments). Finally, we
used BiomaRt  (Durinck et al., 2009) in order to obtain orthologs between
species, to fetch gene symbols and functional annotations and to compile
92
specific gene lists, like the pain genes list downloaded from the pain genes
database.
Functional enrichments
Regarding functional enrichment, we used customised R scripts that
rely  on  functions  and  classes  implemented  in  the  topGO  (Alexa  and
Rahnenfuhrer,  2010) package.  We  implemented  customised  functions  to
adapt the package’s functionality  to our needs.  Our goal  was to  perform
over-representation  analysis  for  gene  ontology  (Ashburner  et  al.,  2000)
terms. Gene ontology (GO) is a project aiming at annotating gene properties
with a structured vocabulary divided into three distinct domains. Cellular
component, molecular function, which describes gene function at the basic
molecular level and biological process, which describes series of molecular
events with a certain start and end that are important for the function of
organisms,  organs,  tissues  and  cells.  GO is  structured  in  the  form of  a
directed acyclic graph, where parent terms are the three distinct domains and
then, as we go down the tree, we find more specific terms. Thus, terms are
organised in a parent-child hierarchy and all child terms can be described, in
a more general way, by their parent terms. As the biological process (BP)
annotation describes series of biological events of higher order, carried out
by  organised  molecular  assemblies,  we  performed  enrichment  analysis
looking for over-represented GO terms of biological process.
Due  to  its  structure  as  a  directed  acyclic  graph,  GO terms  show
strong dependencies between them. In addition, some broader terms, higher
in the tree structure, which may not capture the actual underlying biological
process, can be scored higher than more relevant and specific terms even if
we use a hyper-geometric distribution with multiple correction, i.e. when we
explicitly take into account the size of the respective GO family.  
Several  methods  have  been  proposed  that  take  into  account  the
structure of the GO graph. Two of them are implemented in  topGO and
involve the elimination of genes mapped to significant GO terms from terms
that are higher up in the hierarchy and weighting of genes based on the
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scores  of  neighbouring  GO  terms  (Alexa  et  al.,  2006).  The  elimination
method  works  bottom-up  and  iteratively  removes  genes  associated  with
significant  GO  terms  from  its  ancestors.  On  the  other  hand  the  weight
method  introduces  a  scoring  system in  order  to  decide  if  a  child  better
represents interesting genes than its ancestor and thus identifies the most
significant local  node. We used these algorithms combined with the Fisher
Exact test  and the Kolmogorov-Smirnof (KS) test  as implemented in the
topGO package to calculate significance. 
In every over-representation / enrichment analysis it is important to
define a  gene universe and a set  of  interesting genes according to  some
parameters. As the universe of genes, i.e. all genes that can be potentially
significantly differentially  expressed,  we usually used all  genes than had
more than 0 counts in all samples of at least one condition. As the set of
interesting genes looking for enrichment we selected either all genes with an
adjusted p.value from the DESeq2 Wald-test less than 0.05 or genes selected
with a binary function that assigns 0 or 1 to genes found to have an adjusted
p.value  <  0.05  in   certain  conditions  and  strains.  When  we  looked  for
enrichments in genes that were significantly DE in one species or strain and
not  in another,  or genes  significantly DE in a  species or strain and also
significantly DE in another, we used as the universe of genes all genes that
were significantly DE in the reference species or strain. So we looked for
enrichments in genes that were commonly, significantly DE in two strains,
or in two different species, or genes significantly DE only in one condition,
strain or species and not in others. Then we reported the ranking of GO
terms by the elimination algorithm with KS test, the weight algorithm with
Fisher  and  KS  test  and  the  simple  exact  Fisher  test.  We  selected  and
presented enriched terms by their ranking according to the weight algorithm
using the Fisher test. We also printed out the GO sub-graph made by the top
enriched biological process in order to gain insights in the relationships of
the  enriched  biological  process  terms.  Our  analysis  does  not  take  into
account  gene  length  bias,  but  is  rather  an  over-representation  analysis
looking  for  significantly  over-represented  GO  terms  associated  with  the
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significantly  DE genes,  compared  to  the  gene  universe.  There  are  other
methods that normalise for gene length biases but DESeq2, which is  the
method  we  used  for  DE  analysis,  has  been  proven  to  have  very  good
performance without normalising for length biases.
In  the  next  two  chapters  we  present  results  from  applying  this
computational  pipeline  and  we  also  further  discuss  its  details.  We  first
present results from rats that underwent the SNT pain model and then from
mice that underwent the SNI pain model.    
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Transcriptional changes of protein coding 
genes and novel LncRNAs in rat’s DRG 
after the SNT pain model
Overview
In  order  to  study  the  transcriptional  changes  occurring  in  well
induced  pain  states,  we  applied  our  customised  pipeline,  presented  in
chapter Methods, section Reconstruct genes of putative LncRNAs, to Next
Generation Sequencing data from rat’s Dorsal Root Ganglion (DRG). The
pain  model  we  used  is  the  Spinal  Nerve  Transection  (SNT)  and  for
producing controls samples we used sham operated animals. The application
of our customised pipeline gives us the advantage of analysing Differential
Expression (DE) not only for annotated gene models but also for ab initio
predicted Long Non-Coding RNAs  (LncRNAs). Our hypothesis that certain
protein coding genes and novel LncRNAs contribute to neuropathic pain
was assessed by identifying novel LncRNAs and neuropathic pain mediators
DE between SNT and sham operated rats.  We also gained more insights
regarding the rat’s DRG transcriptome as we identified putative LncRNAs,
intergenic (LincRNAs) or antisense of protein coding genes, and associated
their expression profiles with that of pain mediators. Surgeries, behavioural
tests  and  tissue  extraction  were  carried  out  in  Steve  MacMahon’s  lab
(CARD centre), King’s College London, by Ana Antunes-Martins. Library
preparation and sequencing was carried out at Oxford Genomics, Oxford.
All data analysis was done by me.
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Background
The Spinal Nerve Transection pain model
The Spinal Nerve Transection pain model is a model of peripheral
neuropathy,  where  a  trauma  is  surgically  introduced  in  the  peripheral
nervous system in order to induce reproducible sensory dysfunction,  i.e.
allodynia, hyperalgesia and spontaneous bursts of pain. 
The SNT model involves the tight ligation and transection of the L5
and sometimes L6 spinal  nerve branches  (figure 1) and produces  a well
induced  and  reproducible  phenotype  with  tactile  allodynia  as  its  main
component  (Bennett et al.,  2003; Mogil, 2009). In this case only the L5
spinal nerve was transected and the L4 and L6 branches are carefully left
intact. All rats received SNT surgeries on their left sciatic nerve branches.
Moreover we used sham operated animals, where the spinal nerve has been
exposed but not ligated, to generate control samples.
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Figure 1: SNT pain model, the L5 and sometimes L6 spinal nerve branches 
are tightly ligated and transected. The L4 branch remains intact.
Spinal Nerve 
Transection
RNA-Seq and library preparation
Data  was  obtained  for  rats  which  underwent  Spinal  Nerve
Transection and for rats which only underwent sham surgery and were used
as  the  control  group.  Tissue  from  Lumbar  5  (L5)  of  the  Dorsal  Root
Ganglion (DRG) was harvested and RNA was collected  21 days after the
SNT surgery. The timepoint chosen allowed us to assess expression changes
due  to  painful  neuropathy,  as  on  Day  21  we  assumed  that  most  of  the
inflammatory response has been resolved.
From each condition four replicates  were taken,  comprising DRG
tissue  from  3  pooled  animals.  Pooling  samples  of  the  same  condition
produces higher quantities, i.e. yield of RNA, for library preparation, and
can marginalise unwanted sample specific effects that could introduce an
artificially high within samples dispersion. Thus we had 12 replicates for
each condition, pooled together into 4 samples for each condition, 8 samples
in total. As a consequence of pooling samples together, the 4 replicates we
had per condition were not actual biological replicates. Pooling data from
multiple animals would eliminate some of the variance making the injury
induced  molecular  response  easier  to  detect  and  more  consistent.  All
animals were male adult rats, thus we had no sex-effects to control for. 
The  8  samples  for  both  conditions  were  sent  for  sequencing  to
Oxford  Genomics  Center,  High  Throughput  Genomics.  Total  RNA was
provided  to  the  sequencing  centre,  where  the  ribodepleted  fraction  was
selected  for  further  sequencing.  Ribodepletion  excluded  the  ribosomal
RNAs. Subsequently, the ribodepleted RNA was converted to cDNA using
the strand-specific (deoxy-UTP strand-marking) dUTP protocol which is the
leading  protocol  for  strand-specific  synthesis  of  cDNA. Sequencing  was
carried out in 4 sequencing lanes with samples multiplexed according to the
condition for each lane and with a sequencing depth of more than 50 million
reads for each sample. 
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Aligning RNA-seq reads to genome
Oxford Genomics RNA-sequencing centre produced flat text FastQ
sequencing files. Quality metrics were encoded using the Sanger standard
and  Phred  score  (Ewing  and  Green,  1998).  This  metric  assesses  the
probability that the corresponding base call is wrong. Sequencing was done
in four sequencing lanes, producing four technical replicates per sample. In
general all these lanes gave high yield, consistent GC content,  consistent
and expected  sequence  inserts between the paired-end adapters and high
quality base calling (see table 1). Regarding RNA-seq read duplicates, as
they  are  only  computationally  identified  as  reads  mapped  to  identical
positions,  they  cannot  be  separated  to  PCR  amplification  artefacts  and
natural ones. Recent studies  (Parekh et al., 2016) suggest that removal of
duplicates worsens the false discovery rate of differentially expressed genes
and does not improve precision of the analysis. However, in our samples
duplicates were very low, approximately 7%. 
Lane % GC % GCmapped
σpos(
%GC)
insert ± MAD % exonic % exon cov'ge %N
maxpos %
N
%lowQ %lowQend avgQ
3.1 51.0 ± 10.7 50.7 ± 10.0 3.97 151 ± 42 20.4 89.9 0.0 0.1 0.0 0.0 35.1
3.2 50.9 ± 11.0 50.5 ± 10.6 2.70 150 ± 42 20.5 89.9 0.0 0.0 0.0 0.0 34.5
Lane % GC % GCmapped
σpos(
%GC)
insert ± MAD % exonic % exon cov'ge %N
maxpos %N %lowQ %lowQend avgQ
4.1 53.1 ± 11.1 52.8 ± 10.6 3.52 153 ± 42 18.5 89.0 0.0 0.1 0.0 0.0 35.0
4.2 52.9 ± 11.4 52.5 ± 11.0 2.41 153 ± 42 18.5 89.3 0.0 0.0 0.0 0.0 34.5
Lane % GC % GCmapped
σpos(
%GC)
insert ± MAD % exonic % exon cov'ge %N
maxpos %N %lowQ %lowQend avgQ
1.1 50.7 ± 10.7 50.6 ± 10.3 4.30 154 ± 42 19.9 89.7 0.0 0.2 0.0 0.0 34.9
1.2 50.7 ± 11.1 50.4 ± 10.9 2.84 152 ± 42 20.0 89.8 0.0 0.1 0.0 0.0 33.3
Lane % GC % GCmapped
σpos(
%GC)
insert ± MAD % exonic % exon cov'ge %N
maxpos %N %lowQ %lowQend avgQ
2.1 51.1 ± 10.4 51.0 ± 10.0 3.74 158 ± 46 23.3 90.1 0.0 0.3 0.0 0.0 34.8
2.2 51.3 ± 10.8 51.0 ± 10.5 2.81 156 ± 44 23.4 90.3 0.0 0.0 0.0 0.0 32.8
Table 1: Quality controls for all 4 sequencing lanes.
To produce binary files of RNA-seq reads mapped to the genome
(BAM  files)  used  for  downstream  analysis  we  used  the  STAR  aligner
(Dobin et al., 2013).   We mapped all FastQ files  to the most comprehensive
rat  genome  assembly  (rn5)  downloaded  from  the  ENSEMBL  genome
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browser.  Reads were aligned for each sequencing lane in parallel and then
the sorted BAM files were merged with their respective technical replicates
of the same sample, in order to produce 8 merged, sorted and indexed BAM
files. We merged BAM files generated from the same sample in order to
acquire the best possible read coverage for all genomic loci, including loci
that are transcribed into lowly expressed LncRNAs
As the rat’s genome is not that well annotated, unlike the genome of
the mouse or human,  there was a larger percentage of unmapped reads.
13.94% was  the  highest  percentage  of  unmapped  reads  per  sample.   In
general, we had more than 73% of uniquely mapped reads per sample, with
the  exception  of  two  samples  where  the  uniquely  mapped  reads  were
68.63%  and  67.53%.  These  mapping  percentages  are  good,  but  not
excellent. However, taking into account multi-mapped reads gave us more
than 84.5% of reads aligned to rn5 genome in every sample, a percentage
which is considered very good and better than similar studies (Gong et al.,
2016). 
Consequently, we collapsed technical replicates before counting any
reads,  in  order  to achieve the best  coverage possible  in  lowly expressed
areas of the genome. Then we proceeded to count reads for known genes
using  the  ENSEMBL genomic  features  annotation,  in  the  form of  gene
transfer format (GTF) files, programmatically downloaded directly into R
using the biomaRt  (Durinck et al., 2009) interface. Counting was done in
parallel using HTSeq (Anders et al., 2015) with the intersection not empty
strategy (see chapter  Introduction,  section Analysing RNA-seq data).  We
used the recommended options for HTSeq for paired-end sequencing, sorted
BAM files by genomic location with strandedness generated from the dUTP
library.  We assigned counts on the gene level, grouping together multiple
transcripts derived from the same gene.
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Experimental Design
As we only had one factor of interest with two conditions, i.e. SNT
operated animals and sham operated animals as controls, we used a simple
design with an intercept term holding the mean of all samples.  Log fold
changes were moderated and shrunk towards the intercept term, i.e. when
we did not have enough information for a specific gene due to high variance
or  too  low counts,  its  log  fold change was shrunk towards  the intercept
according to the generally observed log fold changes for genes with similar
normalised mean counts (see chapter Methods, section Calculate DE and
associate expression profiles of putative LncRNAs and genes). 
From each  experimental  condition  four  replicates  were  available,
enough  to  calculate  within  conditions  variation  and  generate  accurate
estimations of DE. The generalized linear model we fitted for each gene had
one coefficient for  condition,  and according to the GLM notation had the
following form: ~ condition.
Further quality control
Before analysing DE we assessed how RNA-seq multi-mapped reads
and reads that were overlapping more than one feature of the annotation,
were  distributed  across  samples.  As  another  step  of  quality  control  we
examined how consistent was the expression of genes across samples.
In  BAM files,  RNA-seq reads  have  a  hexadecimal  header  which
holds information regarding the quality of base calling but also regarding
the way the reads have been mapped to the genome. Reads can be mapped
to the genome in more than one positions,  but with an optimal mapping
position, or in multiple positions with equal probabilities. The latter reads
are  called  multi-mappers.  Moreover,  in  the  counting  step,  reads  can  be
assigned to only one genomic feature / gene model. If this is not the case
and the read cannot be confidently assigned to only one feature then the read
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is  called  ambiguous.  Multi-mappers  can  produce  a  very high  number  of
non-unique alignments in the counting step.
In  the  context  of  analysing  putative  LncRNAs  we  examined
ambiguous reads for both the ENSEMBL annotation and for the customised
annotation generated from our pipeline in the form of a GTF file that holds
putative LncRNAs. As seen in figure 2, there is very small fluctuation in the
number of non-unique alignments between samples and a very stable and
small number of ambiguously counted reads in any of the annotations. The
non-unique alignments are not the number of multi-mapped reads, but rather
how many times these reads  have  been aligned to  the genome and thus
identified  in  counting  step.  The  very  small  and  consistent  number  of
ambiguous  reads  indicates  that  all  samples  are  of  good  quality  for  DE
analysis  and  also  that  the  customised  annotation  of  LncRNAs has  good
structure suitable for downstream analysis.
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Figure 2: Number of non-unique alignments  (violet) and ambiguously counted reads (pink) for ENSEMBL genes (left) and predicted LncRNAs (right). 
Non-unique alignments arise from multi-mapped reads as they are being counted multiple times. All values have been log2 transformed.
 Next  we  assessed  how  consistently  ENSEMBL  genes  were
expressed across all samples. Genomic contamination or RNA degradation
could lead to spurious spikes in gene expression. Thus we calculated the
amount  that  the  coefficient  of  a  gene’s  linear  model  can  change  if  we
remove a sample and refit the model. That is the Cook’s Distance and in
figure  3  shows  the  distribution  of  Cook’s  distances  for  all  genes  in  all
samples.  The median of  Cook’s  distances  which is  less  than 1 (negative
logarithm)  shows  that  no  particular  sample  is  highly  influential  to  be
considered an outlier (Cook and Weisberg, 1982). 
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Figure 3: Boxplot of Log10  Cook’s distance for all ENSEMBL genes in all samples.
From the plot is evident that the majority of Cook’s distances is less than 1 and the 
distribution is consistent between samples.
 These  results  indicated  good  quality  of  samples  and  thus  we
proceeded to the analysis of DE genes.
Results
Differential Expression analysis of known genes
We used DESeq2 (Love et al., 2014) to analyse count-based RNA-
seq data. DESeq2 estimates log fold changes of genes and infers statistical
significance of the observed change.  For more details regarding differential
expression  analysis  see  chapter  Introduction,  section  Analysing  RNA-
sequencing data and chapter Methods, section Calculate DE and associate
expression profiles of putative LncRNAs and genes.
First we normalised and log transformed counts in a way that does
not  overestimate  LFC for  genes  with  low  counts,  using  the  regularized
logarithm  transformation  (rld),  which  shrinks  LFC  for  genes  with  low
counts  (Love et al., 2014). The rld transformation also produces a centred
mean distribution of counts with equal variances between samples, which
makes  it  ideal  for  visualisation  purposes.  Then  we  clustered  samples  to
examine how gene expression could separate them according to biological
condition. All clustering was blind to the experimental design.
All  samples  were  clustered  according  to  their  relative  euclidean
distance.  Furthermore  principal  component  analysis  was  carried  out  to
check  if  samples  were  optimally  separated  by  the  two  first  principal
components.  From the respective figure we concluded all  of the samples
clustered  well  with  their  respective  family  and  different  biological
conditions  could  be  easily  separated  using  the  two  first  principal
components (Figure 4 and 5). The top 500 ENSEMBL genes regarding their
variance across all samples were used for these plots.
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Figure 4: Hierarchical clustering of samples 
according to regularized log2 counts of 
ENSEMBL genes.
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Figure 5: Principal Components analysis of regularized log2 counts of 
ENSEMBL genes. The top 50 genes contributing to PC1 and PC2 are in 
Appendix 1.
Significantly DE genes
Using  DESeq2  and  the  Wald  test  with  the  Benjamini–Hochberg
correction  to  control  false  discovery  rate  and  adjust  p.values  we  have
assessed the significance of the differential expression of genes. There were
in total 14291 genes with nonzero total read counts across conditions. The
total number of genes in rat is less than that in human and mouse, this is a
direct consequence of the poorer annotation of the rat’s genome. 
1. ENSEMBL genes significantly differentially expressed (DE) with an
adjusted p.value < 0.05 between SNT and Sham operated rats:
LFC > 0 (up)     : 2953, 14% 
LFC < 0 (down)   : 3358, 15% 
outliers      : 31, 0.14% 
The fraction of significantly DE genes identified (29%) implies that
major  changes  are  happening in  the  DRG’s  transcriptome after  the  pain
model. This is consistent with literature, recently (Wu et al., 2016) found
that 1,163 out of of 27,463 (40%) genes were significantly DE in mice DRG
after the SNL pain model. 
As expected we observed significant transcriptional changes after the
well induced pain state of peripheral neuropathy and the amount of genes
significantly up-regulated and down-regulated was balanced. Out of the 430
genes functionally validated to be implicated in pain and downloaded from
the “pain genes” database  (Lacroix-Fralish et  al.,  2007) 244 passed the
independent gene selection of DESeq2 and their DE was calculated. Out of
these 244, 115 (47%) had an adjusted p.value < 0.05  and 45 (18.4%) had an
adjusted p.value < 0.05 and also a log2 fold change > 1. Thus a significant
percentage  of  these  pain  genes  were  found  to  be  significantly  DE.  The
relationship of the log2 fold changes and the p.values for all genes after the
pain surgery can be seen in figure 6, pain genes are text label and all genes
that had either high fold changes or significant p.values are colour coded.
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Figure 6: Volcano plot showing the 
relationship between the log2 fold 
change of genes and the p.value. 
Genes that reach very significant 
p.values < 0.05 and also show high 
log2 fold change > 1 are colour 
coded in green. Known pain genes 
are text labelled on the plot.   
Functional enrichment
Based  on  the  above  findings  that  suggested  a  strong  molecular
signature  of  transcriptional  changes  related  to  the  neuropathic  pain
phenotype, we proceeded to rigorously assessing the functional enrichment
of the set of significantly differentially expressed genes between SNT and
sham operated rats. Moreover, as the number of significantly DE genes is
large,  we  can  summarize  these  transcriptional  changes  in  the  level  of
biological processes. To do this we looked for statistically significant over-
represented  Gene  Ontology  (GO)  terms  regarding  biological  process
(Ashburner  et  al.,  2000).  In  the  GO  context  a  biological  process  is
considered any process with a certain start and end where all the distinct
steps of the process are accomplished by organised assemblies of molecular
functions. We assessed the significance of over-represented GO terms using
both count base exact tests, namely the Fisher exact test and some of its
variations, and non-parametric hypothesis tests, namely the Kolmogorov–
Smirnov  (KS)  test  and  its  variations  (see  Methods,  section  Functional
enrichments). We have ranked enriched GO terms by the weighted Fisher
test and for completeness we have retained the KS test ranking. To identify
the  top  20  enriched  biological  processes  we  selected  the  top  processes
according to the weighted Fisher test that had an exact Fisher test p/value <
0.05. These top 20 enriched GO terms are in table 2 and the GO subgraph
generated from the top of them in figure 7. 
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Table 2: The top 20 enriched GO terms ranked according to the KS and fisher exact test. We also present the number of genes annotated under each 
GO, the number of genes found to be significantly DE and the expected number if there was no enrichment.
GO.ID Term decription Annotated Significant Expected Rank in weightKS p.value classicFisher p.value weightFisher
GO:0071805 potassium ion transmembrane transport 118 84 53.83 1 1.4e-08 7.1e-07
GO:0035725 sodium ion transmembrane transport 89 64 40.6 3 4.1e-07 8.1e-06
GO:0034765 regulation of ion transmembrane transport 265 165 120.89 4 2.6e-08 4.5e-05
GO:0009612 response to mechanical stimulus 198 129 90.33 13 1.8e-08 5.2e-05
GO:0007165 signal transduction 3000 1568 1368.58 6 2.0e-18 6.2e-05
GO:0019228 neuronal action potential 28 23 12.77 2 8.0e-05 8.0e-05
GO:0000122 negative regulation of transcription from RNA polymerase II promoter 499 269 227.64 11 8.6e-05 8.7e-05
GO:0051592 response to calcium ion 95 63 43.34 17 3.6e-05 9.2e-05
GO:0048791 calcium ion-dependent exocytosis of neurotransmitter 21 18 9.58 14 0.00018 0.00018
GO:0090090 negative regulation of canonical Wnt signalling pathway 72 48 32.85 5 0.00024 0.00024
GO:0050770 regulation of axonogenesis 128 78 58.39 36 0.00033 0.00032
GO:0001764 neuron migration 105 63 47.9 30 0.00204 0.00036
GO:0034113 heterotypic cell-cell adhesion 28 22 12.77 32 0.00038 0.00038
GO:0042391 regulation of membrane potential 273 164 124.54 20 8.2e-07 0.00056
GO:0001779 natural killer cell differentiation 13 12 5.93 42 0.00061 0.00061
GO:0048266 behavioral response to pain 16 14 7.3 8 0.00067 0.00067
GO:0071260 cellular response to mechanical stimulus 76 49 34.67 62 0.00069 0.00069
GO:0051965 positive regulation of synapse assembly 51 35 23.27 39 0.00075 0.00075
GO:0070306 lens fiber cell differentiation 19 15 8.67 45 0.00323 0.00085
GO:0007160 cell-matrix adhesion 131 73 59.76 22 0.01240 0.00099
We observed a very significant enrichment in GO terms related to
ion channels, mainly potassium and sodium. Moreover we had significant
enrichments  in  biological  processes  related  to  neuron  regeneration  and
development,  such  as  regulation  of  axonogenesis  and  synapse  assembly.
Furthermore, higher order behavioural terms related to pain phenotype were
observed e.g response to mechanical stimulus and behavioural response to
pain. Processes related to signalling such as signal transduction, neuronal
action potential, calcium ion dependent exocytosis of neurotransmitter are
also significantly enriched. This enrichment is consistent with the literature 
(Lötsch et al., 2013) and also reflects our understanding of the biological
processes that are functionally important in neuropathic pain. 
As  discussed  in  the  chapter  Introduction,  section  Pain  at  the
molecular level, ion channels are some of the main pain mediators and are
expressed  in  nociceptors  in  order  to  transmit  pain  signals  and  regulate
neuronal  excitability  (Basbaum  et  al.,  2009).  Sodium  channels  transmit
information from the periphery to the dorsal horn; potassium channels act as
breakers on excitability and are involved in mechanotransduction; Transient
receptor potential (TRP) channels are known to activate nociceptors after
thermal, chemical and mechanical stimuli. Maladaptive neuronal plasticity
and sensation are crucial for maintaining neuropathic pain and the same is
true  for  regeneration  of  neurons  and  axons  after  nerve  injury.   We  can
confirm  that  we  observed  an  extended  repertoire  of  dysregulated  genes
heavily  related  to  nociception,  response  to  stimuli  and  pain  signal
transduction which is consistent with the amount of pain genes dysregulated
as  seen  in  the  volcano  plot  of  figure  6.  In  particular  terms  related  to
potassium and sodium channels and neuron regeneration were also found to
be significantly enriched mainly in BALB/c mice showing high mechanical
hypersensitivity after the Spared Nerve Injury pain model and presented in
the next chapter. These results are consistent with similar studies in rat DRG
after peripheral nerve injury (Gong et al., 2016). 
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Figure 7: Gene Ontology 
subgraph leading to the top five 
(red boxes) highly enriched GO 
terms. From Left to right the 
highly significant leaves (red 
boxes) of the graph are: Sodium
ion transmembrane transport, 
potassium ion transmembrane 
transport, regulation of ion 
transmembrane transport, 
signal transduction, response to 
mechanical stimulus 
Expression patterns of ion channels and pain genes
Guided  from  the  enrichment  results  and  the  literature  we  next
decided to specifically analyse ion channels and pain genes and selected all
potassium,  calcium,  sodium,  chloride  and  transient  receptor  potential
channels and pain genes. This was done as these genes are known to be
implicated  in  pain,  from our  unbiased analysis  we found that  GO terms
associated with these genes were highly enriched and also validated pain
genes  helped  as  to  identify  and  confirm a  strong molecular  response  to
nerve injury after the pain model. More importantly these genes, which are
significantly  DE  according  to  our  unbiased  DE  analysis  and  also
functionally  important  for  pain,  make a  reference  point  for  comparisons
between the rat and mouse DRG responses after peripheral nerve injury and
for the comparison between the two mouse strains that we will discuss in the
next  chapter.  We  plotted  their  expression  patterns  using  heatmaps  and
examined  how  well  these  specific  gene  sets  could   separate  samples
according to condition.
First,  by  examining  the  expression  pattern  of  pain  genes  derived
from the Pain Genes Database  (Lacroix-Fralish et al., 2007) (figure 8) we
observed  that  all  samples  were  optimally  clustered  with  their  respective
families. This finding was consistent with the PCA plot discussed above.
Moreover we could identify distinct clusters of pain genes that are co-up-
regulated or co-down-regulated after the SNT pain surgery. 
Two samples, SHAM_82519_232 and D21_SNT_86634_231 did not
have the  same transcriptional profile like the other ones. Moreover they did
seem more similar  to each other  than samples from the same conditions
respectively.  This is evident from figure 8 and we also observed that these
samples were closer to each other in the PCA plot (figure 5). As we had no
evidence from the quality assessment that there was any RNA quality or
RNA  abundance  issue,  or  noise  due  to  library  preparation  or  RNA-
sequencing, in fact they had excellent metrics like the other samples, we
decided not to remove them. We think that reporting of data analysis results
should be as complete as possible and inference should be made only based
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on evidence gathered from the data itself. Thus we did not want to speculate
for  a  reason  why  these  samples  did  not  follow  the  expected  pattern  of
transcriptional  changes.  We  should  note  here,  that  such  an  experiment
involves a lot of complicated processes, where errors can be accumulated
and cause observed data variance.   
Regarding potassium channels we observed general down-regulation
after the SNT surgery and excellent separation of samples, figure 9. Thus we
could confirm the hypothesis that potassium channels, which act as brakes
of neuronal excitability, have significantly reduced expression and function
in states  of peripheral neuropathy leading to neuropathic  pain.  Moreover
transient receptor potential channels had a distinct cluster that is consistently
downregulated in SNT animals, contrary to sham, and another cluster which
is  upregulated  and with  an  expression  pattern  that  can  separate  samples
according to condition in a non-supervised manner. The same was also true
for   sodium channels,  which  had a  distinct  cluster  comprised  of  Scn9a,
Scn1b,  Scn4b, Scn10a and Scn11a genes  encoding voltage-gated sodium
channels which were significantly down-regulated after the SNT surgery,
figure 10. On the other hand, chloride channels did not show such distinct
expression patterns between SNT and sham operated animals, figure 11. 
Thus, consistent with the enriched Gene Ontology terms, we could
qualitatively observe the significance of ion channels, mainly potassium and
sodium, in neuropathic pain and their functional role as pain mediators. 
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Figure 8: Expression patterns of pain genes based on rld 
transformed counts. Using only this subset of pain genes 
samples are almost perfectly classified according to 
condition and we could also see balanced down-regulation 
after the SNI surgery (top left) and up-regulation (bottom 
left). Samples SHAM_82519_232 and D21_SNT_86634_231 
did not have such a clear response to nerve injury like the 
others. We had ruled out any reason that may had to do with 
RNA or RNA-sequencing quality of these samples. So as we 
had no evidence from the quality assessment that there was 
any issue we decided not to remove them. 
Figure 9: Expression patterns of voltage-
gated potassium channels.  Most genes 
encoding voltage gated potassium 
channels are consistently down-regulated 
in SNT samples comparing to sham.
Figure 10: Expression patterns of voltage-gated 
sodium channels.  Scn9a, Scn1b, Scn4b, Scn10a 
and Scn11a genes are consistently and 
significantly down-regulated in SNT samples 
comparing to sham.
Figure 11: Heatmaps of ion channels. From left to right: TRP, Chloride and Calcium.
Identification of LncRNAs
After analysing the expression of known genes from the ENSEMBL
annotation,  we  proceeded  to  identify  novel  LncRNAs  and  analyse  their
differential  expression.  We used the customised pipeline presented in the
chapter  Methods,  section  Reconstruct  genes  of  putative  LncRNAs,  to
generate  a  GTF file  with  predicted  novel  LncRNAs  we  calculated  their
coding potential and analysed their DE using DESeq2.  We should note that
due to  the somewhat  poor annotation of  the rat  genome we expected to
identify a lot of un-annotated genomic loci predicted to be transcribed into
putative LncRNAs as: 1. we do not have many annotated LncRNAs in rat 2.
there could also be some not yet annotated protein coding genes in rat 3. due
to the inferior quality of the rat genome assembly we expected some reads
to  be erroneously mapped in  non-annotated  regions  of  the  genome,  thus
producing coverage which could then be identified as false positives.   
As described in Methods, Identify expressed regions outside known
gene models, in order to create an annotation at the gene level for novel
LncRNAs we first  discarded all  reads mapping to  known protein coding
genes. Then we used the remaining to find Islands of Expression outside
known gene models with a coverage of more than one. Subsequently, by
selecting all  de novo splicing junctions identified by STAR  (Dobin et al.,
2013) with  more  than  2  uniquely  mapped  or  multi-mapped  reads,  we
grouped  together,  trimmed  those  islands  of  expression  and  collapsed
multiple overlapping transcripts to putative gene models of LncRNAs. As
the  rat  genome  is  not  that  well  annotated  and  we  observed  significant
differences in protein coding gene models between RefSeq and ENSEMBL
annotations, in order to avoid possibly un-annotated Un-Translated-Regions
(UTR)  flanking  gene  models  or  un-annotated  exons,  we  extended  gene
models by 2000bp (Perkins, 2013). UTRs are transcribed but not translated,
i.e. they do not have coding potential, and thus they can be indistinguishable
from  putative  LncRNAs.  The  same  can  be  true  for  small  un-annotated
exons. So we applied this screening method in order to avoid false positives
due to the implications of some poorly annotated gene models.
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After we imposed filtering, based on an expression level to be more
than 0 reads across all of the samples in at least one condition, we got 7092
predicted  LncRNAs  in  the  rat  DRG.  We  then  filtered  based  on  coding
potential  assessment  carried  out  by  the  CPC  support  vector  machine
classifier (Kong et al., 2007). Kong et al found that CPC is more accurate in
identifying coding transcripts  and that CPC scores between -1 and 1 are
considered to be in the grey zone. As we imposed several screening filters
and we did not want to discard putative LncRNAs showing small coding
potential  we  considered  all  transcripts  in  the  grey  zone  to  be  putative
LncRNAs. Another reason for considering this approach is that, as reported
by  (Ulitsky and Bartel,  2013),  LncRNAs may be able  to  code for small
peptides.
Regarding their  exon structure,  most of LncRNAs identified from
our  customised  pipeline  are  bi-exonic  and  the  distribution  of  their  exon
numbers heavily tails off after 4 exons, figure 12.
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Expression of LncRNAs in rat’s DRG
After  assigning  reads  to  the  identified  LncRNAs  using  HTSeq
(Anders et al.,  2015) and the  Intersection Not Empty strategy we studied
their expression consistency and strength relative to ENSEMBL genes. As
seen in figure 13 LncRNAs were very lowly expressed, more than 5 times
lower than ENSEMBL in their median value, figure 13.
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Figure 12: Distribution of exon numbers in the predicted LncRNAs
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Figure 13: Median counts for ENSEMBL genes (violet) and predicted LncRNAs 
(green)
In order to further asses the quality of the LncRNA models identified
we proceeded to assess the consistency of their expression across samples.
As a metric for consistency we used Cook’s distance, which stands for the
difference  in  the  coefficient  of  a  linear  model  fitted  for  each  gene,
following a removal of a sample and refitting of the model. A large Cook’s
distance indicates inconsistent expression with spikes that could be due to
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Figure 14: Distribution of read counts for predicted LncRNAs. Average (violet), 
Median (pink), 3rd Quantile (Green)
sequence  artefacts,  i.e.  RNA-sequencing  noise.  We  plotted  the  log10  of
Cook’s  distance,  thus  negative  values  on  the  plot  correspond  to  Cook’s
distances lower than 1, which is considered a very good value. As shown in
figure 15, we observed a very consistent Cook’s distance across samples.
Moreover,  we  identified  the  two  known rat  LncRNAs  which  are
functionally important in pain and expressed in DRG. One is the LncRNA
antisense of the Kcna2 gene  (Zhao et  al.,  2013) and the other is the the
LncRNA antisense of the Scn9a  (Koenig et  al.,  2015). Both of them are
antisense to known pain genes and Kcna2 is functionally associated with
neuropathic pain. Our pipeline was able to identify both of these LncRNAs,
table 3. In the paper identifying the Scn9a antisense LncRNA, the authors
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Figure 15: Boxplot of Log10 Cook’s distances for all predicted LncRNAs for
each sample. 
report  that  it  was  not  significantly  dysregulated  after  pain  models  of
peripheral  neuropathy and the  same was  also true  for  the  Scn9a protein
coding gene. Moreover in the same publication both LncRNAs are found to
slightly  change  their  expression  in  the  same  direction,  without  reaching
significance, in neuropathic pain and inflammatory models. Although in our
case Scan9a and its antisense LncRNA were significantly downregulated. 
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Genomic
Coordinates
Antisense
pain  gene
ENSEMBL
ID
Antisense
pain  gene
symbol
Log2  fold
change  of
LncRNA
Adjusted
p.value  of
LncRNA
Log2  fold
change  of
pain gene
Adjusted  p.value
of pain gene
chr2:22929625
8-229305952(-)
ENSRNOG000
00018285
Kcna2 -0.73 0.17 -1.11 2.325E-06
chr3:59057403-
59276093(+)
ENSRNOG000
00006639
Scn9a -2.36 1.116E-09 -1.086 1.445E-05
Table 3: LncRNAs antisense of Kcna2 and Scn9a gene.
Differential Expression of LncRNAs
We subsequently analysed the DE of LncRNAs using DESeq2. First
we assessed whether our predictions carried any biologically relevant signal
by inspecting how the expression of the identified LncRNAs separated our
samples. A very good separation of sample according to condition, indicated
that these putative LncRNAs are relevant to nerve injury, figure 16.
After successful quality control we proceeded to the DE analysis.
Using DESeq2 and the Wald test with the  Benjamini–Hochberg correction
to  control  false  discovery  rate  and  adjust  p.values,  we  assessed  the
significance  of  differential  expression  of  novel  LncRNAs.  As  discussed
above  we  had  in  total  7092  gene  models  of  predicted  LncRNAs  with
nonzero total read counts across conditions. Comparing rat SNT vs sham
dorsal root ganglion we obtained the following results:
Predicted LncRNAs significantly differentially expressed (DE) with
an adjusted p.value < 0.1 between SNT and Sham operated rats:
adjusted p.value < 0.05
LFC > 0 (up)     : 274, 3.9%
LFC < 0 (down)   : 577, 8.1%  
outliers      : 2, 0.028% 
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Figure 16: Samples’ separation according to the expression of predicted 
LncRNAs. 
The very low number of outliers, suggested that there was no need
for  extensive  moderation  of  log  fold  changes  to  accurately  estimate
differential expression. We should also note that the median counts across
conditions were significant lower than that of ENSEMBL genes, a finding
consistent with the literature for LncRNAs. For known ENSEMBL genes
we  obtained  an  average  median  across  samples  of  44.375  counts,  for
predicted LncRNAs we observed an average median of 9.5, almost a five
fold change.  
LncRNAs and pain-related protein coding genes
In  order  to  infer  the  functional  role  of  some  of  the  predicted
LncRNAs we examined them alongside their  genomic context.  A special
class of LncRNAs are the antisense LncRNAs, lying on the opposite strand
of protein coding genes. Antisense LncRNAs overlap some of the genomic
regions of the gene model on the opposite strand, to varying extents and
they can regulate the gene’s transcription. As expected we identified two
LncRNAs  antisense  of  Kcna2  and  Scn9a  pain  associated  genes  in  rat’s
DRG.  Then  we  investigated  all  antisense  LncRNAs  identified  by  the
pipeline  and studied  them in the  context  of  their  expression  pattern  and
function of the protein coding gene on the opposite strand.
In  total,  we  identified  2300  antisense  LncRNAs  on  the  opposite
strand of protein coding genes.  
In  rat  DRG  SNT  vs  sham  we  have  519  antisense  LncRNAs
significantly DE (adjusted p.value < 0.05). 77 are antisense of pain genes
and out  of  these,  21  are  significantly  DE.  15 significantly  DE antisense
LncRNAs are antisense of significantly DE pain genes, table 4. 
In  this  set  there  were  important  pain  genes  and  ion  channels.
Moreover we identified a pair of protein coding gene and antisense LncRNA
with opposite expression pattern in SNT vs sham. This expression pattern
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could indicate pairs of protein coding genes / antisense LncRNAs where the
antisense LncRNA acts as a competing endogenous RNA which silences the
expression  of  the  protein  coding  gene  (Han  and  Jan,  2013).  Kcnj9,  a
voltage-gated potassium channel, was reported to be associated with opioid
and cannabinoid analgesia in mouse  (Smith et al., 2008). In our study we
identified an antisense LncRNA significantly DE with opposite expression
profile to the Kcnj9 gene.
All LncRNAs antisense of pain genes in rat’s DRG can be seen in Appendix
2.
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Table 4:  Significantly DE LncRNAs antisense of significantly DE pain 
genes  
LncRNA ENSEMBL ID Genesymbol lnc_lfc lnc_pvalue gene_lfc gene_pvalue cpc
chr1:177247980-177271718(-) ENSRNOG00000017679 Cckbr 2.112658187 1.44658406879268E-06 1.9467315106 3.48587574213042E-07 -0.88056
chr10:40573511-40574610(+) ENSRNOG00000012840 Sparc 0.693080439 0.0309146894 0.5219163833 0.0004593778 -0.972695
chr11:31735382-31864076(+) ENSRNOG00000001575 Grik1 -1.2187665724 0.0008949842 -1.4425118869 0.0026368395 -0.940265
chr12:1148261-1148984(+) ENSRNOG00000001090 Stard13 0.9088934954 0.0425706885 1.0436792285 0.0002948938 -1.18939
chr13:95223994-95228919(+) ENSRNOG00000007645 Kcnj9 1.1049036718 6.56002103938819E-05 -1.2226296115 0.0003202419 0.459104
chr2:199111645-199115704(+) ENSRNOG00000028589 Gria2 -1.5735337199 8.73053258903914E-05 -1.7163376183 8.44767579830593E-08 -0.97916
chr2:223469266-223471786(+) ENSRNOG00000030019 Atp1a1 -1.5871758913 3.48442041275082E-05 -1.3611462919 0.000031922 -1.14917
chr3:59057403-59276093(+) ENSRNOG00000006639 Scn9a -2.357018731 1.42524585316199E-09 -1.0866688096 1.44524593696598E-05 -0.815863
chr3:127260488-127283308(-) ENSRNOG00000014152 Kcnip3 -1.5362755276 0.00000623 -1.6266979042 4.14361222986572E-05 -1.15812
chr4:9636853-9646624(-) ENSRNOG00000021441 Reln 1.2405189319 0.0029984059 0.7327351616 0.0018675684 -1.30911
chr4:162569914-162651062(+) ENSRNOG00000005615 Gadd45a 0.9741379114 0.0011496768 1.0547848024 0.0022037369 -0.434463
chr5:3719233-3765605(-) ENSRNOG00000007354 Trpa1 -1.0607031702 0.0005619469 -0.8457661675 0.0203168171 -0.814652
chr5:154402173-154493191(-) ENSRNOG00000013231 Ptafr 0.677320791 0.0271052464 0.6466799012 0.0313546671 -1.52982
chr8:32323519-32324313(+) ENSRNOG00000047179 Aplp2 -1.6363414407 0.0115691932 -0.7368788555 4.68583620320112E-05 -1.12105
chr8:88667082-88711088(+) ENSRNOG00000013042 Htr1b 1.1366503299 5.71176513352015E-05 0.3209479749 0.0322417882 -1.06466
Regarding intergenic LincRNAs we found that the ones that were in
genomic  positions  distant  of  known  ENSEMBL genes  tend  not  to  be
significantly DE. This might indicate that functionally important LincRNAs
tend to be closer to protein coding genes, figure 17.
51 LincRNAs were predicted to have a pain gene as their closest
genomic neighbour. 11 of them were found to be significantly DE and 7
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Figure 17: LincRNAs which are significantly DE (right-most boxplot) tend to be closer 
to ENSEMBL genes, with lower median (thick black line) and interquantile range (box 
height). Using all LincRNAs this difference in distance was significant a two-sample 
Kolmogorov-Smirnov test p-value =0.012.
were DE with a significantly DE pain gene as their closest neighbour, table
6. Amongst them were Opioid receptors Oprm1 and Oprl1; Nefl which is
functionally important for maintaining the neuronal caliper and intracellular
transport;  the  transient  receptor  potential  channel  Trpa1;  the  serotonin
receptor Htr1b; the neurotransmitter receptor Gria2 and the Disc1 which is
related to neurogenesis. All these pain genes have a highly correlated DE
LincRNA in very close genomic proximity.
As LincRNAs can be in cis  regulators of gene expression either by
inducing or silencing the expression of genes in close genomic proximity
(Ulitsky and Bartel, 2013) we looked for pairs of protein coding genes and
LincRNAs with highly correlated or anti-correlated expression patterns. All
LincRNAs with a pain gene as their closest gene had positive correlations.
   As we observed generally high correlation between LincRNAs and
their  closest  genomic  neighbour  we  decided  to   assess  significance  of
correlation utilising a randomisation / permutation approach using random
pairing, see chapter Methods, section Calculate DE and associate expression
profiles of putative LncRNAs and genes.  
Given this approach, correlation coefficients larger than |0.75| were
considered high.  Thus all these pain genes had highly correlated expression
pattern with the DE LincRNA in close proximity. We further discuss these
results in the next chapter, in the context of the findings in mouse DRG after
the Spared Nerve Injury (SNI) model.
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Table 6: Significantly DE LincRNAs with a significantly DE pain gene as their closest 
neighbour 
lincRNA Distance symbol lnc_lfc lnc_pvalue gene_lfc gene_pvalue cpc correlation cor_pvalue
chr1:44859521-44866436(+) -2315 Oprm1 -1.931967645 0.000117154 -1.7423528505 9.17347862170065E-06 -1.09013 0.9965496173 1.02427666792693E-07
chr3:180942195-180950495(+) -2001 Oprl1 -0.8233498412 0.0312150005 -0.6804312538 0.0018394514 -1.2441 0.9499586396 0.0003016362
chr5:3736367-3743944(+) 20844 Trpa1 -2.0459213473 0.0007126908 -0.8457661675 0.0203168171 -0.960516 0.9623583176 0.0001296
chr8:88679840-88686412(-) 11861 Htr1b 0.9101055677 0.0263185643 0.3209479749 0.0322417882 -1.29518 0.7759879765 0.023593051
chr15:56397166-56423098(+) -24859 Gfra2 -0.8000409826 0.0027784304 -0.3810290672 0.006427851 -1.03822 0.8690800403 0.0050735161
chr15:46543595-46565684(-) -227842 Nefl -1.202207748 2.41281227165041E-05 -1.4600252628 0.0007791237 -0.95852 0.9494949274 0.0003099898
chr19:68771054-68772954(+) -2004 Disc1 0.7821331406 0.0152716877 0.5686654777 0.0147929284 -1.21019 0.873943157 0.0045462053
Discussion
We  have  gained  valuable  insights  into  genes  and  the  biological
processes  that  are  functionally  important  for  neuropathic  pain  after
peripheral  neuropathy  in  rat.  We  confirmed  that  ion  channels,  genes
associated  with  inflammation,  neuron regeneration  and development  and
opioid receptors are significantly dysregulated in rat’s DRG under the SNT
pain model. Moreover we established a strategy for identifying LncRNAs
from RNA-seq and we calculated their DE alongside protein coding genes.
We identified hundreds  of  predicted LncRNAs significantly  DE between
rats which underwent the SNT pain model and control samples. 
We specifically looked at ion channels as GO biological processes
related  to  ion  channels  were  amongst  the  most  significantly  enriched
processes in the set of DE genes. Moreover voltage gated ion channels are
validated  to  be  major  contributors  in  pain  and  nociception.  In  the  next
chapter we found that two different mouse strains. One with high and one
with low hypersensitivity after the pain model, had different transcriptional
profiles of ion channels and pain genes. Regarding pain genes, are validated
to be implicated in  pain and helped us  prioritize LncRNAs that  may be
functionally important to neuropathic pain. But more importantly, the fact
that these genes had significantly different transcriptional profiles in rat was
stressed  also  by  the  fact  that  these  gene  families  (pain  genes  and  in
channels)  had  also  different  profiles  between  the  high  and  low
hypersensitivity mouse strains and that the high strain mouse is more similar
to rat than the low pain strain. We present these results in the next chapter.
Thus we confirmed that we had a very significant transcriptional response
for all genes but also regarding pain genes and ion channels in rat and we
also gathered evidence that this response is more similar to the response of
mice having higher induced hypersensitivity after peripheral nerve injury. 
In total,  we identified 21 LncRNAs significantly DE antisense of
pain genes. One of these pairs, the Kcnj9 gene and its antisense LncRNA
had  opposite  expression  pattern,  which  supports  the  hypothesis  that
antisense  LncRNAs  might  silence  the  gene  on  the  opposite  strand.
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Furthermore  we  observed,  in  general,  high  positive  correlation  between
LincRNAs  and  their  closest  protein  coding  gene.  7  of  these  LincRNAs
(table 6) were significantly DE and with highly and significantly positively
correlated  expression  to  that  of  pain  genes,  which  were  their  closest
genomic  neighbour.  These  results  fit  with  the  hypothesis  that  either  the
transcription of the LincRNAs or the product of transcription, the LincRNA
itself, induces the expression of pain genes in cis, or the transcription of the
LincRNAs  could  be  a  by-product  of  the  gene’s  transcription,  also  a
moreover regulatory mechanism could be in function,  the protein coding
gene could regulate  another  gene using the LincRNA as  an intermediate
regulator.  Thus  we  identified  a  stringent  subset  of  LncRNAs  which  are
consistently and sufficiently expressed in DRG, significantly DE in rats that
underwent the pain model, and associated in terms of their genomic context
and  expression  pattern  to  pain  genes.  This  subset  is  comprised  from
LncRNAs for  which  we  have  evidence  suggesting  they  are  functionally
important  for  the nerve injury  response.  This  hypothesis  requires  further
validation in the wet lab.
In the next chapter, we will further study transcriptional changes of
genes  and  LncRNAs in  DRGs of  two mouse  strains  with  high  and low
induced hypersensitivity after the SNI pain model of peripheral neuropathy
and we will compare the results presented in this chapter.
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Transcriptional changes of LncRNAs and 
protein coding genes in DRG of two 
mouse strains experiencing high and low
induced hypersensitivity
Overview
To  further  investigate  the  underlying  biological  processes  and
mediators  of  neuropathic  pain  we  exploited  our  customised  pipeline
presented, in Methods, in order to analyse Next Generation Sequencing data
from mouse models  of  pain.  Moreover  we investigated  whether  mice  of
different strains,  showing significantly different  levels of hypersensitivity
after pain surgery, show altered expression patterns of their protein coding
genes and LncRNAs. Our hypothesis that certain protein coding genes and
novel LncRNAs contribute to neuropathic pain are further assessed in the
current chapter, using the advantages provided by the much better annotated
mouse  genome  and  a  more  comprehensive  experimental  design  which
assesses the impact of various factors including sex, strain and biological
condition. We expect to find some of the conserved differentially expressed
LncRNAs,  identified  in  Rat  Dorsal  Root  Ganglions  (DRGs),  to  be  also
significantly DE between mice with induced neuropathic pain and healthy
animals, as well as between strains with high and low hypersensitivity in the
well induced neuropathic pain state. We used the Spared Nerve Injury (SNI)
model of neuropathic pain. Surgeries and behavioural tests were carried out
in  Jeffrey  Mogil’s  lab  at  McGill  University,  Montreal,  Canada  by  Jean
Sebastien Austin. Tissue extraction was carried out by Jean Sebastien Austin
and  me  at  McGill  University.  RNA extraction  was  carried  out  by  John
Dawes at David Bennet’s lab, NDCN, NPP, Oxford University and library
preparation and sequencing was carried out at Oxford Genomics, Oxford.
All data analysis of behavioural and sequencing data was done by me.
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Background
The Spared Nerve Injury pain model
In order to induce reproducible sensory dysfunctions like allodynia,
hyperalgesia and spontaneous bursts of pain (Jaggi et al., 2011), in a period
of time broad enough to allow extensive behavioural, clinical and molecular
assays  to  be  implemented,  we  used  the  Spared  Nerve  Injury  model  of
peripheral neuropathy. As presented in the Introduction, in this model two of
the branches of the sciatic nerve are axotomised and one is left untouched,
spared, thus the model's name Spared Nerve Injury (SNI). In order for the
model to be implemented correctly considerable caution is needed in order
to not injure the untouched nerve. Different combinations exist, tibial and
common peroneal axotomised and sural spared or the other way around. In
our particular case we axotomised the common peroneal nerve and the sural
nerve.  Sparing  only  the  tibial  branch  (figure  1)  produces  consistent  and
robust  mechanical  allodynia  and  hyperalgesia  without  increasing  heat
sensibility  (Shields et al.,  2003). All surgeries were carried out at Jeffrey
Mogil's lab in McGill University by lab technician Jean Sebastien Austin.
Surgical  procedures  followed  published  guidelines  (Shields  et  al.,  2003)
according to which: After incision of skin and muscle, the common pereneal
nerve and the sural nerve were tightly ligated with 9-0 silk suture. Then the
two ligated  branches  were carefully  transected in  order  to  remove about
2mm of the stump of each distal nerve. 
All mice received SNI surgeries on their left sciatic nerve branches.
As the tibial nerve supplies sensory sensation for the sole of the foot, the
paw and the skin of the paw, we assessed hyperalgesia after the SNI surgery
on the left mouse paw. As a control, for each animal we also took repetitive
measurements  for  the  right  paw,  contralateral  to  the  injury.  To  generate
control, sham samples, the same surgical and anaesthetization procedures
were  followed,  but  instead  of  ligating  or  transecting  the  nerve  branches
these were just exposed.
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Behavioural tests 
Behavioural  tests  were  carried  out  using  Von Frey  filaments  (see
figure 2), one day, 7 days, 14 days, 21 days and 28 days after the surgery.
These  timepoints  allow  us  to  have  a  comprehensive  view  of  the
establishment and progress of painful  neuropathy.  In order to establish a
base line four (4) different measurements were taken from the left (affected
by the surgery) and the right (non-affected  by the surgery) paw of the mice.
Von Frey filament tests were repeated for the ipsilateral (left), figure 3, and
contralateral (right), figure 4, paw. After the baseline had been established
repeated  measurements  were  taken  with  von  frey  filaments  of  different
strength, in order to identify withdraw thresholds that increase mechanical
sensitivity by 50%. The researcher who performed the tests was blind to the
strain and condition of the animals.   As seen in figure 3 and 4 we have
significant  and well  induced hypersensitivity  in  the  form of  a  consistent
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Figure 1: SNI pain model, the common peroneal ans sural nerve branches are 
axotomised. The tibial nerve is spared.
decrease in the paw withdrawal thresholds for the ipsilateral paw of the SNI
animals. Painful  neuropathy is maintained from Day 1 to Day 28 and it
increases with time. On the other hand we can see random natural variation
for sham, i.e.  control, samples both in ipsilateral and contralateral paw. In
addition  we  can  see  no  significant  trend  towards  hypersensitivity  in  the
contralateral paw.
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Figure 2: Mouse undergoing Von Frey filament testing for hypersensitivity 
in the pain lab
Figure 3: Hindpaw withdrawal thresholds to Von 
Frey filament stimulation + SEM in grams. Both 
strains show significant induced hypersensitivity 
after the SNI surgery compared to baseline (two way 
ANOVA on Day 7 SNI p.value = 8.406e-06 ***  and 
paired Welch t-test on Day 28 SNI vs baseline for 
BALB/c p.value = 7.855e-06 ### and for B10.D2 
p.value = 9.581e-06 ###). BALB/c strain showed 
significantly different response to SNI surgery on 
Day 7 vs B10.D2 (two way ANOVA p.value = 
0.008278 **) and induced hypersensitivity on Day 28
after SNI surgery for BALB/c vs B10.D2 strain was 
significantly different (Welch t.test p.value = 
0.002395 ##)
Mouse strains and phenotypes
In the current study we used two different  mouse strains,  namely
B10.D2  and  BALB/c.  B10.D2  is  a  recombinant  congenic  strain,  and
therefore carries a fraction of the genome of one strain together with the
genetic background of another (Martin et al., 1992). In general recombinant
congenic strains  allow us to  study the combined effects  of  minor  genes,
while  on  the  other  hand inbred  strains  allow us  to  effectively  study the
effects of major genes as most minor effects are masked. B10.D2 strain has
been widely used in studies regarding the immune system response, thus it
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Figure 4: Withdrawal thresholds (in grams) for each mouse strain and 
timepoint. Right Ipsilateral paw. Solid lines are for the SNI mice, dashed lines 
are for mice that underwent Sham surgery only
is  very  relevant  in  studies  that  study  neuropathic  pain,  pain  with  a
significant inflammatory component.  In terms of phenotyping, this strain
can show prolonged allograft  rejection,  increased susceptibility to certain
pathogens and impaired chemotactic responses of neutrophils  
(“JAX®  Mice  &  Services,”  n.d.)The  Jackson  Laboratory,  Bar  Harbor,
Maine.  World  Wide  Web.  URL:  https://www.jax.org/,  6/2016).  In  pain
studies B10.D2 mice have found to show low mechanical allodynia 5 and 7
days after SNI surgery (Sorge et al., 2012). In this study B10.D2 showed the
lowest allodynia amongst 18 other mouse strains. Moreover this phenotype
was  associated  with  genetic  variability  of  the  P2RX7  receptor  pore
formation. B10.D2 mice, which carry the Leu451 allele, were experiencing
far less allodynia and were insensitive to treatment that blocks the formation
of P2RX7.     
In contrast to B10.D2, the strain BALB/c  (Eppig et al., 2015) is a
commonly used inbred which presents susceptibility to the demyelinating
disease upon infection with Theiler's murine encephalomyelitis virus. The
most striking phenotypic characteristic of this particular strain is that it is
Albino. Males are aggressive and will fight littermates. They are commonly
used in  cancer  and immunology studies  as  well  as  in  the  production  of
monoclonal antibodies. They are known for being less susceptible to certain
types of cancer  (“JAX® Mice & Services,” The Jackson Laboratory, Bar
Harbor,  Maine.  World  Wide  Web.  URL:  https://www.jax.org/,  6/2016).
BALB.c mice show high allodynia after SNI surgery. In the study of (Sorge
et al.,  2012) BALB.c showed higher allodynia amongst 18 inbred mouse
strains. On the other hand, it shows relatively low sensitivity, consistently,
both  in  hot  and  cold  heat  stimuli   (Mogil  and  Adhikari,  1999).  Direct
comparison between these two strains  (Sorge et al., 2012) showed that the
observed  variability  was  due  to  the  Leu451  allele  of  P2RX7,  which  is
present in B10.D2 and blocks pore formation which in turn leads to low
allodynia. On the other hand the Pro451 allele, which is present in BALB/c
strain activates pore formation leading to more allodynia.
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Our behavioural results, figure 3, are consistent with the literature
and indicated  a   robust  pain  phenotype for  both  strains  for  a  prolonged
period of time after the SNI surgery. Moreover we found, as expected, that
the BALB/c strain showed significantly different response to SNI surgery on
Day 7 vs B10.D2 (two way ANOVA p.value = 0.008278) and significantly
higher induced hypersensitivity on Day 28 after SNI surgery  vs the B10.D2
strain (Welch t.test p.value = 0.002395).  Finally both strains have almost
the same baseline mechanical hypersensitivity.
Dissections
After  the  SNI  surgery  and  the  behavioural  tests,  the  mice  were
dissected.  The  animals  were  first  euthanized  by  spinal  cord  dislocation.
Then under the microscope muscle, connecting tissue and spinal cord were
removed  in  order  to  expose  the  Dorsal  Root  Ganglions  (DRGs).  All
dissections were performed on dry ice and RNase Decontamination Solution
was used in order to prevent RNA degradation. For the purpose of our study
we needed tissue from lumbar DRGs 4 and 5. In order to identify the L5
DRG we used the iliac crest or the tip of the iliad bone, “the first articular
process more than 1mm rostral to the iliac crest” (figure 5)  (Rigaud et al.,
2008) was  used  as  the  landmark  for  identifying  L5  in  all  samples.  We
harvested L4 and L5 DRGs from each animal and stored tissue in sterile
eppendorf tubes using plenty of dry ice in cryobox containers, see figure 5. 
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Figure 5: Left: Identification of the L5 DRG using the projection of the tip of the iliac bone.
 Right: Eppendorf tubes with mice DRGs stored in cryoboxes.
RNA isolation and extraction
Dissected DRG tissue were sent from Montreal to Oxford in RNAse-
free eppendorf tubes placed in dry ice at −78.5°C. RNA was then extracted
by Dr.  John Dawes according to the hybrid method of combined phenol
extraction (TriPure, Roche) and column purification (High Pure RNA tissue
Kit,  Roche)  (Bartus et  al.,  2016). According to this  method two steps of
RNA isolation and extraction take place subsequently, resulting in sufficient
yield of high quality pure RNA. The concentration of RNA in the samples
was measured using a nanodrop and proved sufficient for sequencing. 
According to the hybrid method, DRG tissue was first homogenized
in TriPure and then mixed with chloroform, following the phenol extraction
method. After centrifuging the aqueous liquid, which stays on the top of the
tube and contains the nucleic acids, was removed. This solution was then
subjected to the column purification method. Following this protocol, the
clear  aqueous  liquid  was  placed  in  Roche  High  Pure  RNA tissue  Kit
columns and washed several times in order to purify the RNA. RNA was
then extracted with the mRNeasy kit and all samples were subjected to on-
column  dnase  digestion  in  order  to  prevent  genomic  contamination  i.e.
presence of DNA in the RNA samples. 
Dataset
As  seen  in  Figure  3,  BALB/c  and  B10.D2  strains  had  the  same
baseline, significant and consistent increase in mechanical hypersensitivity
after surgery and also presented the expected behaviour of low withdrawal
threshold/high  hypersensitivity,  for  BALB/c  and  high  withdrawal
threshold/low hypersensitivity, for B10.D2. Additionally we had consistent
and expected variance for the sham groups.  Based on these findings and on
our  initial  hypothesis  of  identifying  DE  genes  and  LncRNAs  between
strains with high and low mechanical hypersensitivity (indicating high and
low pain, after SNI surgery) we selected BALB/c and B10.D2 strains for
RNA-sequencing.  As  described  above  we  harvested  4  DRGs  from each
animal, L4 and L5. We had 24 animals, 12 of each strain. Two samples were
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accidentally mixed together and destroyed during RNA-extraction, thus we
used 22 samples for downstream analysis.  
RNA-Seq and library preparation
The  selected  22  samples  were  sent  for  sequencing  to  Oxford
Genomics Center, High Throughput Genomics. Total RNA was provided to
the sequencing center, and the ribodepleted fraction of it was selected for
further  sequencing.  Ribodepletion  excluded  the  ribosomal  RNAs,  see
Introduction/RNA-sequencing. The ribodepleted RNA was then converted
to  cDNA using  the  strand-specific  (deoxy-UTP strand-marking  protoco)
dUTP protocol which is the leading protocol for strand-specific synthesis of
cDNA  (see  Introduction  chapter,  section  RNA  isolation  and  library
construction). 
Aligning RNA-seq reads to genome
Oxford  Genomics  produced FastQ sequencing files  which  encode
quality metrics following the Sanger standard, i.e. Sanger qualities, using
the standard Phred score (Ewing and Green, 1998) to asses the probability
that  the  corresponding base  call  is  wrong.  Sequencing was done in  five
sequencing lanes producing five technical replicates per sample. In general
all  these  lanes  gave  high  yield,  consistent  GC  content,  consistent  and
expected  sequence  insert between the paired-end adapters and high quality
base calling (see table 1). Duplicates were low, approximately 9% for all 5
technical replicates of the 22 samples.
Lane % GC % GCmapped
σpos(
%GC)
insert ± MAD % exonic % exon cov'ge %N
maxpos %N %lowQ %lowQend avgQ
1.1 48.3 ± 9.6 47.8 ± 9.4 4.45 197 ± 59 20.8 59.9 0.0 0.3 0.0 0.0 34.0
1.2 48.3 ± 10.3 47.8 ± 10.0 2.61 195 ± 59 21.8 61.6 0.0 0.6 0.0 0.0 31.0
Lane % GC % GCmapped
σpos(
%GC)
insert ± MAD % exonic % exon cov'ge %N
maxpos %N %lowQ %lowQend avgQ
2.1 48.1 ± 9.5 47.7 ± 9.4 4.46 191 ± 54 20.7 58.6 0.0 1.1 0.0 0.2 33.9
2.2 48.2 ± 10.2 47.6 ± 10.0 2.62 190 ± 53 21.7 60.3 0.0 1.0 0.0 0.1 30.8
3.1 48.2 ± 9.6 47.7 ± 9.4 4.45 192 ± 54 20.7 58.7 0.0 1.0 0.0 0.2 33.9
3.2 48.2 ± 10.3 47.6 ± 10.0 2.62 190 ± 54 21.7 60.4 0.0 1.1 0.0 0.1 30.9
4.1 48.2 ± 9.6 47.7 ± 9.4 4.45 192 ± 55 20.7 58.8 0.0 2.4 0.0 0.1 33.9
4.2 48.2 ± 10.3 47.7 ± 10.0 2.61 191 ± 55 21.6 60.5 0.0 1.3 0.0 0.1 30.7
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Lane % GC % GCmapped
σpos(
%GC)
insert ± MAD % exonic % exon cov'ge %N
maxpos %N %lowQ %lowQend avgQ
5.1 48.1 ± 9.6 47.7 ± 9.4 4.46 192 ± 55 20.7 58.4 0.0 0.4 0.0 0.0 32.5
5.2 48.2 ± 10.3 47.5 ± 10.0 2.58 191 ± 55 21.6 59.9 0.0 0.1 0.0 0.0 30.0
Table 1: Quality controls for all sequencing lanes. 1st lane, lanes 2,3,4, lane
5.
Next we mapped all  of the sequencing samples  using the spliced
STAR-aligner  (Dobin  et  al.,  2013) to  the  latest  mouse  genome (mm10)
downloaded from the ENSEMBL genome browser. Reads were aligned for
each sequencing lane in parallel and then the sorted BAM files were merged
with their respective technical replicates, from the same sample, in order to
produce 22 merged, sorted and indexed BAM files. The mapping percentage
was very good,  with a  mean across  samples  of  88.05% and all  samples
above 85% except for the Sample66_BALB.c_SNI_F with 73.1%.  These
numbers are considered very good and indicate samples of high quality. 
We collapsed technical replicates before counting any reads, in order
to achieve the best coverage possible in lowly expressed areas of putative
LncRNAs. Then we counted reads for known genes using the ENSEMBL
annotation.  Again this was done in parallel,  using HTSeq  (Anders et  al.,
2015) with the “intersection not empty” strategy (see Introduction, section
Analysing RNA-seq data). We also   inverted reads' strand for counting as
dUTP library produces reads with inverted strandedness.  Intersection not
empty counting strategy first calculates a disjoint version of the annotation
and thus ensures that reads mapped to overlapping features are counted only
once. In order to assign reads to known genes we used ENSEMBL’s (Flicek
et  al.,  2011) genome-build  GRCm38.p4,  based  on  genome  version
GRCm38, last updated in December 2015. We assigned counts on the gene
level grouping together multiple transcripts derived from the same gene.
Experimental Design
As described above we had two strains for downstream analysis, one
with  high pain (BALB/c) and one with low pain (B10.D2), 22 samples in
total.  Samples  are  balanced  regarding  the  strain,  11  samples  from  the
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B10.D2 strain and 11 from the BALB/c strain. 12 samples underwent sham
surgery  and  10  the  SNI  pain  model.  Ideally  samples  should  have  been
stratified for every experimental factor, but as we have enough replicates for
each distinct combination of strain and condition (n > 3) we can efficiently
estimate dispersion within conditions of interest and assess the significance
of differences between conditions of interest. 
In this experiment we had two conditions of interest, SNI vs Sham
surgery and two types of strain,  B10.D2 vs BALB/c strain. In the context of
the generalized linear model formulation, we had 3 coefficients of interest,
condition  (  with  levels  sham  or  SNI),  strain  (  with  levels  BALB/c  or
B10.D2) and sex (with levels Male or Female). First we assumed that sex
coefficient  can  be  added  uniformly  across  samples,  as  the  differences
between sexes are not of primary interest. Nor we are interested in a strain
or condition effect that affects only one sex. We would like to adjust for any
differences occurring due to the sex difference in order to effectively assess
genes dysregulated due to changes in strain and condition. Thus we used an
additive  or  blocking  design  for  gender.  Regarding  the  coefficients  of
primary  interest,  strain  and  condition,  we  assumed  that  there  is  some
interaction between them. Thus the coefficient for condition is not the same
across strains and vice versa. In this way we investigated all possible levels
of the factor condition (sham or SNI) for each strain separately. Moreover
we  tested  if  and how different  is  the coefficient  of  condition  between
strains. For a more detailed discussion  regarding comparing conditions see
Methods, section  Comparing conditions using Generalized Linear Models
(GLMs). We used a nested interaction model for strain and condition which
allowed us  to  test  all  possible  interactions  between them.  The GLM we
fitted for each gene is of the following form:  
~ sex + strain*condition.
Then we tested if the coefficient of condition is significantly different from
zero for:
1. The baseline strain BALB/c (the main effect, high pain)
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2. The low pain strain B10.D2 (the main effect plus the interaction term
representing only the difference of the coefficient for B10.D2 strain)
3. The interaction term, only assessing whether the log fold changes SNI vs
sham are significantly different between B10.D2 vs BALB/c.
Further quality control
Before  the  analysis  we  assessed  how  reads  were  distributed  on
distinct features (genes, LncRNAs) of the annotations (gene sets in the form
of GTF files) used and how consistent was the expression pattern of genes
across  samples.  We had  used  two  types  of  annotation,  one  is  the  latest
ENSEMBL/GENCODE annotation the other is a customised annotation of
predicted LncRNAs identified from our customised pipeline.
 Then we examined how RNA-seq reads  were  distributed  on the
annotations’ features. RNA- seq reads carry a distinct header coded in the
hexadecimal system. This header flags reads according to their mapping and
quality attributes. Reads can be uniquely mapped, mapped in more than one
position on the genome but with only one optimal mapping position and
mapped in multiple positions with equal probabilities (multi-mappers). As a
consequence  these  multi-mapped  reads  are  aligned  in  several  genomic
regions  and  produce  multiple  non-unique  alignments,  we  assessed  how
many they were  and how they could  affect  gene  expression  analysis  by
measuring the number of non-unique alignments they produced. Moreover,
as  transcript  abundance  estimation  involves  counting  of  the  reads
overlapping distinct features of the annotation, reads can overlap one feature
alone  or  they  can  overlap  more  than  one  feature  (ambiguous  reads).
Ambiguous  reads  can  only  be  examined  in  the  context  of  a  specific
annotation  as  they  emerge  as  a  combination  of  read  mapping  and  the
annotation structure. Ambiguous reads are reads that can be aligned to the
genome, but the position that they are mapped happens to overlap more than
one genomic feature. As we used two different types of annotations, i.e. a
standard ENSEMBL and RefSeq annotation and a customised annotation for
predicted  novel  LncRNAs,  we  examined  ambiguous  reads  for  both
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annotations.  A particular  sample  with  more  ambiguous  reads  and  multi-
mappers than the other samples may indicate genomic contamination, RNA
degradation or poor sequencing quality. 
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Figure 6: Number of non-unique alignments due to multi-mappers (violet) and ambiguous reads (pink) for each sample. The left plot presents the 
distribution for ENSEMBL genes; the right plot for predicted novel LncRNAs. Sample 59 has a significant spike of multi-mapping and ambiguous 
reads. The same is also true for Sample 66. Our customised annotation of predicted LncRNAs gave very good results in terms of ambiguously 
assigned reads, having near zero for all samples, in the counting step.
As seen in figure 6, Sample 59 has significantly more non-unique
alignments due to multi-mapped reads than the other samples and produces
much more ambiguous reads for both annotations. As the amount of multi-
mappers,  i.e.  ambiguously  mapped  reads  on  the  genome,  is  solely  an
attribute of the sample and does not depend on the annotation, it suggests
that Sample 59 suffers from poor quality. Moreover, most probably due to
the high number of multi-mappers, it produces more ambiguous reads, i.e.
reads overlapping more than one feature of a genomic annotation, regardless
the of the annotation. Sample 66 had also a significantly higher number of
multi-mappers and also produced  higher ambiguous reads in the counting
step.  We  should  note  here  that  our  customised  annotation  of  predicted
LncRNAs had a consistently low number of ambiguous reads, similar to the
ENSEMBL genes, indicating good quality of annotation with no randomly
overlapping features that could produce a lot of ambiguous reads.   
Next we examined the distribution of the gene’s Cook’s distances in
all samples. Cook’s distance is the difference in the coefficient of a linear
model  if  we remove a  sample  and refit  the  model.  Thus it  assesses  the
consistency of expression of genes across samples. Higher Cook’s distances
observed  in  a  particular  sample,  indicate  that  genes  in  this  sample  are
expressed in an outlying fashion. High Cook’s distances of particular genes
indicate that these genes are not consistently expressed but they have rather
serious spikes in their expression across samples, thus this is a way to detect
outliers. The distribution of Cook’s distances across all samples can be seen
in figure 7.  Again Sample 59 showed higher Cook’s distance than all other
samples,  followed  by  Sample  66.  Sample  66  also  had  the  highest
interquartile range, i.e. spread between the 1st and the 3rd quartile, indicating
higher dispersion of gene expression than all the other samples. 
Based on these findings that consistently indicated poor quality of
these samples, plus on the fact that Sample 59 showed a significantly lower
percentage  of  mapped  reads  we  decided  to  exclude  both  Sample  66
(BALB/c  SNI)  and  Sample  59  (B10.D2  Sham),  as  these  samples  had
significantly inferior and outlying quality metrics. Given that these samples
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are from both strains and conditions we did not change our experimental
design and we ended up with 10 BALB/c and 10 B10.D2 mice. 
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Figure 7: Boxplots of ENSEMBL genes’ Log10 Cook’s distance across all samples. The 
thick black line represents the median. Sample 59 has higher Cook’s distance than all the 
other samples. Sample 66 has the higher interquantile range represented by the height of 
the boxplot. Gene expression is very consistent across all other samples
Results
Differential Expression analysis of known genes
Before  analysing  gene  expression  we  clustered  samples  in  an
unsupervised  way,  blind  to  the  samples’  annotation,  using  hierarchical
clustering according to the euclidean distance. In this way we assessed how
samples of different conditions and strains were separated. 
We first normalised and log transformed counts in a way that does
not overestimate Log Fold Changes (LFC) for genes with low counts using
the regularized logarithm transformation (rld)  (Love et al., 2014). Then we
proceeded to perform clustering and generated visualisations. Clustering of
all  20  samples  selected  for  downstream  analysis  indicated  that
transcriptional changes are more significant between strains, and that within
strains there is a clear separation between conditions, figure 8. There is also
separation between sexes in some extent. 
 Moreover if we separately inspect clustering of samples for each
strain  we  can  see  that  most  of  the  samples  clustered  well  within  their
respective family,  except for one outlying sample for the BALB/c strain,
figure 9. Principal components analysis of gene expression  patterns for both
strains  showed  that  we  have  better  separation  between  Sham  and  SNI
samples for the BALB/c strain than for the B10.D2 strain, figure 10.
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Figure 8: Hierarchical clustering of samples according to regularized 
log2 counts of ENSEMBL genes. Samples are clustered first according to 
strain and then according to condition. Genders are also separated within
strain and condition.
Figure 9: Clustering of BALB/c (left) and B10.D2 (right) sample according to regularized log2 counts of ENSEMBL genes.
Figure 10: PCA for BALB/c strain (left) and B10.D2 strain (right).The top 50 ENSEMBL genes contributing to PC1 and PC2 are in Appendix 3.
Expression patterns of ion channels and pain genes
Being aware of the significance of  ion channels in neuropathic pain
(Basbaum et al., 2009) and having established very prominent changes of
the expression level of ion channels and pain genes in rat DRG we used the
same log transformed counts to analyse the transcriptional patterns of ion
channels and pain genes across different strains and conditions. 
Nociceptors express voltage gated channels in order to transmit pain
from the peripheral nervous system. Moreover a set of known pain genes
validated in knock-out studies from rodent models of pain in combination
with a list curated from meta-analysis studies of pain (LaCroix-Fralish et al.,
2011; Lacroix-Fralish et al., 2007), is enriched with genes coding for these
channels as well as genes involved in inflammatory process, apoptosis and
neurogenesis. Therefore we decided to specifically look at ion channels and
known pain genes. We selected all potassium, calcium, sodium, chloride,
transient  receptor  potential  channels  and  pain  genes  and  plotted  their
expression patterns in heatmaps and examined how these specific gene sets
could separate samples from different strains according to condition.
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First,  by  examining  the  expression  patterns  of  pain  genes
downloaded from the the pain genes database (Lacroix-Fralish et al., 2007)
we found that all SNI samples were grouped together and the same was true
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Figure 11: Expression pattern of pain genes based on rld transformed counts. Using only this subset of pain 
genes samples are perfectly clustered according to conditions and we can also see balanced down-regulation 
(top left) and up-regulation (bottom left) after the SNI surgery.
for all Sham samples, see figure 11. In addition the effect of strain was less
prominent than in the whole ENSEMBL gene set.  Samples were optimally
separated according to condition (SNI vs Sham) based on the expression of
pain genes, while based on the expression of the whole ENSEMBL gene set
samples  were  optimally  separated  first  according  to  strain  and  then
according  to  condition. Moreover  there  was  a  distinct  subset  of  genes
upregulated after the SNI surgery and a distinct subset downregulated after
the surgery. As it is expected when we selected only pain genes which were
significantly (adjusted p.value < 0.05) DE in both strains, we observed a
very clear separation between conditions as well as distinct groups of co-up-
regulated and co-down-regulated genes, figure 12.        
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Figure 12: Common 
significantly DE pain genes in 
both strains. The grey 
rectangle denotes the SNI 
samples 
To examine the differences between strains, we produced heatmaps
for all the expressed ion channels in our dataset, for each strain separately.
Interestingly we can see that expression of potassium and sodium voltage-
gated channels provides optimal separation between animals with painful
neuropathy and animals that have undergone sham surgery for the BALB/c
strain. In BALB/c strain there were two distinct profiles of transcriptional
changes regarding these channels, very similar to what we observed in rat.
However  genes  encoding  for  these  channels  did  not  optimally  classify
samples from the B10.D2 strain, figure 13. Regarding B10.D2 strain, there
were  mostly  three  profiles  which  did  not  separate  samples  according  to
condition, except for chloride channels. Chloride channels could optimally
separate  samples  according  to  condition  for  both  strains;   Thus  the
expression profile of ion channels for the high pain (BALB/c) strain is very
similar to rat (figures 9,10,11 pages 103:105) while on the other hand the
transcriptional response doe thw low pain strain (B10.D2) is different. TRP
and calcium channels’ expression pattern did not optimally separate samples
according to condition for either strain. 
The above observations suggest that BALB/c sample, which exhibits
significantly  higher  induced  mechanical  hypersensitivity  after  the  SNI
surgery than B10.D2, had a  more prominent pain signature at the molecular
level  mainly  associated  with  the  expression  pattern  of  voltage-gated
potassium and sodium channels. Moreover pain genes and especially those
which were significantly DE in both strains (figure 12), comprised a set of
genes with a robust dysregulation pattern that can separate SNI from Sham
samples. The same was also true for chloride channels (figure 13). On the
other hand potassium and sodium voltage-gated channels are more robustly
dysregulated in  the high pain strain BALB/c (figure 13) than in B10.D2
strain.
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Figure 13: Heatmaps of ion channels for BALB/c strain (left column) and B10.D2 strain (right 
column). Potassium and sodium channels expression provides optimal separation of samples 
according to condition for BALB/c strain but not for B10.D2 strain. Chloride channels optimally 
separated both strains.
Significantly DE genes
Using  DESeq2  and  the  Wald  test  with  the  Benjamini–Hochberg
correction to control false discovery rate, we assessed the significance of
differential expression of genes. We had a total of 16063 genes with nonzero
total read counts across conditions. The generalized linear model we fitted
to the data gave the following results for each coefficient:
1. ENSEMBL genes significantly differentially expressed (DE) with an
adjusted p.value < 0.05 between Male and Female mice:
LFC > 0 (up)     : 165, 0.47% 
LFC < 0 (down)   : 8, 0.023% 
outliers      : 54, 0.15%
2. ENSEMBL genes significantly DE with an adjusted p.value < 0.05
SNI vs sham mice for the BALB/c (high pain) strain:
LFC > 0 (up)     : 933, 2.7% 
LFC < 0 (down)   : 931, 2.7%
outliers      : 54, 0.15% 
3. ENSEMBL genes significantly DE with an adjusted p.value < 0.05
SNI vs sham mice for the B10.D2 (low pain) strain:
LFC > 0 (up)     : 578, 1.6%  
LFC < 0 (down)   : 687, 2% 
outliers      : 75, 0.47% 
4. ENSEMBL genes with significantly log fold changes, difference of
differences,  with an adjusted p.value < 0.05 SNI vs sham for the
B10.D2 (low pain) vs SNI vs sham for BALB/c (high pain):
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LFC > 0 (up)     : 12, 0.034% 
LFC < 0 (down)   : 24, 0.068% 
outliers      : 54, 0.15% 
These  findings  reinforced  the  hypothesis  that  the  injury  induced
regulation of transcripts at the molecular level is much more prominent for
the high pain strain BALB/c. Moreover, we identified a set of 36 genes with
significantly different responses / log fold changes in the two strains after
the SNI pain surgery. 
There is a common core of 846 significantly DE genes between the
two strains SNI vs sham. The high pain strain / BALB/c has an additional
set of 1018 DE genes, while B10.D2 has an additional set of  419 DE genes,
see figure 14.
Thus except for a common core of 846 genes the high pain strain
extends the repertoire of DE genes by a very significant amount. 
Functional Enrichment
By  calculating  the  Gene  Ontology  functional  enrichments  for
biological  process  according  to  several  ranking  methods  (see  chapter
Methods), we found the top over-represented terms for the DE gene sets
presented above. In order to select the top enriched GO-terms we selected
the first 20 terms which have the lowest P.value according to the weighted
Fisher test and at the same time have a P.value < 0.05 according to the exact
Fisher test. For completeness we also included the rank of the GO terms
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Figure 14: Venn diagram of significantly DE 
genes in mouse strains
846
BALB/c
1018
B10.D2
419
according to the non-parametric weighted Kolmogorov-Smirnov test. In the
following tables we also present the total number of genes annotated with
each GO term and the number of significantly DE genes associated with that
term in our dataset. 
Regarding DE genes SNI vs Sham, in the high pain, BALB/c strain,
we  observed  enrichments  of  biological  processes  very  relevant  to
neuropathic pain, table 2. The top 20 terms include terms related to nervous
system  cell  death  and  regeneration,  such  as  the  negative  regulation  of
neuron  apoptotic  process,  positive  regulation  of  synapse  assembly,  axon
guidance, positive regulation of programmed cell death, negative regulation
of neuron projection development, positive regulation of cell proliferation
and  peripheral  nervous  system  development.  Moreover  there  are
significantly  enriched  terms  related  to  signalling  and  ion  channels,  like
potassium ion transmembrane transport,  regulation of ion transmembrane
transport,  cell  adhesion,  regulation  of  calcium  ion  transport,  signal
transduction,  regulation  of  potassium  transmembrane  transport.  Terms
related to learning and locomotory behaviour have been found to be part of
the biological process of pain  in functional genomic studies 
(Lötsch et al., 2013) and are generally well established in the literature and
intuitively accepted. These findings are consistent with the pattern identified
from the analysis  of  the gene  expression of  ion channels  and show that
potassium channels are particularly important for the high pain phenotype
observed  in  the  BALB/c  strain.  They  also  show that  a  set  of  processes
ranging from signalling, development of axons and neuron cells, behaviour
and higher cognitive processes like learning, are  essential  in establishing
pain after peripheral neuropathy. 
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Table 2: Top 20 enriched GO terms for biological process in SNI vs Sham for BALB/c strain. The columns hold the GO ID, term description, nr of 
annotated genes for the term, nr of significantly DE genes for the term, expected nr of significant DE genes, rank according to p.values from wight KS 
test, p.value for fisher exact test, p.value for weight fisher test
GO.ID Term Significant Expected Rank.in.weightKS P.value classicFisher P.value weightFisher
GO:0043524 negative regulation of neuron apoptotic process 34 15.7 28 9.197727535066E-06 0.0000092
GO:0071805 potassium ion transmembrane transport 37 15.7 3 4.147362272456E-07 0.0000103
GO:0051965 positive regulation of synapse assembly 20 7.11 8 1.12743454507609E-05 0.0000113
GO:0007411 axon guidance 34 15.92 29 0.000012772 0.0000131
GO:0008360 regulation of cell shape 29 13.32 13 3.71215580856528E-05 0.0000371
GO:0032060 bleb assembly 7 1.24 36 5.05165264741591E-05 0.0000505
GO:0034765 regulation of ion transmembrane transport 65 33.65 6 1.104676982964E-07 0.0000899
GO:0008306 associative learning 18 8.36 127 0.0012 0.0000925
GO:0046661 male sex differentiation 17 10.39 18 0.02747 0.0000986
GO:0007155 cell adhesion 177 119.35 50 2.32207945015E-08 0.00014
GO:0051924 regulation of calcium ion transport 37 20.44 151 0.00024 0.00018
GO:0045109 intermediate filament organization 7 1.47 74 0.00021 0.00021
GO:0007165 signal transduction 516 403.9 12 1.99006995E-11 0.00028
GO:1901379 regulation of potassium ion transmembrane transport 13 5.98 72 0.00511 0.00031
GO:0008344 adult locomotory behavior 24 9.6 194 0.000014836 0.00059
GO:0043068 positive regulation of programmed cell death 72 55.89 124 0.0142 0.00071
GO:0002495 antigen processing and presentation of peptide antigen via MHC class II 5 2.03 17 0.04456 0.00074
GO:0010977 negative regulation of neuron projection development 23 11.86 9 0.00129 0.00086
GO:0008284 positive regulation of cell proliferation 104 74.52 79 0.00024 0.00094
GO:0007422 peripheral nervous system development 13 6.32 92 0.00834 0.0011
Table 3: Top 20 enriched GO terms for biological process in SNI vs Sham for B10.D2 strain. The columns hold the GO ID, term description, nr of 
annotated genes for the term, nr of significantly DE genes for the term, expected nr of significant DE genes, rank according to p.values from weight KS
test, p.value for fisher exact test, p.value for weight fisher test
GO.ID Term Significant Expected Rank.in.weightKS P.value classicFisher P.value weightFisher
GO:0043524 negative regulation of neuron apoptotic process 25 10.45 39 3.65475727E-05 0.000037
GO:0048485 sympathetic nervous system development 7 1.28 19 0.00013 0.00013
GO:0019228 neuronal action potential 10 2.56 33 0.00014 0.00014
GO:0007613 memory 21 7.52 270 1.36898081E-05 0.00019
GO:0045109 intermediate filament organization 6 0.98 50 0.00019 0.00019
GO:0044406 adhesion of symbiont to host 6 1.05 5 0.00032 0.00032
GO:0071805 potassium ion transmembrane transport 22 10.45 24 0.00068 0.00044
GO:0021604 cranial nerve structural organization 5 0.83 238 0.00075 0.00075
GO:0051965 positive regulation of synapse assembly 13 4.81 34 0.00081 0.00081
GO:0007155 cell adhesion 111 80.74 293 0.00031 0.00104
GO:0008306 associative learning 15 5.56 259 0.00034 0.00109
GO:0007638 mechanosensory behavior 5 0.9 217 0.0012 0.0012
GO:0007628 adult walking behavior 9 2.78 499 0.00135 0.00135
GO:0030574 collagen catabolic process 6 1.35 142 0.0015 0.0015
GO:0060547 negative regulation of necrotic cell deaath 4 1.05 131 0.01728 0.0016
GO:0050768 negative regulation of neurogenesis 26 16.09 71 0.01032 0.00179
GO:0071417 cellular response to organonitrogen compound 39 23.23 62 0.00098 0.00182
GO:0014059 regulation of dopamine secretion 6 1.73 411 0.00592 0.00184
GO:0010996 response to auditory stimulus 5 0.98 271 0.00184 0.00184
GO:0048385 regulation of retinoic acid receptor signaling pathaway 5 0.98 335 0.00184 0.00184
We observed similar enrichment results for the B10.D2 strain SNI vs
Sham.  The  top  term  was  again  negative  regulation  of  neuron  apoptotic
process and several GO terms related to nervous system cell development,
like  sympathetic  nervous  system  development,  positive  regulation  of
synapse  assembly,  negative  regulation  of  necrotic  cell  death,  negative
regulation of neurogenesis. On the other hand, regarding terms related to ion
channels,  in  this  strain  we  only  observed  enrichment  for  potassium ion
transmembrane  support,  neuronal  action  potential  and  cell  adhesion.
Interestingly genes DE in this strain were more enriched in terms related to
biological processes of higher order related to memory, learning, behaviour
and response to stimuli. Also important for the generation of pain sensation,
both in brain and the peripheral nervous system is the term associated with
to dopamine secretion.
To  further  analyse  differences  in  the  gene  expression  response
between strains after the SNI surgery, we calculated GO enrichments for
genes that had significantly different log fold changes between strains. This
comparison  was  very  stringent  as  we  did  not  compare  normalised
expression values between conditions, but rather log fold changes. Thus we
looked for LFCs which were significantly different, so that they cannot be
explained by the general trend of DE between SNI vs Sham for the baseline
strain.  As  we  only  had  26  genes  with  significantly  different  responses
between strains, the number of genes which were actually associated with
the enriched terms were only one or  two genes.  Nevertheless,  we found
some  terms  which  may  explain  the  difference  in  the  intensity  of  pain
between strains, table 4. 
First,  we  observed  enrichment  for  genes  related  to  the  immune
system and hormone secretion. Terms related to T-cells were highly enriched
and  this  confirmed  that  T-cell  activation  and  infiltration  after  peripheral
nerve  injury  is  a  major  contributor  to  hypersensitivity  (Costigan  et  al.,
2009).  Moreover  T-cell’s  function  is  part  of  the  immune  component  of
neuropathic  pain  which  is  only present  in  the  central  nervous system of
adult animals. But more importantly we observed enriched terms for axon
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guidance, potassium ion transport and chemokine secrtetion. Being aware
that  chemokine  expression  is  important  in  the  context  of  inflammatory
response of the immune system after nerve injury (White and Wilson, 2008)
and that their upregulation is associated with neural signalling processing,
which in turn is crucial for maintaining neuropathic pain (White et al., 2005;
White  and  Wilson,  2008),  we  can  hypothesize  that  genes  that  regulate
chemokine  expression  and  inflammatory  response  are  important  for  the
differences of pain intensity observed between the two strains.  Moreover
axon  guidance  and regeneration  of  injured  neurons  is  also  known to  be
important in modulation of painful neuropathy after injury in the peripheral
or  central  nervous  system.  More  specifically  improved  regeneration  and
axon growth has been found to restore motor  behaviour in animals after
peripheral neuropathy  (Ma et al., 2011). Experimental studies have found
that  axon  regeneration  has  a  strong  genetic  component  (Tedeschi  et  al.,
2016).  BALB/c  mice  after  Spinal  Cord  Injury  (SCI),  which  is  a  central
nervous system pain model,  have been found to have significantly less axon
regenerative capacity than other strains, including a B10 variant,  B10.PL
(Basso  et  al.,  2006).  Thus  induced  regeneration  of  injured  neurons,
differentially  regulated  inflammatory  response  and  chemokine  secretion
might be the driving factors of the less intense mechanical hypersensitivity
observed in the B10.D2 strain compared to the BALB/c strain. Moreover in
the BALB/c strain 25% of pain genes were called as significant DE with
adjusted  p.values  <  0.05  while  in  the  B10.D2  strain  we  observed  only
15.9%.  Thus  the  observed  differences  in  pain  intensity  could  be  also
associated with the number of significantly dysregulated pain genes. 
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Table 4: Top 20 enriched GO terms for biological process in genes with significant different response between strains. The columns hold the GO ID, 
term description, number of annotated genes for the term, number of significantly DE genes for the term, expected number of significant DE genes, 
rank according to p.values from weight KS test, p.value for Fisher exact test, p.value for weight Fisher test
GO.ID Term Annotated Significant Expected Rank.in.weightKS P.value classicFisher P.value weightFisher
GO:0032350 regulation of hormone metabolic process 38 2 0.03 1610 0.00049 0.00049
GO:0045625 regulation of T-helper 1 cell differentiation. 10 1 0.01 572 0.00866 0.00866
GO:0045628 regulation of T-helper 2 cell differentiation 10 1 0.01 1573 0.00866 0.00866
GO:0051798 positive regulation of hair follicle development 10 1 0.01 1380 0.00866 0.00866
GO:0090197 positive regulation of chemokine secretion 10 1 0.01 1889 0.00866 0.00866
GO:2000849 regulation of glucocorticoid secretion 10 1 0.01 1939 0.00866 0.00866
GO:0007411 axon guidance 165 2 0.14 3336 0.00882 0.00882
GO:0046632 alpha-beta T cell differentiation 80 2 0.07 4276 0.00215 0.00896
GO:0002830 positive regulation of type 2 immune response 12 1 0.01 119 0.01038 0.01038
GO:0006590 thyroid hormone generation 12 1 0.01 3814 0.01038 0.01038
GO:0045623 negative regulation of T-helper cell differentiation 12 1 0.01 3158 0.01038 0.01038
GO:0006521 regulation of cellular amino acid metabolic process 13 1 0.01 4482 0.01124 0.01124
GO:0007210 serotonin receptor signaling pathway 14 1 0.01 3945 0.0121 0.0121
GO:0045624 positive regulation of T-helper cell differentiation 14 1 0.01 717 0.0121 0.0121
GO:2000833 positive regulation of steroid hormone secretion 14 1 0.01 4270 0.0121 0.0121
GO:0070633 transepithelial transport 15 1 0.01 4200 0.01296 0.01296
GO:1901018 positive regulation of potassium ion trasport 15 1 0.01 4575 0.01296 0.01296
GO:0007202 activation of phospholipase C activity 16 1 0.01 3163 0.01382 0.01382
GO:0043032 positive regulation of macrophage activation 16 1 0.01 1307 0.01382 0.01382
GO:0043306 positive regulation of mast cell degranulation 16 1 0.01 1710 0.01382 0.01382
         We next examined the direction of changes in the expression of the
most interesting of the genes that were found to have significantly different
(adjusted p.value < 0.05) responses between BALB/c and B10.D2 strains.  
 Acan, which is associated with calcium ion binding and extracellular
matrix  has  been  found  to  be  up-regulated  in  patients  with  painful
Femoroacetabular Impingement (Chinzei et al., 2016), was significantly up-
regulated in BALB/c strain (p.value = 9.975E-06, log fold change = 2.51)
while it was slightly down-regulated in B10.D2 strain (log fold change =
-0.54). 
Duoxa1,  which  is  a  p53-regulated  neurogenic  factor  whose
expression  is  induced by overexpression  of  p53 and intensifies  neuronal
differentiation (Ostrakhovitch and Semenikhin, 2011), was also significantly
up-regulated in BALB/c  (p.value = 5.589E-030, log fold change = 3.02)
and not DE in B10.D2. 
Gal,  a neuropeptide involved in nociception which functions  as  a
cellular messenger of the nervous system and is related to neuropathic pain
(Mechenthaler, 2008), was significantly more upregulated in the BALB/c
(log fold change = 4.4) strain than in the B10.D2 strain (log fold change =
1.8).
Interestingly  though,  Il4ra  which  encodes  the  alpha  chain  of  the
interleukin-4  receptor  and  is  found  to  be  implicated  in  inflammatory
macrophage-dependent neuropathic pain  (Kiguchi et al., 2015), was stable
in B10.D2 strain but significantly up-regulated in BALB/c strain after the
SNI surgery (p.value = 1.18E-08, log fold change = 0.7). Even though Il4ra
is  known  to  induce  M2  macrophages  which  reduce  neuroinflammation
(Casella et al., 2016). Il4ra has also been found to reduce neuropathic pain
in mice after sciatic nerve injury, (Kiguchi et al., 2015) . 
After SNI surgery Chl1 and Gap43, which are related to synaptic
plasticity  and axon  guidance,  and are  known to  be  crucial  for  neuronal
regeneration after nerve injury (Cheng et al., 2013; Yamanaka et al., 2011) ,
were significantly more up-regulated in BALB.c (high pain strain) than in
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B10.D2 strain. Increased maladaptive plasticity of the peripheral and central
nervous  system  is  indeed  a  characteristic  of  both  neuropathic  and
inflammatory pain (Michael Costigan et al., 2009).   
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Identification of LncRNAs
After analysing the expression of the known genes we proceeded to
identify novel LncRNAs and analyse their differential expression. We used
the  pipeline  described  in  chapter  methods  to  identify  4970  predicted
LncRNAs with non-zero counts. Next we assessed the coding potential of
these putative LncRNAs and found 936 with a coding potential score, as
calculated  by  CPC,  of  more  than  1.  Thus  we  discarded  936  identified
transcripts  as  coding  and  we  ended  up  with  4034  predicted  models  of
putative LncRNAs.
Mouse is a very well annotated organism and since we used the latest
mouse  genome (mm10) we observed 402 already annotated  or  predicted
LncRNAs by the ENSEMBL/GENCODE consortium pipeline, expressed in
our  dataset.  We  then  compared  and  looked  for  overlaps  between  these
ENSEMBL LncRNAs  and  the  ones  predicted  from RNA-seq  using  our
customised  pipeline.  Using  our  pipeline,  we  were  able  to  identify  317
(78.8%) out of these 402 ENSEMBL LncRNAs with more than 50% exonic
sequence overlap.  A plot of the log mean counts of identified vs missed
LncRNAs, figure 15, shows that the average log 2 counts for the missed
LncRNAs are significantly lower than for those identified by our pipeline.
As our aim is not a complete reconstruction of the transcriptome, but rather
finding novel LncRNAs, which may be functionally important in certain
biological  processes  because  they  are  significantly  DE,  we  identified
LncRNAs which  are  sufficiently  and consistently  expressed  in  order  for
their expression pattern to be further analysed. These results indicate that by
controlling possible false  positives and sequencing artefacts,  our pipeline
identified a stringent set of putative LncRNAs that could have functional
importance in specific biological conditions.
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Moreover,  before  assessing  coding  potential,  we  examined  the
predicted LncRNAs in the context of their exon numbers. GENCODE has
found that  most  of  annotated  LncRNAs have two exons  (Harrow et  al.,
2012). Our predictions have a distribution of exon number which is very
similar  to  GENCODE’s  findings.  The  distribution  of  exons  is  heavily
skewed to the left  and biased towards bi-exonic LncRNAs, then tails off
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Figure 15: Log mean counts of Identified and Un-identified ENSEMBL 
LncRNAs in the mouse RNA-seq dataset.
heavily  after  5  exons,  with  near  zero  predictions  of  more  than  8 exons,
figure 16.
Some examples of annotated LncRNAs identified by our pipeline are
in figure 17. 
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Figure 16: Distribution of exon number in the predicted LncRNAs. Most of 
the transcripts are predicted to have 2 exons. 
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Figure 17: Annotated LncRNAs as predicted in our dataset. For each IGV genome browser 
screenshot: in the first track named “RefSeq genes” is the RefSeq annotation, in the second 
track named “ENSEMBL_mm10_LncRNAs” is the ENSEMBL annotation, in the third track is 
our predicted gene models of LncRNAs (in the blue box).  From top to bottom:
1. ENSMUSG00085282 ENSEMBL LncRNA. This is a complex transcript with 4 exons of 
different lengths. We should note the significant differences between ENSEMBL and 
RefSeq annotations. Our predicted LncRNA matches the ENSEMBL annotation in exon 
number and structure.
2. ENSMUSG00000089699 ENSEMBL LncRNA. Refseq does not include this LncRNA in its
mm10 annotation. We predicted the exact gene model given by ENSEMBL. This is bi-
exonic LncRNAs with two relatively small exons.  
3. NR_040391 RefSeq LncRNA. ENSEMBL pipeline has not predicted this LncRNA and it 
does not include it in its mm10 annotation. We predicted a gene model, with not good 
agreement with RefSeq with two exon less than the RefSeq annotation.
4. ENSMUSG00000097869 ENSEMBL LncRNA. This is a bi-exonic antisense LncRNA with
a very small exon and a larger one. We predicted both exons. RefSeq annotation does not
include this LncRNA at all.
5. ENSMUSG00000087413 ENSEMBL LncRNA. This is again a bi-exonic LncRNA. We 
predicted both exons. RefSeq annotation does not include this LncRNA at all.
1)
2)
3)
4)
5)
 Expression of predicted LncRNAs in mouse DRG
After  assigning  reads  to  the  identified  LncRNAs  using  HTSeq
(Anders et al., 2015) and the Intersection Not Empty strategy, we examined
their  expression  strength  relative  to  protein  coding  genes.  Predicted
LncRNAs  had,  as  expected,  significantly  lower  median  expression  than
protein coding genes. Median values of LncRNAs were 10 times lower than
those for ENSEMBL protein coding genes. This pattern was consistent in all
samples, figure 18. As we have deeper sequencing for the mouse samples,
i.e.  more reads  per sample,  and thus higher  dynamic range we observed
much  higher  difference  between  the  median  expression  of  ENSEMBL
protein coding genes and LncRNAs in mouse than in rat (10 fold compared
to 5 fold). In mouse we had 70-80 million reads per sample vs 50 million
reads per sample in rat, but the difference was also due to the much better
mapping  of  reads,  i.e.  the  actual  number  of  reads  used  for  downstream
analysis, in mouse than in rat.  
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Figure 18: Median read counts for predicted LncRNAs (green) compared to median read 
counts for ENSEMBL protein coding genes (violet). In general LncRNAs were expressed 10
times lower than genes.
Differential Expression of LncRNAs
We subsequently analysed differential expression of LncRNAs using
DESeq2. First we assessed the quality of our data by inspecting how the
expression of these novel LncRNAs separated our samples, see figure 19.
This  would  indicate  whether  they  carry  a  biological  signal  relevant  to
neuropathic  pain.  Then we assessed the consistency of the expression of
LncRNAs in our dataset by calculating the Cook’s distance for each sample,
i.e. the change of the coefficient of a linear model fitted to the LncRNAs’
expression  if  we  remove  the  respective  sample  and  refit  the  model.  A
consistent  Cook’s  distances  plot  would  indicate  that  we  did  not  have
spurious expression spikes, genomic contamination or highly inconsistent
expression  of  novel  LncRNAs,  figure  20.  Regarding  maximum  Cook’s
distance which can reveal whether there are lot of outlying LncRNAs, we
observed a very similar distribution to that of ENSEMBL genes, with very
few outliers and generally small distances. The only expected difference is
that  the  values  for  LncRNAs were  10  times smaller  than  the  values  for
ENSEMBL genes,  following  their  fewer  numbers  and  lower  expression
strength, figure 21.
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Figure 19: Clustering of samples according to the expression of predicted 
LncRNAs. Samples are clustered in the same fashion as for known genes, 
first by strain and then by condition and within these two by gender.
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Figure 20: Log10 Cook’s distance of the expression of novel LncRNAs for each sample in 
our mouse RNA-seq dataset. Very similar Cook’s distance in terms of median value and 
interquantile range for each sample, indicated very consistent expression of novel LncRNAs.
Figure 21: Maximum Cook’s distance of LncRNAs (left) and ENSEMBL genes (right)
After successful quality control we performed DE analysis.  Using
DESeq2  and  the  Wald  test  with  the  Benjamini–Hochberg  correction  to
control false discovery rate and adjust p.values, we assessed the significance
of differential expression of predicted LncRNAs. We had a total of 4970
LncRNAs  with  nonzero  read  counts  across  conditions.  By  fitting  the
generalized  linear  model  we  obtained  the  following  results  for  each
coefficient:
1. Predicted LncRNAs significantly differentially expressed (DE) with
an adjusted p.value < 0.1 between Male and Female mice:
LFC > 0 (up)     : 2, 0.04% 
LFC < 0 (down)   : 1, 0.02% 
outliers      : 97, 2% 
2. Predicted LncRNAs significantly DE with an adjusted p.value < 0.05
SNI vs sham mice for the BALB/c (high pain) strain:
LFC > 0 (up)     : 101, 2% 
LFC < 0 (down)   : 70, 1.4%
outliers      : 0, 0% 
3. Predicted LncRNAs significantly DE with an adjusted p.value < 0.05
SNI vs sham mice for the B10.D2 (low pain) strain:
LFC > 0 (up)     : 60, 1.2% 
LFC < 0 (down)   : 64, 1.3% 
outliers      : 97, 2% 
4. Predicted  LncRNAs  with  significantly  different  log  fold  changes
(difference of differences)  with an adjusted p.value < 0.05 SNI vs
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sham for the B10.D2 (low pain) vs SNI vs sham for BALB/c (high
pain):
LFC > 0 (up)     : 0, 0% 
LFC < 0 (down)   : 6, 0.234% 
outliers     : 97, 2% 
Although  there  were  fewer  predicted  LncRNAs  found  to  be
significantly  DE  than  ENSEMBL  genes,  in  terms  of  percentages  the
numbers are very similar and the above findings are very similar to those
obtained for known ENSEMBL genes in terms of the extent of significant
dysregulation  across  strains  and  conditions.  This  data  reinforced  the
observation that the pain response at the molecular level is more prominent
for the high pain strain BALB/c. These observations suggested that both, for
known  genes  and  predicted  LncRNAs,  there  is  more  significant
dysregulation in the high pain strain BALB/c, than in the low pain strain
B10.D2. We should also note that the median counts across conditions were
significantly lower than that of genes, a finding consistent with the literature
for LncRNAs (see chapter Introduction, section Long non-coding RNAs).
As we were interested to study all novel gene models / transcribed
loci predicted from our pipeline, we calculated DE for all of them and then
we discarded  the  ones  that  showed positive  coding  potential. Regarding
coding potential scores we had an enrichment of transcripts with positive
coding potential amongst the predicted LncRNAs which were significantly
DE.  This  is  reasonable,  as  gene  models  found  to  be  protein  coding  are
expected to have higher expression strength, thus higher read counts, which
leads to a more confident estimation of the actual log fold changes and of
differential  expression.  Thus,  it  is  reasonable  to  have   relatively  more
predicted  protein  coding  transcripts  in  the  set  of  transcripts  with  lower
p.values,  figure 22.  Out of the 6 transcripts  initially identified as having
significantly  different  responses  to  SNI  between  strains,  2  had  positive
coding potential. Thus only the remaining 4 can be considered LncRNAs.
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On the other hand, it is evident from the plot in figure 21 that the two other
comparisons are much less affected from excluding the predicted transcripts
with high coding potential.
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Figure 22: Distribution of CPC scores for all predicted LncRNAs and for 
those significantly DE (adj. p.value < 0.05). The red line represents the 
threshold of CPC score = 1. Above it transcripts are considered protein 
coding. 
Antisense LncRNAs and pain-related protein coding genes
In order to infer the functional role of some of the novel LncRNAs
identified  we  examined  them alongside  their  genomic  context.  Thus  we
selected all the novel LncRNAs which overlap any of the genomic region of
protein coding genes  on the  opposite  strand.  In  total  we identified 2415
expressed antisense LncRNAs on the opposite strand of 3568 protein coding
genes. We did not limited our analysis only to LncRNAs antisense of pain
genes, but we selected and further discussed above the LncRNAs identified
significantly DE and antisense of significantly DE genes.  
Not  many of the identified antisense LncRNAs were significantly
DE. In BALB/c strain SNI vs sham we had 8 LncRNAs significantly DE
(adjusted p.value < 0.05) antisense of significantly DE (adjusted p.value <
0.05)  protein  coding  genes.  More  specifically  we  identified  LncRNAs
antisense of Tpd52l1,  Nalcn,  Scn1a, Tshz2, Ttc39a,  Arhgap35, Gm19424
and Ralyl. The LncRNAs antisense of Nalcn and Tshz2 were anti-correlated
to  the  protein  coding gene,  i.e.  in  both  cases  the  antisense LncRNAs is
significantly  up-regulated  while  the  sense  gene  is  significantly  down-
regulated.
The antisense LncRNA (log fold change = 3.5, p.value = 1.33E-22,
cpc score = -0.44) of Nalcn (log fold change = -0.23, p.value = 0.004) was
not found to be significantly DE in B10.D2 strain and neither was Nalcn
gene.  Thus  we identified  a  couple  of  protein  coding gene  and antisense
LncRNA,  which  had  opposite  expression  patterns  and  were  both
significantly DE only in high pain strain BALB/c. Nalcn is an important
gene  in  neuropathic  pain,  it  is  a  sodium-leak  channel,  which  regulates
neuronal excitability (Lu et al., 2010). 
Tshz2 (log fold change = -0.268, p.value = 0.009), a gene which is
expressed in the nervous system and regulates developmental processes, and
its antisense LncRNA (log fold change = 2.48, p.value = 3.98E-7, cpc score
= -1.247) are another pair of protein coding gene and antisense LncRNA
that were not DE in the low pain strain B10.D2.
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    In B10.D2 strain we had 8 significantly DE LncRNAs antisense of
significantly dysregulated genes. In this strain we found a significantly DE
LncRNA (cpc score = -0.852) antisense of sodium channel Scn1a. Both the
protein  coding gene  and the  LncRNA were  significantly  down-regulated
after  SNI  surgery.  The  same  is  true  for  Nrp2  gene,  an  important  gene
associated with  axon guidance and innervation of inner organs  (Maden et
al., 2012).
By looking at transcription antisense of pain genes downloaded from
the  PainGenes  database  (Lacroix-Fralish  et  al.,  2007) we  identified  73
expressed transcripts antisense of pain genes. Out of these 60 were putative
LncRNAs (cpc score < 1). One of these is the antisense LncRNA of the
Scn9a gene. This particular antisense transcript of Scn9a has been recently
identified and published (Koenig et al., 2015), although it is not included on
the ENSEMBL annotation. In Koenig et al., this transcript was not found to
be DE after SNI surgery and this is also the case for the samples in our
dataset.  However,  this  specific  antisense  LncRNA  was  found  to  be
significantly DE in rat after SNT surgery. All the LncRNAs that were found
antisense of pain genes, their cpc score and their DE analysis for SNI vs
Sham for the BALB/c strain are shown in Appendix 4.
In B10.D2 strain we found 72 expressed transcripts antisense of pain
genes,  and  60  of  them  are  putative  LncRNAs  as  they  do  not  show
significant coding potential. All LncRNAs antisense of pain genes together
with their  coding potential  and DE analysis for SNI vs Sham in B10.D2
strain are in Appendix 4.
All LncRNAs antisense of pain genes expressed in B10.D2 mouse
DRG were also expressed in BALB/c mouse DRG.  This consistency in
expression reinforces the hypothesis, that even though most of them were
lowly expressed and they are not found to be significantly DE after SNI
surgery, they are actual antisense LncRNAs which may have a functional
role regulating the protein coding gene on the opposite strand.  
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Intergenic LncRNAs and pain genes
Long  Intergenic  non-coding  RNAs (LincRNAs)  can  also  regulate
protein coding gene expression in-cis or in-trans. Sometimes the product of
transcription,  the  LincRNA  per  se is  important  for  regulating  gene
expression,  whereas  in  other  cases  the  act  of  transcription  itself  induces
gene expression.  For more details  see chapter Introduction,  section Long
non-coding RNAs. We identified 2096 LincRNAs in total with no coding
potential. 101 were found to be significantly DE (adj. p.value < 0.05) in SNI
vs Sham in BALB/c strain and 79 in B10.D2 strain. 43 of them had one pain
gene as their closest genomic feature.  We selected and discuss below all
LincRNAs significantly DE, in close proximity and highly correlated with
significantly DE protein coding genes.
53  LincRNAs  were  significantly  DE  (adj.  p.value  <  0.05)  and
adjacent to significantly DE ENSEMBL genes in BALB/c SNI vs sham and
47 in B10.D2 SNI vs sham. In terms of distance between LincRNAs and
ENSEMBL genes, half of them are less than 32.5Kb away from genes and
25% of  them less  than  7Kb,  with  a  few outliers  being  in  more  remote
genomic regions  with no adjacent  genes.  Moreover  when we considered
only the pairs of LincRNA and adjacent genes which were both significantly
DE in both strains, there were no distant LincRNAs, figure 23.
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In order to find putative LincRNAs likely to be in-cis regulators of
the  expression  of  pain  genes,  we  looked  for  highly  correlated  pairs  of
protein coding pain genes and adjacent LincRNAs. 
Since genomic features of close proximity usually have correlated
expression  (Thygesen and Zwinderman, 2005) and the LincRNAs follow
the same pattern  (Ulitsky and Bartel,  2013), we established a correlation
threshold  using  a  randomization/permutation  approach  described  in
Methods.
190
Figure 23: Distance between ENSEMBL genes and LincRNAs. Most of them are in 
close and moderate genomic proximity. 
We considered all LincRNAs with significant correlation estimates
(p.value  < 0.05)  and  a  correlation  coefficient  of  normalised  read  counts
across samples higher than 0.67 to be highly correlated. In order to account
for the difference in scales and also in order to moderate fold changes for
LincRNAs with low counts, we used the regularised log transformation of
read counts for both ENSEMBL genes and LincRNAs.
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Table 7: LincRNAs with highly correlated expression to pain genes
lincRNA ENSEMBL_id Distance symbol cpc correlation cor_pvalue
chr4:132107492-132108725(-) ENSMUSG00000050511 -2001 Oprd1 -1.02247 0.9366318108 1.24159438286142E-09
chr13:54233180-54236274(+) ENSMUSG00000034987 -10748 Hrh2 0.140287 0.8928979827 1.18692713879653E-07
chr15:72505532-72506966(-) ENSMUSG00000036760 -5153 Kcnk9 -0.981673 0.9375715301 1.08915854113434E-09
chr19:22992291-22995602(+) ENSMUSG00000052387 -2407 Trpm3 -1.22812 0.8618264664 1.04443712678481E-06
Using  this  approach  we  found  4  LincRNAs  with  significantly
correlated  expression  to  their  adjacent  pain  gene.  All  LincRNAs  had
positive correlation to their closest pain gene. These LincRNAs are adjacent
to  pain  genes  Oprd1,  Hrh2,  Trpm3  and  Kcnk9,  table  7.  They  are  all
upstream of their adjacent pain gene in very close genomic proximity. 
The  only  pair  of  LincRNA  and  adjacent  gene  that  were  both
significantly  DE  in  both  strains  is  the  pair  of  Oprd1  gene  and
chr4:132107492-132108725(-) LincRNA, figure 25. Oprd1 is an important
pain  gene,  it  reduces  calcium  ion  currents  and  induces  potassium  ion
conductance. It is an opioids receptor and mediates opioids analgesia. As we
recently  demonstrated,  contribution  of  endogenous  opioids  leads  to
congenital insensitivity to pain in humans and mice  (Minett et al., 2015).
Furthermore, it has been found that genetic differences in heat sensitivity
might be related to sex-specific mediation of opioid analgesia by the Oprd1
gene  (Mogil  et  al.,  1997).  Indeed  in  our  dataset  Oprd1  is  more
downregulated  in  the  high  pain  strain  and the  same is  also  true  for  the
adjacent LincRNA.
Comparing the mouse results to rat under the SNT pain model
Examining the above results in the context of the results obtained in
rats that underwent the SNT pain model we observed that the amount of
significantly dysregulated genes is much higher in rat than in mouse. This
could be due to the higher within samples dispersion we observed in mouse
samples. But more interestingly the high pain mouse strain BALB/c is much
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Figure 25: Oprd1 pain gene and chr4:132107492-132108725(-) adjacent 
LincRNA in the genome browser
more similar  to  rat  than  the low pain  mouse strain  B10.D2,  both  in  the
amount  of  significantly  dysregulated  genes  and  their  direction  of  fold
change,  figure  26.  434 ENSEMBL genes  are  commonly  up-regulated  in
BALB/c  strain  and  rat  and  393  are  commonly  down-regulated.  The
respective numbers for the B10.D2 strain are 288 and 253. 
We subsequently identified the significantly over-represented gene
ontology (GO) terms of biological processes in these subsets of commonly
DE genes, table 8 and 9. For this particular enrichment we used as the gene
universe  all  significantly  DE  genes  in  either  strain,  then  with  a  binary
function we selected only the ones the were significantly DE in both strains.
In  the  top  10  enriched  GO  terms  we  again  found  enrichment  for  axon
guidance,  regulation  of  apoptosis  and  cell  proliferation,  terms  related  to
immune system; signal transduction, cell matrix adhesion and extracellular
matrix organisation and only in BALB/c and rat, G-protein coupled receptor
signalling. Thus this subset of common terms  provides a summarisation at
the level of biological processes of the common core of genes dysregulated
in both pain models (SNI and SNT) and species (mouse and rat).  
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Figure 26: Venn diagram of DE genes in B10.D2, BALB/c mice and rat 
B10.D2BALB/c
Rat
434 Up
393 Down
Rat
288 Up
253 Down
Table 8: GO enrichment for DE genes with the same direction in both BALB/c mouse strain and rat
GO.ID Term Description Annotated Significant Expected Rank in weightKS p.value classicFisher p.value weightFisher
GO:0032060 bleb assembly 11 7 0.22 5260 4.0e-10 4.0e-10
GO:0045944 positive regulation of transcription from RNA polymerase II promoter 998 48 20.15 30 2.4e-08 4.8e-07
GO:0035590 purinergic nucleotide receptor signaling pathway 10 5 0.2 5299 7.6e-07 7.6e-07
GO:0043029 T cell homeostasis 44 8 0.89 5275 2.4e-06 2.4e-06
GO:0007165 signal transduction 5302 191 107.03 2278 2.4e-19 7.8e-06
GO:0007160 cell-matrix adhesion 171 19 3.45 5285 1.9e-09 8.5e-06
GO:0043524 negative regulation of neuron apoptotic process 152 13 3.07 245 1.3e-05 1.3e-05
GO:0030198 extracellular matrix organization 201 15 4.06 3898 1.5e-05 1.7e-05
GO:0007411 axon guidance 168 13 3.39 114 3.8e-05 2.8e-05
GO:0035588 G-protein coupled purinergic receptor sinalling 16 4 0.32 5307 0.00025 3.2e-05
GO enrichment for DE genes with the same direction in both B10.D2 mouse strain and rat
Table 9: GO enrichment for DE genes with the same direction in both B10.D2 mouse strain and rat
GO.ID Term Description Annotated Significant Expected Rank in weightKS classicFisher weightFisher weightKS elimKS
GO:0032825 positive regulation of natural killer cell differentiation 10 4 0.13 5137 6.0e-06 6.0e-06 0.944 0.94361
GO:0007160 cell-matrix adhesion 171 11 2.27 5195 1.9e-05 3.4e-05 0.969 0.60792
GO:0043524 negative regulation of neuron apoptotic process 152 10 2.02 359 3.7e-05 3.7e-05 0.025 0.02470
GO:0007411 axon guidance 168 11 2.23 244 1.6e-05 5.1e-05 0.012 0.00135
GO:0042698 ovulation cycle 93 8 1.23 5317 3.3e-05 7.4e-05 1.000 0.54108
GO:0045944 positive regulation of transcription from RNA polymerase II promoter 998 31 13.24 14 1.0e-05 0.00013 2.8e-06 2.2e-06
GO:0048485 sympathetic nervous system development 23 4 0.31 5139 0.00022 0.00022 0.944 0.94419
GO:0008285 negative regulation of cell proliferation 585 23 7.76 316 3.8e-06 0.00023 0.020 0.00057
GO:0035590 purinergic nucleotide receptor signaling pathway 10 3 0.13 5291 0.00026 0.00026 1.000 0.99990
GO:0030574 collagen catabolic process 24 4 0.32 5119 0.00026 0.00026 0.939 0.93882
Regarding  LncRNAs,  as  expected  we  observed  modest  syntenic
conservation,  i.e.  LncRNAs  in  equivalent  genomic  positions  between
species. 147 LincRNAs were identified in the same relative position of the
same closest adjacent ENSEMBL gene. Out of these 4 had a pain gene as
their closest genomic feature, table 10.
 
 
Moreover  the  only  syntenically  conserved  LincRNA with  higher
than random and significant  correlation to  its  adjacent  gene in  rat  is  the
LincRNA chr1:44859521-44866436(+)   which  is  close  and  correlated  to
Oprm1.  The  LincRNA  is  upstream  of  the  gene  and  is  significantly
downregulated as is the protein coding gene. Oprm1 is an opioid receptor
like Oprd1, associated with pain intensity and opioid analgesia and it also
interacts with Oprd1 forming an heterodimer. Thus we have identified two
pairs of significantly DE LincRNAs, highly correlated with opioid receptors
Oprm1 and Oprd1, in rat and mouse respectively. These opioid receptors in
turn interact to form heterodimers. We should note that the fold change of
the opioid receptor and the gene is the same, i.e. down-regulation after SNI
surgery, in both species, an indication that the LincRNAs might induce gene
expression.
Regarding  antisense  LncRNAs,  as  expected,  we  identified  both
Scn9a  and Kcna2 antisense LncRNAs in both species and strains. Neither
these antisense transcripts are part of the ENSEMBL/GENCODE or RefSeq
annotation. Kcna2 antisense does not reach significance in rat nor in mouse,
Scn9a does reach significance in rat but not in mouse after SNI surgery, as
also reported in (Koenig et al., 2015), table 11.
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lincRNA ENSEMBL_id Distance symbol
chr2:55315059-55415131(+) ENSMUSG00000026824 20839 Kcnj3
chr2:75673219-75673509(-) ENSMUSG00000015839 -2004 Nfe2l2
chr14:68043810-68081656(+) ENSMUSG00000022055 2207 Nefl
chr14:70872255-70874020(+) ENSMUSG00000022103 16110 Gfra2
Table 10: Syntenically conserved LincRNAs between rat and mouse with 
the same pain gene as their closest gene
Table 11: Conserved antisense LncRNAs on the opposite strand of Scn9a and Kcna2 genes
LncRNA Gene ID Gene symbol Lnc lfc Lnc p,value Gene lfc Gene p.value CPC score Organism
chr2:229296258-229305952(-) ENSRNOG00000018285 Kcna2 -0.669228825 0.2201968759 -1.118629743 2.325746E-06 -0.977888 Rattus Norvegicus
chr3:107107205-107115062(-) NM_008417 Kcna2 -0.712913105 0.1374298266 -0.332733876 0.0020456076 0.447681 Mus musculus BALB/c 
chr3:107107205-107115062(-) NM_008417 Kcna2 -0.30151431 0.785324861 -0.25723331 0.0196038072 0.447681 Mus musculus B10.D2 
chr3:59057403-59276093(+) ENSRNOG00000006639 Scn9a -2.357018731 1.425246E-09 -1.08666881 1.445246E-05 -0.815863 Rattus Norvegicus
chr2:66634323-66642309(+) ENSMUSG00000075316 Scn9a 0.0687529985 0.9926893542 -0.145395638 0.2883473421 -1.12072 Mus musculus BALB/c 
chr2:66634323-66642309(+) ENSMUSG00000075316 Scn9a -0.419457319 0.9347317631 -0.022210573 0.9319527903 -1.12072 Mus musculus B10.D2 
In  general  we  identified  388  syntenically  conserved  antisense
LncRNAs on the opposite strand of orthologous genes in mouse and rat.
Moreover we identified 25 syntenically conserved LncRNAs antisense of
pain  genes,  table  12.  Very  important  pain  genes  were  found to  have  an
antisense  non-coding  RNA transcribed  in  both  species.  Moreover  Fyn,
Prkca,  Scn9a, Trpm3 and Atp1b3 pain genes have an antisense LncRNA
with opposite expression patterns. 
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Table 12: LncRNAs antisense of pain genes, syntenically conserved 
between mouse and rat
LncRNA Gene ENSMEBL ID Gene symbol cpc
chr10:39555935-39560136(-) ENSMUSG00000019843 Fyn -0.472081
chr11:55394494-55395613(+) ENSMUSG00000018593 Sparc -1.05264
chr11:63150892-63151309(-) ENSMUSG00000018217 Pmp22 -0.886487
chr11:70239888-70246096(+) ENSMUSG00000000320 Alox12 0.125631
chr11:81966759-81995840(+) ENSMUSG00000020704 Asic2 -0.833933
chr11:102739325-102762503(-) ENSMUSG00000020926 Adam11 0.539235
chr11:107935614-107937468(+) ENSMUSG00000050965 Prkca -0.893234
chr13:112505712-112508381(-) ENSMUSG00000021756 Il6st -1.01211
chr14:103778950-103851424(+) ENSMUSG00000022122 Ednrb 0.298243
chr15:101214611-101225267(-) ENSMUSG00000000531 Grasp -0.116895
chr16:87934064-87936434(+) ENSMUSG00000022935 Grik1 -1.01687
chr16:92690953-92693516(+) ENSMUSG00000022952 Runx1 -1.09998
chr19:6969343-6970896(+) ENSMUSG00000024960 Plcb3 -0.934247
chr19:22435556-22448608(-) ENSMUSG00000052387 Trpm3 -0.191057
chr2:66634323-66642309(+) ENSMUSG00000075316 Scn9a -1.12072
chr2:75671430-75690556(+) ENSMUSG00000015839 Nfe2l2 0.169968
chr2:127481675-127485719(+) ENSMUSG00000079056 Kcnip3 -1.07449
chr3:60782742-61004319(-) ENSMUSG00000027765 P2ry1 0.749763
chr3:101592328-101592581(+) ENSMUSG00000033161 Atp1a1 -1.18998
chr4:132560740-132604797(-) ENSMUSG00000056529 Ptafr -0.216132
chr5:43867709-43869237(-) ENSMUSG00000029084 Cd38 -1.12311
chr6:125241923-125242339(-) ENSMUSG00000030337 Vamp1 -0.713977
chr7:91253594-91259556(-) ENSMUSG00000052572 Dlg2 -1.2575
chr7:114635520-114636347(+) ENSMUSG00000030669 Calca -1.18392
chr9:96345647-96364371(+) ENSMUSG00000032412 Atp1b3 -1.00742
Discussion
In  this  study  we  have  studied  transcriptional  changes  in  mouse
DRGs  after  SNI  surgery  without  being  restricted  by  the  annotated  gene
models found in both major genomic annotation consortia. As our aim was
not  to  perform a  complete  reconstruction  of  the  transcriptome,  we  only
selected a sub-set of predictions on which we could have more confidence
based  on  the  expression  consistency,  strength,  pattern  and  differential
expression  between  conditions  of  interest.  Of  course  all  results  we
presented, regarding LncRNAs, have derived from predicted  models and
thus  require  Q-PCR validation in  the wet  lab in  other  samples  to assess
biological reproducibility.
In this study of the SNI model of peripheral neuropathy, we used
mouse strains with significantly different responses and intensity of induced
mechanical hypersensitivity after the pain surgery. We found that the high
pain  strain  BALB/c,  has  more  genes  significantly  DE between  SNI  and
sham operated animals than the low pain strain B10.D2. The high pain strain
had more prominent transcriptional changes in voltage gated potassium and
sodium ion channels indicating that different responses on the dysregulation
of  genes  encoding  these  channels  play  significant  role  in  maintaining
neuropathic pain and differentiating its  severity between strains.  BALB/c
strain had a  very similar  profile  of transcriptional  changes  regarding ion
channels and pain genes to rat, on the other hand B10.D2 strain did not have
significant  responses  of  these  genes  differentiating  conditions.  Moreover
rats  that  underwent  the  SNT pain  model  and  had  significantly  induced
mechanical hypersensitivity were much more similar to the high pain strain
than the low pain strain. 
Biological  processes  of  axon  guidance,  regulation  of  neuronal
regeneration  and  development  as  well  as  regulation  of  ion  channels,
signalling and response to stimuli, learning and memory are highly enriched
amongst  the biological  process  related to genes  significantly DE in both
mouse  strains.  These  processes  are  essential  for  the  phenotype  of
neuropathic  pain.  Regarding  genes  with  significant  different  responses
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between  strains  we  found  that  these  are  highly  enriched  for  biological
processes  related  to  axon  guidance  and  neuron  development  and
regeneration, as well as potassium ion transport, immune system response
and chemokine  regulation.  Moreover  genes  related  to  neuronal  plasticity
and  calcium  channels  were  also  enriched  amongst  the  genes  with
significantly different response between the high and low pain strain. 
The  above  findings  were  extended  by  the  identification  of  4034
LncRNAs, expressed in mouse DRG. These non-coding transcripts that are
mostly bi-exonic are expressed 10-times lower than protein coding genes
but  nevertheless  they  have  a  consistent  expression  pattern  that  could
separate samples according to the biological condition, namely SNI or sham
surgery, BALB/c or B10.D2 strain. They were found to be significantly DE
SNI  vs  sham  in  very  similar  percentages  to  those  of  known  genes  in
BALB/c  and  B10.D2  strain.  171  DE  LncRNAs  were  found  to  be
significantly dysregulated in the high pain strain and 124 in the low pain
strain.  As  expected,  we  have  also  found  modest  syntenic  conservation
between rat and mouse predicted LncRNAs  
Out of the predicted antisense LncRNAs, 8 are significantly DE and
antisense of significantly DE genes. Moreover two of them have an opposite
expression pattern, similar to that of Kcna2  (Zhao et al., 2013) and Scn9a
(Koenig et al., 2015) antisense transcripts. The pair of protein coding gene
Nalcn  - antisense LncRNA was only found significantly DE in the high
pain strain. Nalcn, a sodium leak channel, is important for the regulation of
neuronal  excitability  by  contributing  a  basal  Na+  leak  conductance  in
neurons  (Ren,  2011).  Thus  Nalcn  might  be  regulated  by  this  antisense
LncRNA and contribute to the different levels of pain intensity after the SNI
surgery between strains.  The same is  true also for Tshz2 gene,  which is
related  to  neuron development,  and its  antisense  LncRNA with opposite
expression pattern found to be significantly DE only in the high pain strain.
Amongst antisense LncRNA we have also identified, the published but not
included in the ENSEMBL or RefSeq annotation,  LncRNAs antisense of
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Kcna2 and Scn9a. In general 60 LncRNAs were predicted antisense of pain
genes.
Regarding intergenic LincRNAs most of them were in medium to
close proximity to known genes and those found to be relatively close to
known genes were also enriched for significantly DE. 53 were significantly
DE with a significantly DE closest genomic neighbour in BALB/c strain and
47 in B10.D2. 4 of them were highly and significantly correlated with their
closest  protein  coding  pain  gene.  These  pairs  of  LincRNA and  highly
correlated  closest  pain genes  include a  transient  receptor  potential  and a
potassium channel, a histamine receptor and an opioid receptor. Moreover,
there is a significantly DE LincRNA close to the significantly DE Oprd1
opioid receptor in mouse, where in rat there is a significantly DE LincRNA
closest to, the partner of Oprd1, Oprm1 in the same upstream position of the
opioid receptor and with the same direction of change – down-regulation.
Thus these LincRNAs might regulate  in-cis those opioid receptors that are
significantly DE and functionally important for neuropathic pain.
In this  study we have efficiently used RNA-sequencing to predict
LncRNAs and at the same time to quantify transcription changes in mouse
DRGs between SNI and sham operated animals, but also between strains of
high and low mechanical hypersensitivity. We have summarized our results
by reporting enriched biological processes related to neuropathic pain and
also found that novel LncRNAs are putative mediators of neuropathic pain.
We have  computationally identified a subset of intergenic and antisense
LncRNAs, which given their genomic context, DE and expression pattern
suggests they might be functionally important for maintaining neuropathic
pain or differentiating its intensity.  
As LncRNAs are not highly conserved across species and are highly
tissue  specific  we  should  be  very  careful  in  translating  our  findings  to
human or other species. On the other hand some very important LncRNAs
have  been  highly  tissue  or  developmental  stage  specific  but  conserved
across species. In this study the usage of animal models of pain gave us the
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ability  to  study  the  transcriptional  profile  and  identify  LncRNAs  in  the
highly  pain  relevant  tissue  of  DRG.  As  harvesting  of  DRGs under  well
induced pain states would have been impossible without animal models of
pain we believe that the usage of animal models gave us valuable insights
regarding the response to peripheral nerve injury and the molecular changes
involved. Moreover we found some conserved LncRNAs between mouse
and  rat  DRG and  we will  further  study  if  these  are  conserved  in  other
species.     
We  should  note  that  all  results  of  DE  LncRNAs  are  based  on
predictions  from  RNA-seq  data  of  a  biologically  relevant  experiment.
Future work of this project will involve functional validation of these targets
as  well  as  integration  of  more  data  types  from  high-throughput  assays
regarding chromatin modifications and transcription start-site prediction.
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Clustering  of  patients  with  diabetic
neuropathy  reveals  distinct  neuropathic
pain dimensions
Overview
In  this  chapter  we  present  methods  and  results  from  analysing
clinical  data  and  self-reported  quality  of  life  questionnaires  data  from
patients  with  diabetes  mellitus  suffering  from  painful  or  painless
neuropathy. Our aim is to identify distinct sensory profiles or pain qualities
using self-reported questionnaires and in general assess the ability of these
tests  to  capture  the  phenotype  of  diabetic  neuropathy  observed  in  our
dataset.  We  will  also  associate  these  sensory  profiles  with  results  from
quantitative sensory testing and clinical markers and also test self-reported
questionnaires for agreement between their results.  
Introduction
As the International Association for the Study of Pain (IASP) defines
it,  Neuropathic  Pain  is  “pain  initiated  or  caused by a  primary  lesion  or
dysfunction  in  the  nervous  system.”  (Treede  et  al.,  2008).  Thus,  for  the
diagnosis  of  neuropathic  pain  an  underlying  disease  or  lesion  on  the
somatosensory system, which has in turn neuropathic pain as a symptom,
should be identified. Particularly, patients suffering from diabetes mellitus
exhibit diabetic peripheral neuropathy pain in percentages ranging  from 28-
49%; and of those patients 25-50% develop a neuropathic pain phenotype
(Themistocleous et al., 2016). Thus painful neuropathy is one of the most
frequent complications of diabetes. 
In order for the optimal treatment to be delivered, neuropathic pain
must be correctly diagnosed. This can be a difficult task as this kind of pain
is  due  to  highly  heterogeneous  clinical  conditions.  For  the  accurate
diagnosis of neuropathic pain numerous subjective pain questionnaires and
standardised sensory tests have been developed. Due to this heterogeneity of
causes and clinical symptoms there is an emerging need to classify patients
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of neuropathic pain accordingly and provide them with the most effective
treatment as soon as possible. As the developers of The Neuropathic Pain
Symptom Inventory (NPSI) questionnaire state “In this context, we thought
it would be of interest to develop and validate a specific self-questionnaire
for the assessment of the different symptoms of neuropathic pain. Ideally,
such a questionnaire could represent a useful and exploitable tool for large
cohorts of patients in multicentre studies and give information comparable
to  that  provided  by  quantitative  evaluation,  as  regards  the  nature  and
intensity of the various painful symptoms. ” (Bouhassira et al., 2004) .
The Neuropathic Pain Symptom Inventory (NPSI)
The approach described above gave birth to the NPSI self-completed
pain questionnaire, presented in 2004 and designed to evaluate the different
symptoms of  neuropathic  pain  and to  assess  its  intensity.  NPSI  is  not  a
screening tool for neuropathic pain but its main goal is rather to measure
psychometric properties that can be effectively used to classify patients with
painful neuropathy who may have differential response to treatment.  The
test has been proven to have good construct validity, precision and recall.
The  English  version  of  NPSI  is  comprised  of  12  questions,  which  are
grouped  together  in  order  to  give  the  following  5  sub-scores:  Burning
(superficial)  spontaneous  pain  derived  from  question  1  (Q1),  Pressing
(deep) spontaneous pain derived from Q2 and Q3, Paroxysmal pain derived
from  Q5  and  Q6,  Evoked  pain  derived  from  Q8,  Q9  and  Q10,
Paresthesia/dysesthesia derived from Q11 and Q12 (Bouhassira et al., 2004).
The  sum  of  these  sub-scores  gives  the  total  score  and  the  average  the
average  total  score.  For  each  question  the  patient  has  to  respond  in  a
numeric quantitative scale from 0 to 10,  where 0 means no pain and 10
means the worst pain imaginable. There are also two questions which can be
answered in an ordinal categorical scale, namely “During the past 24 h, your
spontaneous pain has been present for how many hours?” and “During the
past 24 h, how many of these pain attacks have you had?” which aim to
evaluate  spontaneous  paroxysmal  and  ongoing  pain.  Given  these  5  sub-
scores, NPSI has been found to be able to distinguish between five distinct
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clinical dimensions of neuropathic pain which are also relevant to response
to treatment. 
An example of a digital version of NPSI can be seen in figure 1.
Although  recent  studies  have  used  data  analysis  techniques  in  order  to
identify clusters of patients with distinct pain signatures, or in other words
dimensions of neuropathic pain or sensory profiles  (Freeman et al., 2014),
there are different pain profiles emerging under different conditions causing
neuropathic pain. 
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Figure 1: A digital version of the NPSI questionnaire as it is in the database used by the 
current study.
Douleur Neuropahique en 4 Questions (DN4)
A year after introducing NPSI, the French Neuropathic Pain Group
introduced a new clinician-administered questionnaire comprising of only 4
questions,  thus the name DN4, which has been found able to distinguish
between patients  suffering from neuropathic  pain versus  non-neuropathic
pain (Bouhassira et al., 2005). Thus DN4 is a screening tool for neuropathic
pain. This small and simple questionnaire, comprising of a small number of
features  sufficient  to  identify  neuropathic  pain,  has  great  sensitivity  and
specificity  in  distinguishing  between  non-neurological  lesions  and
neurological  lesions.  DN4 is  a  clinician-administered  questionnaire.  It  is
deliberately very small and simple, so it can be used both by specialists and
non-specialists, on a very large scale, locally or remotely. DN4 and NPSI
are complementary tools. In terms of the scoring method, DN4 has 4 groups
of questions where only a binary response is allowed. A positive response
scores  1 and a  negative scores  0.  If  the sum of  all  questions  in  these 4
groups, ranging from 0 to 10, is above 4 then DN4 classifies the patient as
suffering  from  neuropathic  pain.  An  English  version  of  the  DN4
questionnaire, as used in our study, is in figure 2.
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Figure 2: The English form of the DN4 questionnaire. 
Toronto clinical scoring system (TCSS)
The TCSS is a  simple screening tool, similar to DN4, that has been
developed  in  order  to  asses  the  presence  and  severity  of  diabetic  poly
neuropathy  (Bril  and  Perkins,  2002).  TCSS is  completed  after  a  simple
neurological examination on the foot and the upper limb. More specifically
it  assesses  the  presence  of  symptoms  of  pain,  numbness,  tingling  and
weakness on the foot and also ataxia  and upper limb symptoms. Then a
score of 1 is assigned for the presence of each syndrome. In addition, it
assesses the response of tendon reflexes on both left and right side using a
scale of 0 for normal, 1 for reduced and 2 for absent reflexes.  Finally a
series of sensory tests including pinprick, temperature, light touch, vibration
and position are carried out and a score of 0 is assigned for normal sensation
and 1 for abnormal. Again these tests are carried out for the right and left
side.  An extra  binary  score  (0-1)  indicates  if  the  patient  has  underlying
neuropathy.  Then  the  following  sub-scores  are  calculated:  Symptoms,
Reflex,  Sensation.  Those scores can be adjusted,  when the indication for
neuropathy has been taken into account, or un-adjusted when not. The total
score  is  the  sum  of  all  scores  and  ranges  from  0  to  19.   A  TCSS
questionnaire as used in our study is in figure 3.  
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Figure 3: The TCSS pain questionnaire 
The Quantitative Sensory Testing (QST)
QST is  a  standardised  protocol  of  sensory testing  which  assesses
evoked perception in response to a standardised stimulus developed by the
German Neuropathic Pain Network (DFNS) in 2006  (Rolke et al., 2006) .
QST protocol  involves  assessment  of  heat  and mechanical  detection and
pain  thresholds.  More  specifically  mechanical  detection  threshold  is
assessed by Von Frey filaments and a 64 Hz tuning fork, pain threshold is
assessed  by  pinprick  stimuli  and  blunt  pressure  and  heat  detection
thresholds with computerized generators of thermal stimuli. Sub-scores for
Cold and Heat Detection Thresholds (CDT, HDT), Mechanical Detection
Threshold  (MDT),  Mechanical  Pain  Threshold  (MPT),  Mechanical  Pain
Sensitivity  and  Pain  Allodynia  (MPS,  ALL),  Wind-Up  Ratio  (WUR),
Vibration Detection Threshold (VDT) and Pressure Pain Threshold (PPT)
are  calculated  and z-transformed.  Given  these  13  sub-scores,  26  distinct
hyper- or hypo-phenomena can be measured. Moreover QST results can be
used  for  group  comparisons  and  the  identification  of  somatosensory
phenotypes.  The DFNS consortium has provided expected distributions of
measurements, standardized procedures and reference values. 
The 7-Day pain diary
The 7-Day Pain Diary is a record keeping log where patients record
the intensity and time of pain they experience throughout the day. Pain diary
records pain for 7 days and patients are asked to to complete it from 9am to
9pm throughout the day. The scoring scale is 0 for “no pain” to 10 for “the
worst pain imaginable”.  Mean average scores for the 7-day period and the
standard deviation are usually calculated. Patients are also asked to shade in
body-maps  where  they  experience  pain  as  well  as  any  pain  treatment
medication they might  take.  Pain diaries can be completed online,  using
specialised mobile apps or administered in hard-copy form. 
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Clinical markers
We also identified correlations between scores and groups of patients
classified according to quality of life questionnaires and clinical variables.
More  specifically  we  have  examined  relationships  between  different
questionnaire derived scores and HbA1c blood test, Intra Epidermal Nerve
Fibre Density (IENFD), the age, gender and Body Mass Index (BMI) of
patient, the duration of diabetes and neurological examinations such as the
MRC sensory test, the Warm and the Cold Sensibility Index (WSI – CSI).
HbA1c is one of the main blood tests for diabetes.  HbA1c measures
glycated haemoglobin and provides an amassment of long-term glycemic
control as it gives an indication of average glucose levels for a period of two
to three months. HbA1c has been found to be correlated with the risk of
long-term diabetes complications (Khan et al., 2016). HbA1c is measured in
mmol/mol or in percentage and the normal levels are below 42mmol/mol or
below 6% respectively. 
IENFD is a neurological examination which identifies the density of
small  nerve  fibres.  IENFD  provides  an  assessment  of  small-fibre
neuropathy, like diabetic neuropathy. The consensus method involves skin
biopsy using a 3mm circular punch tool, usually at the ankle, and then the
nerve density is quantified in fibres per mm.  A low IENFD indicates small-
fibre neuropathy and is associated with a higher probability of developing
neuropathic pain but it cannot be correlated with the intensity of it (Lauria et
al., 2010).  
The MRC sensory score is a standardised sensory score derived from
neurological examination as described by the Medical Research Council.
The  WSI  and  CSI  scores  are  defined  as:  WSI  =  (warm  pain  detection
threshold  −  warm threshold)/(warm pain  detection  threshold  −  reference
temperature) and CSI (cold pain detection threshold − cold threshold)/(cold
pain  detection  threshold − reference temperature)  (Themistocleous et  al.,
2016).  
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Methods
The  main  goal  of  this  study  was  to  identify  distinct
dimensions/qualities  of  neuropathic  pain  which  can  optimally  separate
patients according to their respective sensory profiles, pain symptoms and
severity. We aimed to find pain qualities which correlated well with pain
intensity. 
Imputing missing values
Most  of  the  algorithms  used  and  especially  PCA have  difficulty
handling  missing  values,  so  we  either  need  to  discard  incomplete
observations,  i.e.  patients  or  samples  with any missing  value,  or  impute
missing values. In studies where we have plenty of data points per sample
instead  of  a  big  number  of  individual  samples,  an  efficient  strategy  for
imputing missing values is necessary. We can always use the simple strategy
of imputing missing values with the mean value for the specific variable, but
usually this  is  not  advised.  Although this  may preserve some descriptive
statistics like the mean and the standard deviation it can also seriously affect
the downstream analysis and inference statistics (Josse and Husson, 2012).
Instead  we  have  used  a  method  for  handling  missing  values  with
multivariate  data  analysis.  In  this  way  missing  values  were  imputed  by
using  a  Principal  Component  Analysis  (PCA)  model.  The  number  of
principal  components  used  was  estimated  by  cross-validation,   each
cell/datapoint,  or  a  certain  percentage  of  cells,  of  the  data  matrix  is
alternatively  removed  and  predicted  with  a  PCA model  using  different
dimensions ranging from a minimum to a maximum number.  The number
of components which led to the smallest mean square error of prediction
(MSEP) was  retained.  Next,  missing  values  were  completed  first  by  the
mean of the variable and then by iterative PCA steps until convergence of
the  algorithm when the  PCs were  not  changed by the imputation of  the
missing value. The R package missMDA (Josse and Husson, 2012) has been
used for this process.
214
Clustering
To optimally partition data in a way that more similar objects were
grouped together we performed clustering.  In this study we used various
forms of clustering but mostly unsupervised k-means clustering. We have
usually clustered data not according to the original values but according to
some  transformed  values  by  a  certain  function,  like  log2,  PCA or  the
varimax  rotated  loadings.  A  brief  overview  of  the  k-means  clustering
algorithm is as follows:
K-means clustering  (Hartigan and Wong, 1979) selects K centroids
(K rows of the data matrix chosen at random) and assigns each data point to
its closest centroid, then by iterative steps it recalculates the centroids using
the  average  of  all  data  points  in  a  respective  cluster  and  consequently
assigns  data  points  to  their  closest  centroids.  Iterations  stop  and  the
algorithm ends when all  observations cannot be further reassigned or the
maximum number of iterations has been reached. 
As k-means clustering depends on the predefined number of clusters
we used the following method for defining the optimal number of clusters:
We plotted the within clusters sum of squares, i.e. the sum of the squared
differences of each observation of the group from the group mean against
the number of clusters. Where we observed a distinct drop, i.e. elbow, in the
within groups sum of squares when we moved from a solution with a certain
number of clusters to another we could identify the best fit.
Data Analysis and statistical tests
We have used exploratory data analysis techniques and unsupervised
clustering in order to identify the optimal number of clusters which separate
individuals and at the same time reduce the dimensionality of the problem.
We have clustered patients and shrunk our data using data points related
with  the  NPSI pain questionnaire  and QST. Then we inspected how the
loadings of a sub-set  of principal components calculated from the above
data analysis could be associated with pain intensity, sensory profiles and
clinical  variables.  We  have  also  assessed  how these  clusters  of  patients
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correlate  with  scores  from  other  neuropathic  pain  tools  and  clinical
variables.  
First our analysis involved converting raw data points in a form that
could  be  effectively  analysed.  This  data  wrangling  process  involved
recoding of categorical variables, scaling and normalization of quantitative
ones and imputing missing values.
QST  scores  were  first  scaled  and  z-transformed.  PCA  is  very
sensitive to  the scaling of data and to the distribution of variance (Principal
Component  Analysis,  2002) thus  we carefully  normalised  and dealt  with
missing  values  as  described  above before  proceeding  into  calculation  of
principal components.
For all downstream analysis we have created two different datasets
from the original data: all patients and only patients with painful neuropathy.
Moreover in the exploratory factor analysis of the NPSI data we divided the
subset  of  patients  with  painful  neuropathy  into  2  datasets,  patients  with
painful neuropathy with all NPSI data and with the two categorical variables
measuring paroxysmal pain excluded.
Regarding statistical analysis we calculated Pearson's correlation for
continuous numerical variables, Spearman's correlation when dealing with
discrete, ordinal ranked scores and Kruskal-Walis non-parametric test to test
for  dependences  between  variables  and  factors.  Kruskal-Walis  test,
essentially  a  non-parametric  alternative  to  one-way  ANOVA,  is  used  in
order to asses how a numeric variable or ranked score can be associated
with a categorical factor with 3 or more levels. The null hypothesis of the
test is that the mean ranks of the groups which are coded by the different
levels of the respective factor are equal. We will reject the null hypothesis if
p.values are less than 0.05. As it is a non-parametric test it does not rely on
an assumption of normality. Thus it can be used where the assumptions for
one-way  ANOVA are  not  met.  Particularly  in  our  data,  as  published  in
(Themistocleous  et  al.,  2016),  only  the  QST  z-scores  were  normally
distributed and thus this is the only case we used one-way ANOVA to assess
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the effect of numeric variables in categorical factors. In order to perform
comparison between groups we used the two-tailed student’s t-test. 
As this is not a hypothesis driven study, but rather an exploratory
analysis, we only tested for significance individual comparisons. We did not
tried to prove any hypothesis by performing multiple tests, thus we did not
increased the probability of type I errors. As we did not tried to answer a
question having the form: what are the correlated pairs of variables under
the  assumption that  most  pairs  are  not  correlated;  we did not  raised  the
probability of erroneously rejecting the null hypothesis just by performing
multiple tests. Thus we only controlled for the comparison wise error rate
(CER) and an adjustment for multiple tests was unnecessary  (Bender and
Lange,  2001).  Results  of  the statistical  tests  presented  in  this  chapter  of
exploratory  analysis  should  only  be  considered  as  descriptive  and  not
inferential.   
Recoding variables
Recoding categorical variables was an important step of the analysis.
The goal was to find a way to transform categorical variables in a way that
preserves the natural order and properties of the attribute measured. In the
current  study  we  have  recoded  two  categorical  variables  in  the  NPSI
questionnaire that assesses the duration and frequency of spontaneous pain:
“During  the  past  24  h,  your  spontaneous  pain  has  been  present?”  with
possible answers/values of ”Permanently”, “Between 8 and 12h”, “Between
4 and 7h”, “Between 1 and 3h” and “Not Available” and “During the past 24
h,  how  many  of  these  pain  attacks  have  you  had?”   “More  than  20”,
“Between  11  and  20”,  “Between  6  and  10”,  “Between  1  and  5”,  “Not
Available”.  In  the  database,  these  variables  have  the  respective  names
spontaneous  ongoing  pain  (NPSI_SPONTONGOING)  and  spontaneous
paroxysmal pain (NPSI_SPONTPAROXYSMAL). As there is no obvious
reason for any bias in the distribution of answers we can assume that they
are  uniformly  distributed.  Thus,  we  can  represent  hour  intervals  and
intervals of certain counts of paroxysmal pain attacks by their mean value.
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This  recoding  gave  us  the  following  mapping  between  categorical  and
numeric values: 
Spontaneous Ongoing pain Ordinal Value Numerical recoding
Permanently 24
Between 8and 12h 10
Between 4 and 7h 5.5
Between 1 and 3h 2
Table 1: Recoding of Spontaneous Ongoing pain variable
Spontaneous Paroxysmal pain Ordinal Value Numerical recoding
20 or more 20
Between 11 and 20 15.5
Between 6 and 10 8
Between 1 and 5 3
Table 2: Recoding of Spontaneous Paroxysmal Pain variable
Transform scores into categorical variables
Subsequently  we  transformed  the  different  NPSI  pain  sub-scores:
deep  spontaneous  pain,  evoked  pain,  paresthesia/dysesthesia,  paroxysmal
pain, superficial spontaneous pain and average NPSI total score into distinct
ordinal  variables  of  pain  severity.  For  each  of  the  five  scores:  Burning
(superficial)  spontaneous  pain,  Pressing  (deep)  spontaneous  pain,
Paroxysmal pain, Evoked pain, Paresthesia/dysesthesia,  we have used the
following mapping which is found in studies of various types of neuropathic
pain 
(Alschuler et al.,  2012; Freeman et al., 2014; Miró et al., 2016) to better
reflect the categorisation of pain intensity:
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NPSI scores Pain Intensity Categories
0 No neuropathic pain
(0-4) Mild
[4-7) Moderate
[7-10] Severe
Table 3: Pain severity categories derived from NPSI scores
As the NPSI average total score is the average of all these five sub-scores,
we assigned the same pain intensity categories to the NPSI average total
score variable. We did not transform the NPSI total score, i.e. the sum of all
these sub-scores.
Normalization and imputation of missing values
Bringing all  variables  into  the  same scale  in  order  to  be  directly
comparable  is  essential  for  downstream  data  analysis,  as  PCA is  very
sensitive to the distribution of variance in the dataset. We normalized and
scaled all values derived from the NPSI questionnaire in a way that  centred
the values, mean = 0, for all variables and scaled, sd = 1, for all variables.
Moreover  all  QST parameters  have  also  been  transformed  into  z-scores
(mean  =  0,  sd=1)  thus  all  numbers  represent  distance  from  the  mean
measured in the units of the standard deviation. We carried out this scaling
of the data as the first step of a principal component analysis. 
As we clustered data  by the NPSI questionnaire  we discarded all
individuals  which  had  no  NPSI  data,  i.e.  where  all  values  of  the
questionnaire  were  not  available.  Thus  we discarded  11 patients,  7  with
painful  and  4  with  painless  neuropathy.  Any  other  missing  values  were
imputed  by  a  Principal  Component  Analysis  (PCA)  model  (see
Introduction/Imputing missing values).    
Dataset
In order  to carry out the current  study and gain valuable insights
regarding neuropathic pain we have used a comprehensive curated dataset of
patients with diabetic neuropathy compiled by Andreas Themistocleous and
219
Juan  Ramirez,  David  Bennet's  group,  NDCN, Oxford.  The  database  has
been maintained by Jon Lees, Orengo Group, SMB, UCL. This database
consists of 191 patients' data.  80 have painless neuropathy and 111 have
painful neuropathy of varying severity. 
For  each  individual  patient  the  database  holds  945  data  points,
including subjective physicians diagnosis, clinical markers, data from all the
standard  pain  questionnaires,  neuropathic  pain  screening  tools  and
information  regarding  the  patient’s  clinical  history.  More  precisely,  the
patients' data is arranged into 4 main categories, Basic Information, Physical
Examination, Special Investigations,  Group Definitions. Basic Information
includes  Patient's  History,  Family  History,  Current  Symptoms  and  Pain
Questionnaires.  We will  mainly  focus  on  data  regarding screening tools,
pain  questionnaires  and  standardised  tests  in  order  to  identify  distinct
sensory profiles – qualities of pain, and to associate them with pain severity
and clinical findings. Physical examination includes data from neurological
examinations and group definition define whether the patient has painful  or
painless neuropathy.    
All the data has been downloaded in the form of comma separated
values  flat  text  files  (.csv)  and  analysed  in  the  statistical  programming
environment R. We have used functions from packages “pvclust”, “cluster”,
“dendextend”,  “fpc”  (Galili,  2015;  Hennig,  2015;  Maechler  et  al.,  2015;
Suzuki and Shimodaira, 2015) to perform clustering (centroid based – K
means  and  connectivity  based  -  Hierarchical)  and  visualize  results,
“FactoMineR” and “missDMA”  (Husson et  al.,  2016;  Husson and Josse,
2015) to perform PCA, normalise and impute missing values and “Hmisc”
(Jr et al., 2016) to calculate p.values and confidence intervals for some of
the statistical tests used. 
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Results
Distribution of pain scores across sexes and clinical markers
for patients with painful neuropathy
In  the  current  study  we  analysed  data  from  129  males  and  62
females. Out of those 76  males  and  35  females  had  painful  neuropathy
according to the physicians examination. After removing the 7 patients with
no NPSI data available we ende up with 72 males and 32 females. Out of
these  having painful  neuropathy,  more  females  suffered  from severe  and
moderate  pain  relatively  to  males,  table  4.  One  male  patient  with
neuropathic pain did not score any NPSI subscore above 0, but nevertheless
he is included in the painful neuropathy group as he was diagnosed with
painful neuropathy according to the IASP/neuPSIG grading system (Treede
et al., 2008). 
NPSI scores Gender
Male Female
No  - 0 1 0
Mild - (0-4) 49 15
Moderate - [4-7) 18 10
Severe - [7-10] 4 7
Table 4: Distribution of NPSI scores across genders. Only patients suffering
from painful neuropathy
Although females  report  more  severe  neuropathic  pain  than  men,
Figure 4, there is no association between higher HbA1c concentration or
less  IENFD and  the  patients’ gender,  figure  5.  Interestingly  males  have
lower  median  IENFD  and  higher  interquartile  range  than  females.  All
boxplots found in this study represent the median by a thick black line, the
height of the box represents the interquantile range (IQR), i.e. data points
between the 1st and the 3rd quantile. Whiskers represent the extent of  3rd
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quartile  +  1.5  IQR  and  1st quartile  –  1.5  IQR.  Circular  dots  represent
outlying values which are more than 1.5 times the 3rd quartile or lower than
1.5 times the 3rd quartile.
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Figure 4: Females (mustard) report more severe neuropathic pain than 
males (blue)
Figure 5: No association between gender and HbA1c (left) and IENFD (right).
Moreover,  when  we  examined  how  NPSI  total  average  score  is
correlated to clinical parameters we found significant moderate correlation
between  the  HbA1c  blood  test  and  NPSI  scores  and  significant  mild
negative correlation between the age and NPSI pain scores figure 6, but no
correlation between IENFD fibres/mm and NPSI scores. Similarly there was
no  correlation  between  BMI  and  NPSI  scores  (Pearson  correlation
coefficient  =  0.0439,  p.value=0.659)  and  duration  of  diabetes  and  NPSI
scores (Pearson correlation coefficient = −0.057, p.value = 0.566) regarding
patients with painful neuropathy.
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Figure 6: Significant correlations between NPSI scores and HbA1c (top) and Age (bottom). The red line is the fitted linear model line and the blue line
in the HbA1c plot is the smoothed lowess curve.
Consistency of neuropathic pain screening tests
Moreover when we considered all patients, we observed very high
correlations  between  the  screening  tools  for  neuropathic  pain  DN4  and
TCSS, figure 7; and also between the MRC sensory score and the TCSS
sensation subscore, figure 8. These results indicate that these screening tools
are  very  efficient  in  classifying  individuals  according to  the  presence of
neuropathic pain. This result reinforces the findings in  (Themistocleous et
al.,  2016) where  DN4 was  found  to  have  88.3% sensitivity  and  91.7%
specificity.   Patients  scoring  higher  than  4  in  DN4,  i.e.  the  DN4  score
threshold for neuropathic pain, have consistently higher TCSS total scores
(correlation coefficient = 0.617, p.value = < 2.2e-16). This is mainly driven
by the TCSS symptoms sub-score (correlation coefficient = 0.799, p.value =
<  2.2e-16)  and  also  from  the  TCSS  sensation  subscore  (correlation
coefficient  =  0.478,  p.value  =  7.111e-12).  Regarding  DN4  score  vs  the
TCSS reflex subscore we observed that  patients with painful  neuropathy
show  increased  variance  with  higher  IQR  but  median  values  were  not
significantly different. 
As DN4 is mainly a screening test for the presence of neuropathic
pain and TCSS is also a test for identifying the presence and severity of
neuropathic  pain,  we hypothesized  that  their  scoring  systems might  also
reflect the severity of neuropathic pain in patients with painful neuropathy.
Consistent  with  the  DN4’s  excellent  performance  in  the  cohort  of  all
patients,  the  questionnaire’s  total  score  has  a  strong  and  significant
correlation (Spearman rank correlation Rho = 0.46, p.value = 7.792e−07 )
with the NPSI score in patients with painful neuropathy, figure 9. The same
is true for the TCSS symptoms subscore (Correlation coefficient = 0.316,
p.value = 0.001) but not for other TCSS scores including the TCSS total
score,  figure  10.  This  highlights  that  the  task  of  classifying  patients
according to the presence of neuropathic pain is different to assessing the
severity  of  it.  Thus  for  patients  with  painful  neuropathy  only  the  TCSS
symptom sub-score reflects pain severity according to the NPSI and DN4
scores.  Moreover standardised sensory scores CSI and WSI did not show
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any strong correlation with NPSI scores, except for the MRC sensory score
which has lower median values for patients with severe neuropathic pain,
figure 11.   
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Figure 7: Correlations between TCSS scores and DN4 score. Thick black 
line represents the median. Box length is proportional to variance. TCSS 
total scores vs DN4: correlation coefficient = 0.617034, p.value = < 2.2e-
16). TCSS reflex subscore vs DN4: correlation coefficient = 0.1854959, 
p.value =  0.01194. TCSS symptoms sub- score vs DN4: correlation 
coefficient = 0.7993434, p.value = < 2.2e-16.  TCSS sensation subscore vs 
DN4: correlation coefficient = 0.4787692, p.value = 7.111e-12.  
229Figure 9: DN4  score is strongly correlated to NPSI average score in 
patients with painful neuropathy 
Figure 8: TCSS sensation sub score is very highly correlated to the MRC 
sensory score 
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Figure 10: Correlation of TCSS scores to the NPSI average total score for 
patients with painful neuropathy. Only the symptoms subscore has a 
significant moderate correlation to the pain severity as assessed by the NPSI
questionnaire. 
Figure  11:  The  WSI  and  CSI  did  not  show  any
significant correlation with the NPSI scores for patients
with painful neuropathy. The MRC sensory test does not
reach significance but it has lower median values (thick
black line) in patients with severe neuropathic pain.
Thus we have evidence that the NPSI average score assessing pain
intensity  in  patients  with  painful  neuropathy  is  higher  in  women  and
correlates well  with the concentration of HbA1c /  glycated haemoglobin.
Also age has a negative correlation with pain severity. IENFD and BMI did
not seem to be associated with pain severity. Moreover, although TCSS was
able to classify patients according to to the presence of painful neuropathy
consistently with DN4 , only DN4 is strongly associated with the severity of
the neuropathic pain phenotype. On the other hand TCSS symptom subscore
is  moderately  correlated  with  neuropathic  pain  severity.  Finally  MRC
sensory score, highly correlated in the cohort of all patients to the TCSS
sensory subscore, could not differentiate patients according to pain severity. 
Quantitative Sensory Testing scores associated with self 
reported scores and clinical markers
All patients
Considering  the  complete  compendium  of  patients  with  diabetes
mellitus and since DN4 score was proven to have excellent sensitivity and
specificity (Themistocleous et al., 2016) and was highly correlated with the
TCSS results, we examined how QST was associated with the DN4 score.
We observed  significant  and  strong correlation  of  the  DN4 score  to  the
Mechanical Detection Threshold (MDT) and the Cold Detection Threshold
(CDT)  and weak correlation to the Thermal Sensory Linen and the Heat
Pain  Threshold,  figure  12.  Interestingly  though,  there  is  no  strong  and
significant correlation of any parameter of the QST to the HbA1c which we
have previously  found to  be strongly  correlated  with  the  severity  of  the
neuropathic pain phenotype, figure 13. On the other hand, there is strong
and significant correlation of Intra-Epidermal Nerve Fibre Density (IENFD)
to  the  QST  Mechanical  Pain  Sensitivity  (MPS)  and  Mechanical  Pain
Threshold  (MPT);  moderate  to  Cold  Detection  Threshold  (CPT)  and
Vibration  Detection  Threshold,  figure  14.  This  is  reasonable  as  better
innervation leads to higher thresholds in all QST parameters but at the same
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time we did not find significant correlation between reduced IENFD and
increased pain intensity in patients with painful neuropathy.
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Figure 12: Correlation of DN4 scores to the QST parameters. MDT (correlation coefficient = 
−0.345201 , p.value = 1.70363e−06) and CDT (correlation coefficient = −0.287644 , p.value 
= 8.23913e−05) showed significant and strong correlation. TSL, HPT and MPT showed 
significant moderate correlation.
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Figure 13: Correlation of HbA1c mmol/mol to the QST parameters. In general we observed 
weak correlation.
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Figure 14: Correlation of IENFD mmol/mol to the QST parameters. Most of the QST parameters were 
significantly and strongly correlated with IENFD.
Patients with painful neuropathy
Consistent with the above findings we did not find any significant
correlations with QST and the HbA1c concentration, but we did find again
significant correlations with lower IENFD leading to lower QST thresholds,
figure 15. Thus we were able to confirm, also in the group of patients with
painful neuropathy, that QST can assess very well sensory deficits related to
reduced IENFD, but as expected these deficits are not correlated to pain
intensity.  The  most  strongly  and  significantly  associated  score  was  the
Mechanical Pain Sensitivity (MPS) with Pearson's correlation coefficient =
0.46463 and p.value = 5.10899e−06. Moreover WDT, CDT and TSL scores
related  to  cold  and warm detection  threshold  and to  paresthesia  and the
MPT, CPT score related to mechanical and cold pain threshold were highly
and  significantly  correlated  to  IENFD.  On  the  other  hand  QST is  not
correlated with the pain intensity as assessed by the NPSI questionnaire,
figure 16. This is an expected result as we have already found that NPSI
pain intensity is not associated to IENFD but rather to HbA1c.    
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Figure 15: QST parameters are highly correlated to the IENFD
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Figure 16: QST parameters are not strongly correlated with NPSI average pain score. For QST 
scores WDT, CDT, TSL, HPT, MDT, MPS the higher the pain intensity the lower the QST thresholds 
but we did not observe neither strong nor significant correlation. QST WUR, PPT and VDT had 
higher values in patients with higher pain intensity.
Principal Components Analysis and clustering
Next we proceeded to  principal  component  analysis  of  NPSI and
QST questionnaires aiming to identify pain dimensions that reflect to the
severity of neuropathic pain phenotype and clusters of patients with distinct
pain modalities. From the above results we expected that clustering based
on NPSI data would better reflect the phenotype and that HbA1c, Gender
and Age would be highly associated with clusters of patients with different
severity of painful neuropathy.
After normalization and handling of missing values we carried out
principal components analysis (PCA). We plotted scree plots and selected
the number of principal components after which the rate of the eigenvalue
reduction and the rate of rise of the explained variance gets significantly
slower,  i.e.  the  elbow  in  the  plot  of  the  number  of  components  vs
eigenvalues  and the number  of  components  vs  cumulative percentage of
variance. Then we calculated the loadings which we transformed using the
varimax rotation (see Introduction, section Principal Components Analysis).
Consequently we input these varimax rotated components into a k-
means clustering algorithm. We used 100 initial  random positions of the
cluster centroids and allowed the algorithm to converge in 200 iterations. As
k-means clustering depends on a predefined number of clusters, k, we have
used the same method as for principal components, for defining the optimal
number of clusters. We have plotted the within clusters sum of squares, i.e.
the sum of the squared differences of each observation of a group from the
respective group’s mean against the number of clusters. Where we observed
a distinct drop, i.e. elbow, in within groups sum of squares, when we moved
from a solution with a certain number of clusters to another, we identified
the best fit.      
We also clustered patients according to the values of these varimax
rotated  components  using  hierarchical  clustering  based  on  the  euclidean
distance between data points and the ward method for the actual clustering.
Then we cut the tree produced by the hierarchical clustering so as to have
the same number of groups that optimally partitioned data according to the
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within groups sum of squares as described above. We followed the exact
same  process  analysing  both  QST  and  NPSI  data.  QST’s  principal
components failed to separate samples according to pain severity and also
clustering  did  not  produce  any  groups  of  individuals  associated  with
neuropathic  pain severity,  figure 17.  This is  consistent  with the previous
findings,  as  QST is  correlated  mainly  with  IENFD which  is  not  highly
associated with the severity of neuropathic pain. The results from NPSI data
analysis are presented in detail below.  
After  the calculation of  the principal  components (PC) of NPSI’s
data we examined how much of the data's variance could be explained by
these PCs. For each dataset, namely patients with painful neuropathy using
all variables and patients with  painful neuropathy using only quantitative
variables,  we  found  that  we  should  optimally  retain  3  or  4  principal
components  based on the two elbows in the respective scree plots which
cumulatively  explain  from 66.28% (painful  neuropathy  only  quantitative
variables)  to  67.72%  (painful  neuropathy  only  quantitative  variables  all
variables) of the original data variance, figure 18. 
As  NPSI  is  a  tool  for  assessing  pain  severity  and  identifying
modalities of pain in patients with neuropathic pain we focused only on the
dataset of patients with painful neuropathy.  
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Figure 17: Individuals factor map according to the first two principal components of QST data. No separation of patients according to pain severity 
assessed, was observed either for the NPSI (left) or 7-day pain diary (right) scores.   
Figure 18: Scree plots for patients with painful neuropathy all variables (left), no spontaneous pain variables (right). Blue line represents the number 
of principal components vs the eigenvalue, red line represents the number of components vs the cumulative percentage of variance they explain. In the 
first case the plot’s elbow is in the 4th component, in the second in the 3rd.
Factor analysis and contributions to the Principal Components
As our main aim is to understand and identify distinct qualities of
neuropathic pain it is of great importance to study how different variables /
factors  of  the  NPSI  questionnaire  contributed  to  each  of  the  principal
components. To do so we calculated the loadings for each PC. Regarding
this we observed that different groups of NPSI variables, were consistently
co-occurring  as  the  highest  contributing  factors  for  certain  dimensions  /
principal  components  of  NPSI  data.  We  hypothesized  that  these  groups
represent certain pain modalities.
By observing the variables that are usually better explained together
in the same PC we can identify variables which cumulatively define distinct
qualities of pain. Moreover as we used the varimax rotation to rotate the
orthogonal basis of the loadings of the top components we observed a much
better separation of pain modalities, as there was a certain group of factors
with high values for each component, figure 19. 
When  we considered  the  grouping of  individual  variables  by  the
principal  component  they  contributed  to  primarily,  we  identified  3  or  4
distinct  pain  modalities,  depending  on  the  inclusion  of  the  spontaneous
paroxysmal and ongoing pain variables. These distinct pain modalities are
very consistent as the grouping  remained the same when we included the
two categorical variables and also have some similarities with the findings
of (Freeman et al., 2014). Interestingly we can describe these pain qualities
as Superficial pain and paresthesia/dysesthesia which is comprised by the
three relevant NPSI variables and contributed mostly to the 1st component or
2nd component; Evoked pain which is comprised by Brush Evoked, Pressure
Evoked, Cold Evoked and Pressure variables and contributed mostly to the
2nd  component or to the 1st component when we included the spontaneous
pain  variables;   Deep  and  Spontaneous  pain  contributed  most  to  the  3rd
component or to the 4th  component when we included the spontaneous pain
variables;  and  Spontaneous  Paroxysmal  pain  measured  from  the  two
categorical variables which contributed mostly to the  3rd component when
we included them in our analysis.
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Moreover we observed spatial arrangements that were related to the
average pain severity calculated from the NPSI pain questionnaire when we
plotted data using the first two principal components for each individual,
figure 20.  Also all  principal components were highly correlated with the
NPSI average score and individual patients could be separated according to
pain severity based on the first two principal components. Moderate pain
had the most widespread spatial localization while patients with mild and
severe pain are highly localised showing less variance in the values of their
first two principal components.
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Figure 19: 3 or 4 pain dimensions were 
identified by the principal component 
analysis. Varimax rotated components had 
higher contributions of certain NPSI 
variables. We have coloured NPSI variables 
according to which PC they contributed to 
most. Thus a profile of  Superficial pain and 
Paresthesia/dysesthesia (red) has higher 
values in Dim.1 or Dim.2; Deep and 
spontaneous pain (green) has higher values 
in Dim.3 or Dim.4; Evoked pain (yellow) in 
Dim.2 or Dim.1; Spontaneous paroxysmal 
pain (blue) in Dim.3. Non varimax rotated 
components are in Appendix 5. 
NPSI varimax components
Dim.1 Dim.2 Dim.3
NPSI_BURNING 0.3874855044 0.1402762788 -0.0968122406
NPSI_SQUEEZING -0.0185081649 0.30007923 0.3108276521
NPSI_PRESSURE -0.0528587921 0.4794883509 0.1475736514
NPSI_ELECSHOCKS 0.3891324328 -0.1203497827 0.3667876315
NPSI_STABBING -0.0489514459 0.0604074278 0.7899390011
NPSI_BRUSHEVOKED 0.0346708561 0.4778519953 -0.0661799394
NPSI_PRESSUREEVOKED -0.0137815074 0.4906509384 0.0212559341
NPSI_COLDEVOKED 0.1549155265 0.4079293421 -0.3290505729
NPSI_PANDN 0.6050216663 -0.0819592014 -0.0158411704
NPSI_TINGLING 0.5490501346 0.0053182329 0.0184922917
NPSI varimax components – no categorical variables for spontaneous pain
Dim.1 Dim.2 Dim.3 Dim.4
NPSI_BURNING 0.1124899719 -0.359220715 0.1032697652 -0.085339525
NPSI_SQUEEZING 0.3049677064 0.0174596705 -0.0241409905 0.3167345465
NPSI_PRESSURE 0.4411794206 0.0758380247 0.1640888656 0.1530656024
NPSI_SPONTONGOING 0.007025064 0.0944727571 0.7749909408 -0.037758459
NPSI_ELECSHOCKS -0.1296308841 -0.3850888993 0.0307800766 0.3562147282
NPSI_STABBING 0.0682984314 0.0343873183 -0.0540317709 0.7848606766
NPSI_SPONTPAROXYSMAL 0.0105924115 -0.1480684176 0.5729137354 0.0065411848
NPSI_BRUSHEVOKED 0.4999317558 -0.022279447 -0.0719370702 -0.04227831
NPSI_PRESSUREEVOKED 0.4789664156 0.0102039173 0.0346699114 0.0215214762
NPSI_COLDEVOKED 0.4370140745 -0.192682759 -0.1321704758 -0.349002015
NPSI_PANDN -0.0862476711 -0.5848946933 0.0250498181 -0.014716396
NPSI_TINGLING 0.0176204664 -0.5520416507 -0.0681614815 0.0182757593
Figure 20: Individuals factor map (PCA plot) for painful neuropathy top left and for painful neuropathy without spontaneous pain variables top right. 
Severe average NPSI scores are blue, moderate are red and mild are black. Individuals can be separated according to pain severity from these two 
first principal components.  
NPSI principal components were correlated to clinical markers
After  we calculated the  NPSI principal  components  we examined
them in the context of the clinical variables that could be associated with
them. First, as expected given the NPSI score’s high correlation, we have
significant  correlation  of  these  components  to  the  age  and  gender.  We
present figures from the dataset of patients with painful neuropathy which
include all variables, but results were almost the same for the three retained
components  when  we  excluded  the  Spontaneous  paroxysmal  pain
categorical  variables.  Principal  components  were  significantly  negatively
correlated  to  age,  whereas  the  component  of  superficial  pain  and
paresthesia/dysesthesia  showed  higher  and  most  significant  negative
correlation to age, figure 21.
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Additionally there is a strong effect of the patients gender in these
principal components. Females consistently reported more intense pain and
showed higher values in principal components as well, figure 22.  Regarding
clinical parameters there was no significant correlation between PCs and the
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Figure 21: All PC were negatively correlated to age. The 2nd component, corresponding to 
superficial pain and paresthesia/dysesthesia showed slightly stronger negative correlation
duration  of  diabetes  or  BMI,  only  weak  and  non-significant  negative
correlation between PCs and IENFD and strong and significant correlation
between HbA1c and the varimax rotated PCs, figure 23.
 
In  this  context,  the  3rd component  which  contributes  higher  in
spontaneous  paroxysmal  and  ongoing  pain  has  the  stronger  and  more
significant positive correlation to HbA1c concentration.
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Figure 22: Females (violet) had higher values in PCs than males (blue)
The above principal component analysis identified distinct qualities
of  pain  in  the  dataset.  Moreover,  we  demonstrated  that  these  pain
dimensions are related to pain severity as measured from the average total
NPSI  score.  In  figure  20  we  visualise  how  these  PCs  can  effectively
separate patients according to pain severity and we also show that they are
significantly  correlated  to  age,  gender  and  HbA1c  for  each  patient.
Therefore, we hypothesize that we can identify distinct clusters of patients
given these varimax rotated components.
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Figure 23: HbA1c mmol/mol concentration is highly correlated to the values of the 4 
principal components. The 3rd component, of spontaneous paroxysmal and spontaneous 
ongoing pain showed the higher and most significant correlation.
Clustering
In  order  to  identify  clusters  of  patients  we  input  these  varimax
rotated principal components into the centroid and hierarchical clustering
algorithms.  More  specifically  we  carried  out  k-means  clustering  and
euclidean distance clustering with the Ward criterion (Ward, 1963). 
As mentioned above, prior to clustering we determined the number
of clusters which produced an optimal separation of data. This is particularly
important for the k-means clustering algorithm. To do this we plotted the
within groups sum of squares against the number of clusters. A distinct drop
to  the  rate  of  reducing  the  within  groups  sum of  squares  shows  that  a
solution  of  4  clusters  of  patients  might  be  the  optimal  number  for  all
datasets (figure 24). Thus this would be the number of centroids for the k-
means clustering and the number of groups for the hierarchical clustering.
We then performed k-means clustering and plotted the groups with
the  pain  severity  of  each  individual  colour  coded.  The algorithm started
from 100 initial random centroids and then refined the cluster assignments
by controlling the within cluster variance for a maximum of 200 iterations.
We then colour coded individuals according to pain severity and observed
that  a distinct cluster  was comprised of patients with only mild neuropathic
pain,  two  mixed  clusters  one  predominantly  with  moderate  and  one
predominantly with mild neuropathic pain and one cluster of patients most
of whom were suffering from severe neuropathic pain, figure 24. Thus we
were able to efficiently separate patients according to pain severity in an
unsupervised way using only 3 or 4 varimax rotated principal components
from the NPSI data, figure 26.
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Figure 24: Within groups sum of squares against the number of clusters.  Patients with painful neuropathy – all variables (left), patients with 
painful neuropathy – spontaneous pain categorical variables
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Figure 25: Spineplot of the K-means clustering based on the 3 first varimax
rotated NPSI principal components. The 1st cluster has  patients with 
moderate and severe pain. The 2nd and 3rd with moderate and mild. The 4th 
cluster has only patients with mild pain. Width of the columns represents 
the cluster’s size. 
Figure 26: Cluster plots colour coded by pain severity. Left: patients with painful neuropathy – all variables. Right: patients with painful neuropathy –
no spontaneous pain variables.
NPSI Clusters NPSI Clusters – no categorical variables
Hierarchical  clustering  also  gave  the  same  results.  It  separated
patients according to pain severity into 4 distinct groups. One with patients
having only mild neuropathic pain, one with only severe and some moderate
pain and two with moderate and mild pain, figure 27.
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Figure 27: Hierarchical clustering of patients with painful neuropathy (left) and painful neuropathy – no spontaneous pain variables (right)  
Hierarchical clustering of patients – 
no spontaneous pain variables
Hierarchical clustering of patients
Association of clusters and principal components to clinical 
markers
Next  we  examined  how  the  values  of  clinical  markers  were
distributed in these 4 clusters of individuals related to pain severity. We first
confirmed that clusters were highly associated, not only with NPSI assessed
pain severity, but also with the seven day pain diary mean score (Kruskal-
Walis test of independence p.value = 5.47873e−11) and with the DN4 score
(Kruskal-Walis  test  of  independence  p.value  =  5.64339e−05),  figure  28.
Indeed  patients  assigned  to  the  first  cluster  (dark  red)  have  consistently
higher scores in quality of life pain-questionnaires indicating more severe
neuropathic  pain.  The  least  severe  /  mild  pain  was  observed  in  the  4th
cluster (violet), then we have moderate pain in the 3rd  and 2nd  cluster (the
pain diary score separated clusters better than DN4) and severe pain in the
1st  cluster (dark red). There was also significant dependence, (Kruskal-walis
test  of  independence  p.value  =0.0436883)  between TCSS symptom sub-
score and cluster assignment.
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Figure 28: Association between Pain Diary and DN4 scores to NPSI clusters. Both scores are highly associated to cluster assignment. Note that, as 
expected, all patients with painful neuropathy had DN4 scores > 4. 
Since we found that cluster assignment was associated with scores
that  reflect  the  neuropathic  pain  phenotype  intensity,  we  proceeded  to
examine clinical variables in the context of these clusters. 
Consistent with the results from the analysis of QST data, both for
the  compendium of  all  patients  and for  patients  with painful  neuropathy
only,  we did not find any significant association (One-way ANOVA test)
between QST parameters  and cluster  assignment.  Moreover,  as  expected
there was no significant effect of IENFD on cluster assignment, figure 29,
but  patients  who  were  grouped  together  in  the  1st cluster  of  severe
neuropathic pain showed higher median values of HbA1c concentration and
much higher interquantile range, although high variance of the data did not
let the non-parametric Kruskal-Wallis test reach significance.
 Moreover BMI and duration of diabetes did not have any effect on
cluster assignment, consistent with the finding that they did not correlate to
neuropathic pain intensity. On the other hand age and gender were highly
associated  with  the  NPSI  clustering,  figure  30,  in  a  way  that  younger
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Figure 29: No effect of IENFD on cluster assignment. Patients assigned to a cluster of higher 
severity have higher HbA1c blood concentrations but the effect does not reach significance.  
patients  and  females  were  assigned  to  clusters  of  higher  pain  intensity.
Additionally,  the  TCSS  symptoms  subscore  had  a  significant  effect  on
clustering, indicating that the NPSI questionnaire, and consequently clusters
based  on  this  data,  can  distinguish  patients  according  to  symptoms  of
painful neuropathy, figure 31.  In other words patients grouped in different
clusters are not likely to come from populations with similarly distributed
TCSS symptom scores.  
Finally even though clusters 2 and 3 (violet and pink) were similar in
terms  of  average  pain  intensity  they  have  significant  differences  in  the
distinct pain modalities observed in them. We should note here that Pain
Diary (figure 28) revealed a fine grading of pain intensity between clusters
but  other  scores,  including  NPSI,  and  clinical  markers,  showed  similar
median  values.  Interestingly  these clusters  grouped patients  according to
subtle differences in pain modalities that cannot be observed in the general
NPSI total score or its average value.
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Figure 30: Age and gender are highly associated with cluster assignment. 
 The  non-parametric  Kruskal-Wallis  test  showed  that  patients  of
different  clusters  come  from  populations  with  significantly  differently
distributed NPSI subscores, figure 32. Patients clustered in the 3rd cluster
had significantly higher Paresthesia/Dysesthesia than patients in cluster 2
(two  way  students  t.test,  p.value  =  0.0003039)  and  significantly  higher
paroxysmal pain (two way students t.test, p.value = 0.01929). On the other
hand patients in cluster 2 had slightly higher median values of pain intensity
as assessed from the pain diary,  NPSI and DN4 and significantly higher
median values for Spontaneous and Evoked pain, figure 32. 
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Figure 31:TCSS symptoms sub score has a significant effect on the on 
grouping of patients according to clusters. 
Figure 32: NPSI scores have
significant effect on cluster 
assignment. Moreover 
clustering revealed distinct 
modalities of pain obscured 
from the NPSI total score. 
Namely cluster 3 has 
significantly higher 
paroxysmal pain and 
paresthesia/ dysesthesia than
cluster 2, although cluster 2 
has significant higher 
spontaneous and evoked 
pain and also higher median
values in the total NPSI 
score.
Conclusion
We analysed  data  from patients  with  diabetic  neuropathy,  a  very
common aetiology of neuropathy and neuropathic pain. First we confirmed
that DN4 questionnaire and the TCSS score and more specifically the TCSS
symptoms subscore can distinguish very well between patients with painful
neuropathy and painless neuropathy. QST had some mild correlation with
these scores but also had significant correlation with loss of intraepidermal
nerve fibre density (IENFD). On the other hand tests that were significantly
better in screening patients of painful neuropathy had a high correlation with
HbA1c blood concentration. Moreover the TCSS symptoms subscore is very
highly correlated to the MRC sensory score. Age and sex of the patient was
found to be a very important parameter related to pain intensity. Although
there was no correlation between age or sex and IENFD, HbA1c or BMI.  
In patients with painful neuropathy we found that the NPSI score is
highly correlated to the DN4 values, (even though DN4 was designed as a
screening test)  and the TCSS symptoms subscore.  Moreover  higher  pain
intensity assessed by the NPSI average total score was highly correlated to
HbA1c and not to IENFD. More interestingly we were able to distinguish 3
or  4,  depending  on  the  inclusion  of  categorical  variables  assessing
paroxysmal pain,  distinct  somatosensory profiles  in  the  form of  varimax
rotated  principal  components,  with  consistently  higher  contributions  of
certain  factors  of  the  NPSI  questionnaire.  Namely  superficial  pain  and
paresthesia/dysesthesia;  Deep  spontaneous  pain;  Evoked  pain  and  if  we
included  the  categorical  variables,  spontaneous  paroxysmal  pain.  These
components were able to separate patients according to pain intensity and
they were highly correlated to HbA1c, the age and gender of the patient. In
addition, the pain dimension / principal component of superficial pain and
paresthesia / dysesthesia had higher negative correlation to age, while the
pain  dimension  /  principal  component  of  paroxysmal  pain  had  higher
positive correlation to HbA1c.
Moreover we were able to perform unsupervised clustering based on
these components which reflected very well the pain intensity. In contrast
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QST failed to capture the phenotype of pain intensity and was not able to
separate patients having painful neuropathy in any meaningful way related
to  pain  intensity.  However,  it  identified  difference  between  patients  of
painful and non-painful neuropathy. These distinct clusters based on NPSI
data were associated with age,  sex,  HbA1c and pain intensity.  But more
interestingly  they  represented  distinct  somatosensory  profiles  of  patients
having higher intensity in certain modalities of painful neuropathy, figure
32. These profiles are not related with different underlying diseases causing
neuropathic pain, but they were rather somatosensory profiles related to pain
intensity  within  only  one  aetiology  of  painful  neuropathy,  diabetic
neuropathy. This finding may suggest that symptoms of painful neuropathy
emerge in highly diverged forms and combinations and thus require more
specialised treatment as well as more research in order to identify whether
these clusters are associated with distinct gene expression patterns.
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Conclusions and future work
In  this  thesis  we  have  presented  a  series  of  bioinformatics
approaches  for  the  better  understanding  of  pain,  in  both  its  molecular
signature  and  its  divergent  phenotypes.  Transcriptional  profiling
technologies have been used for the identification of pain related genes and
their expression patterns over the last 15 years. From the first microarray
studies  (Costigan et al., 2002), the pain genes database (Lacroix-Fralish et
al., 2007) and the identification of over-represented GO biological processes
of pain (Lötsch et al., 2013) to systems biology of pain (Perkins et al., 2013)
and the usage of recent high throughput sequencing technologies (Dawes et
al., 2014, 2014). Profiling technologies have identified hundreds of genes
which are differentially expressed in pain relevant tissue and involved in
pain.
RNA-sequencing  (Wang  et  al.,  2009),  a  very  promising
transcriptomics  technology,  has  allowed  us  to  investigate  and  report  the
relative abundance of  thousands of genes between conditions of interest
with unprecedented dynamic range and the ability to identify novel genes as
pain mediators. Less than 8 years ago a  new class of non-protein coding
RNA,  Long  non-coding  RNAs  started  attracting  the  focus  of  many
researchers  studying  their  function  and  evolution  (Guttman  et  al.,  2009;
Ponting  et  al.,  2009).  As  a  consequence  bioinformatic  pipelines  were
developed in order to identify novel LncRNAs and study their expression
pattern (Ilott and Ponting, 2013). Most of these approaches are based on the
breakthrough  of  modern  high  throughput  sequence  by  synthesis
technologies, usually RNA-sequencing.   
Only 3 years ago, antisense LncRNAs were identified as possible
mediators of pain (Han and Jan, 2013). A novel LncRNA, expressed in the
dorsal  root  ganglion,  antisense  of  the  Kcna2  gene  was  found  to  be
implicated  in  neuropathic  pain by silencing the  expression of  the  Kcna2
gene (Zhao et al., 2013). Another antisense LncRNA was found to regulate
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the expression of the Scn9a pain gene on the opposite strand of the genome
(Koenig et al., 2015).
In this study we contributed to the identification of novel LncRNAs
that are putative pain mediators. We also study the transcriptional changes
involved under pain models of peripheral neuropathy both for known genes
and novel LncRNAs.
Our main focus is the transcriptional profiling of neuropathic pain.
Thus we presented methods and results from two studies of well established
animals models of neuropathic pain and a study dealing with clinical data
and  self  reported  pain-questionnaires,  which  reveals  the  divergent
phenotypes and distinct qualities of painful neuropathy. 
Two years ago, a study revealed distinct patterns of symptoms that
characterize somatosensory profiles of neuropathic pain based on the NPSI
pain questionnaire  and Quantitative Sensory Test  (Freeman et  al.,  2014).
This study identified four clusters with distinct pain characteristics profiles.
Moreover,  a  large-scale  observational  study  of  patients  suffering  from
diabetic neuropathy (Themistocleous et al., 2016) revealed that the severity
of  neuropathic  pain was correlated  with higher  HbA1c and that  diabetic
neuropathy is characterised by hypo-sensitivity, which is higher for patients
suffering from moderate and severe neuropathic pain.  On the other hand
paradoxical  heat  sensation  was  not  a  discriminatory  feature  of  painful
diabetic  neuropathy.   We  have  contributed  to  the  study  of  distinct
somatosensory  profiles  of  diabetic  neuropathy  which  are  correlated  with
clinical parameters and the neuropathic pain severity. 
    We  present the main conclusions and future work below. 
Identifying LncRNAs from RNA-seq data
This  thesis  has  been  largely  focused  on  developing  an  efficient
strategy for reconstructing gene models of LncRNAs using RNA-seq data in
an efficient way, without reconstructing the whole transcriptome, and then
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performing a differential expression analysis of these LncRNAs. The goal
was to identify a subset of novel LncRNAs, sufficiently and consistently
expressed and DE between conditions of interest.
We have provided a customised strategy for predicting gene models
of  novel  LncRNAs  without  executing  the  inherently  difficult  and
computationally expensive task of reconstructing the whole transcriptome.
Moreover this strategy identifies LncRNAs which are likely to exist and be
functionally important  as most of them are spliced and multi-exonic and
they are sufficiently and consistently expressed and differentially expressed
between conditions of interest.  The prediction of yet unknown models of
LncRNAs remains a very difficult task. Genomic contamination; erroneous
base calling  in  RNA-seq; reads  mapping to  multiple positions; spurious
splicing junctions and an inherent difficulty to identify transcription start
and end sites using RNA-seq can generate many false positives and noisy
results that can affect all downstream analysis. That is why we decided to
apply a series of stringent filters in order to screen genomic loci appearing
to  have  non-canonical  transcription  that  can  generate  LncRNAs.  RNA-
sequencing with more than 50 million reads per sample and stranded 100bp
paired-end reads was sufficient to perform an ab initio identification of the
vast  majority  (about  80%)  of  expressed  LncRNAs  found  in
ENSEMBL/GENCODE annotation.  The  ones  missed  were  the  ones  that
were  so  lowly  expressed  that  DE  analysis  would  nevertheless  be  very
difficult  to  produce  confident  estimations  of  LFC.  We  should  note  that
increased sequencing depth and a better annotated genome, compared to the
rat  genome,  gave  much  higher  dynamic  range  of  transcription  strength
between  highly  expressed  protein  coding  genes  and  lowly  expressed
predicted LncRNAs.
In chapter 2: Methods, we present a computational pipeline which
identifies novel LncRNAs in an automated way, using an intuitive strategy
of  combining  a  coverage  threshold  approach  of  un-annotated  genomic
regions with de novo identified splicing junctions from a gapped aligner. As
it is crucial for downstream analysis, the method produces, as an output, a
271
set of predicted LncRNAs, in the form of a file following the GTF format
which is  compatible  and ready to be used with state  of the art  counting
techniques and count-based data DE analysis algorithms.
We eventually  established a  pipeline that  transforms raw input  of
RNA-seq fragments to predicted LncRNAs with good agreement with the
ENSEMBL/GENCODE pipeline’s  prediction  of  expressed  intergenic  and
antisense LncRNAs in the rat and mouse DRG. 
We  should  note  again  that  predicting  novel  gene  models  and/or
LncRNAs is not a trivial task. Sequencing noise, random effects, the quality
and  complexity  of  genome  assemblies  and  annotations  and  the  inherent
inability of RNA-sequencing to accurately determine transcription start and
end sites and absolute transcript abundance contributes to the difficulty of
the task. Immediate future work will include the addition to the pipeline of
other sources of information like cap analysis gene expression (CAGE) data
(Okazaki et al., 2002) for determining transcription start sites and ChIP-seq
data to determine chromatin modifications  related to actual transcription.
These would allow for more confident predictions. 
Transcriptional profiling of rodents DRG
In  chapter 3:  Transcriptional  changes of  protein  coding genes
and novel LncRNAs in rat’s DRG, we investigated transcriptional changes
in rat DRG for the SNT pain model. We identified the contribution of ion
channels,  agents  of  neuron  regeneration  and  development  and  opioid
receptors in this well induced pain state. 
We  also  predicted  hundreds  of  novel  LncRNAs  expressed  in  rat
DRG. 21 of these LncRNAs were significantly DE antisense of significantly
DE  pain  genes.  One  LncRNA,  antisense  of  the  Kcnj9  voltage  gated
potassium channel, has opposite expression pattern with the protein coding
on  the  opposite  strand.  Thus  we  hypothesize  that  it  might  regulate  its
expression and thus contribute to neuropathic pain. 
We  also  identified  7  intergenic  LncRNAs  significantly  DE  and
highly correlated with their adjacent pain gene. We hypothesize that these
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LncRNAs  may  contribute  to  neuropathic  pain  by  regulating  their
neighbouring pain gene in cis.
In  chapter  4:  Transcriptional  changes  in  DRG of  two  mouse
strains  experiencing high and low induced hypersensitivity for the SNI
pain model, a follow up study of two mouse strains, BALB/c – high pain
and B10.D2 – low pain, after the SNI pain model we found that the high
pain strain has more significantly DE genes than the low pain strain and that
the high pain strain is much more similar to rat in terms of transcriptional
changes for the pain model. 
Moreover, the high pain strain has more prominent dysregulation of
voltage  gated  potassium  and  sodium  channels.  Functional  enrichment
analysis  revealed  that  biological  processes  of  neuron  regeneration  and
development,  axon  guidance,  regulation  of  ion  channels,  signalling,
response to stimuli, learning and memory were highly enriched.  Thus the
common core  of  enriched  biological  processes  in  both  strains  is  almost
identical with the pain wheel of enriched biological processes for pain genes
(See Introduction , section Pain at the molecular level) (Lötsch et al., 2013).
Moreover genes related to axon guidance, neuron development and
regeneration,  potassium ion transport,  chemokine  regulation and immune
system had significantly  different  responses  for  the  pain  model  between
strains.  We hypothesize  that  these  processes  contribute  to  the  significant
difference in induced allodynia for the SNI model between the two strains.
Regarding predicted LncRNAs, we again found that more of these
were DE in the high pain strain than in the low pain strain. 12 LncRNAs
antisense of pain genes were syntenically conserved between mouse and rat.
4 intergenic LincRNAs with a pain gene as their closest genomic neighbour
were  syntenically  conserved  between  mouse  and  rat.  We  found  in  both
species the known antisense LncRNAs on the opposite strand of Scn9a and
Kcna2 genes.
Two  pairs  of  protein  coding  genes  Nalcn  and  Tshz  –  and  their
respective antisense LncRNA were significantly DE only in the high pain
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strain. Thus we hypothesize that these antisense LncRNAs might be related
with the significant differences in the intensity of pain observed between the
mouse  strains.  Moreover  we  identified  a  significantly  correlated  and
significantly  DE  LincRNA with  its  closest  neighbour,  the  Oprd1  opiod
receptor in mouse and with the Oprm1 opioid receptor in rat.  These two
receptors interact and form hetero-dimers. Thus we hypothesize that these
LincRNAs might contribute to neuropathic pain by regulating these opioid
receptors in both species.  
Most  of  the  LncRNAs  predicted  in  both  species  were  bi-exonic.
About half of the LncRNAs predicted were antisense of annotated protein
coding  genes.  In  addition  most  of  the  DE  LincRNAs  were  in  close
proximity  to  protein  coding  genes.  There  were  no  significantly  DE
LincRNAs  very  far  away  from  known  genes.  Most  of  the  LncRNAs
predicted showed low coding potential.  However  we also predicted gene
models which showed positive coding potential. Some of these were DE.
These might be processed pseudogenes or not yet annotated protein coding
genes. 
These studies gave insights regarding transcriptional changes both in
protein coding genes and LncRNAs in rodents’ DRG for well established
pain models. Immediate future work is to validate these predictions using Q-
PCR and infer the underlying biology of their hypothesized function.  We
are preparing a manuscript  presenting these results  and upon publication
these  will  be  uploaded  to  Pain  Networks  in  order  to  contribute  to  the
publicly available transcriptomics data and the co-expression networks for
pain.
Divergent phenotypes of painful neuropathy
In  chapter 5:  Clustering  of  patients  with  diabetic  neuropathy
reveals distinct neuropathic pain dimensions, we changed our scope in
studying neuropathic pain and presented results  from an analysis  of data
from human patients with diabetic neuropathy. We analysed both clinical
data and data from quality of life – pain questionnaires. First we confirmed
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that DN4 and TCSS are very effective in screening neuropathic pain but are
also correlated with neuropathic pain intensity as measured by NPSI. On the
other hand QST cannot capture the neuropathic pain intensity phenotype. 
More severe pain was highly associated with higher concentrations
of HbA1c, younger age and female gender. All these variables were also
highly associated with NPSI, DN4 and TCSS symptom scores. On the other
hand QST was correlated with IENFD but neither QST scores nor nerve
fibre density (IENFD) were associated with pain intensity.
Moreover, clustering of patients based on the NPSI data revealed 4
distinct somatosensory profiles associated with pain intensity. Higher scores
in deep spontaneous pain and evoked pain were characteristic of the two
clusters of patients with more intense neuropathic pain. On the other hand
high  scores  of  paresthesia  /  dysesthesia  and  paroxysmal  pain  were
characteristics of the cluster of moderate pain. Finally the cluster of mild
pain had low scores in all NPSI sub-scores. These clusters were associated
with the 7-day pain diary scores, TCSS symptom scores, the gender, the age
and HbA1c concentration.
Immediate future work will include sequencing of the skin biopsy
patches  used  in  this  study  in  order  to  establish  possible  transcriptional
differences between the above clusters.
In this thesis we presented a series of bioinformatic attempts aiming
to  the  better  understanding  of  pain.  Technological  advances  and
optimisation  of  current  protocols  will  allow for  better  usage  of  the  vast
amounts of data available. RNA-seq has been established as the standard
transcriptional  profiling  tool  and  standard  analytical  workflows  are
becoming  readily  available,  more  accurate  and  more  accessible.  The
computational  resources  for  identifying  LncRNAs  are  slowly  entering  a
more mature phase and their function can be further investigated, although
serious  biological  and  computational  challenges  remain  ahead.  New
technologies like single cell sequencing  (Gawad et al., 2016) can perform
targeted  profiling  of  specific  cells  in  complex  systems  like  pain  and
nociception.  This  can  further  de-convolute  the  contribution  of  different
biological systems in pain phenotype. 
 Of course all this data will eventually bring forward new challenges
of  bioinformatics  and computational  biology.  We would  only  be  able  to
overcome these challenges by establishing broad collaborations involving a
diverse  spectrum of  scientists,  studying both  animal  models  of  pain and
humans.    
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PC1 PC1_symbol PC2 PC2_symbol
ENSRNOG00000020557 Ryr1 ENSRNOG00000007304 Herc3
ENSRNOG00000010079 Car3 ENSRNOG00000028992 Acan
ENSRNOG00000052355 NA ENSRNOG00000009322 Ccdc126
ENSRNOG00000017645 Mylpf ENSRNOG00000009170 Dmxl2
ENSRNOG00000051895 NA ENSRNOG00000026447 Ptchd2
ENSRNOG00000013262 Myl1 ENSRNOG00000018827 Htr7
ENSRNOG00000059651 NA ENSRNOG00000020650 Slc17a7
ENSRNOG00000061829 NA ENSRNOG00000014323 Extl2
ENSRNOG00000022637 NA ENSRNOG00000006037 NA
ENSRNOG00000019627 Mybpc2 ENSRNOG00000007999 Abra
ENSRNOG00000004583 Mb ENSRNOG00000014302 Dlgap3
ENSRNOG00000020276 Tnni2 ENSRNOG00000032472 Adgrg2
ENSRNOG00000016837 Ckm ENSRNOG00000019318 Syt3
ENSRNOG00000019745 Actn3 ENSRNOG00000009465 Sfrp2
ENSRNOG00000015155 Tnnc2 ENSRNOG00000012015 Lrrc49
ENSRNOG00000047124 NA ENSRNOG00000003756 Lancl3
ENSRNOG00000020332 Tnnt3 ENSRNOG00000020164 NA
ENSRNOG00000005154 Fam150b ENSRNOG00000042477 Clrn1
ENSRNOG00000056493 Mybpc1 ENSRNOG00000026577 Cpne4
ENSRNOG00000057701 Myom1 ENSRNOG00000014453 Anxa5
ENSRNOG00000058083 NA ENSRNOG00000017539 Mmp9
ENSRNOG00000031782 Col6a4 ENSRNOG00000018054 F2rl2
ENSRNOG00000010803 Gabra5 ENSRNOG00000037695 Sgpp2
ENSRNOG00000010478 Serpina3n ENSRNOG00000009577 Ndst4
ENSRNOG00000009907 Mmp8 ENSRNOG00000021015 Sbsn
ENSRNOG00000009465 Sfrp2 ENSRNOG00000014840 Gna14
ENSRNOG00000008478 Mmp13 ENSRNOG00000012038 Htr1d
ENSRNOG00000028992 Acan ENSRNOG00000054795 NA
ENSRNOG00000040350 Mir675 ENSRNOG00000052514 NA
ENSRNOG00000061739 Klrk1 ENSRNOG00000025463 LOC100125362
ENSRNOG00000007178 Cd8a ENSRNOG00000038004 Zfp804a
ENSRNOG00000006926 Atp6v0d2 ENSRNOG00000046468 Ptgfr
ENSRNOG00000015411 Apobec1 ENSRNOG00000057501 Fam81a
ENSRNOG00000014610 Anpep ENSRNOG00000055401 Kcnc1
ENSRNOG00000018286 Chrna1 ENSRNOG00000038297 Plekhd1
ENSRNOG00000021029 Hamp ENSRNOG00000006617 NA
ENSRNOG00000021062 Fxyd5 ENSRNOG00000012196 Asah2
ENSRNOG00000004641 Sstr4 ENSRNOG00000011146 Gyg1
ENSRNOG00000020845 Tyrobp ENSRNOG00000061304 Atp2b3
ENSRNOG00000015076 Cyp26b1 ENSRNOG00000030238 Fndc5
ENSRNOG00000037331 Cd33 ENSRNOG00000011285 Zdhhc22
ENSRNOG00000033564 Cfd ENSRNOG00000011550 Kcnab2
ENSRNOG00000007918 Tbxas1 ENSRNOG00000019648 NA
ENSRNOG00000016037 Mafb ENSRNOG00000042788 NA
ENSRNOG00000015562 Cdh17 ENSRNOG00000029478 Cyp4f39
ENSRNOG00000024082 Gldn ENSRNOG00000007727 Lhfpl4
ENSRNOG00000025691 Pla2g7 ENSRNOG00000058938 Camkv
ENSRNOG00000008015 Fos ENSRNOG00000050419 Avil
ENSRNOG00000008409 Myo1f ENSRNOG00000006639 Scn9a
ENSRNOG00000004578 Cthrc1 ENSRNOG00000018191 Oprm1
Table 1: Top 50 ENSEMBL genes contributing to PC1 and PC2 in rat 
DRG
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Table 1:  All LncRNAs in rat DRG antisense of  pain genes
LncRNA ENSEMBL ID Gene symbol lnc_lfc lnc_pvalue gene_lfc gene_pvalue cpc
chr1:37747286-37751337(-) ENSRNOG00000017601 Srd5a1 -0.0447807219 0.9190998397 0.4351760184 0.0366284775 -1.24251
chr1:81878371-81879779(+) ENSRNOG00000018454 Apoe -0.566801053 0.0567754688 -0.3457943355 0.0702242035 -1.1206
chr1:123544997-124296791(-) ENSRNOG00000010146 Ndn -0.6667793509 0.0606260842 -0.0455532867 0.8217523885 -1.1682
chr1:177247980-177271718(-) ENSRNOG00000017679 Cckbr 2.112658187 1.44658406879268E-06 1.9467315106 3.48587574213042E-07 -0.88056
chr1:191162390-191236103(+) ENSRNOG00000011130 Calca -1.820836666 0.0039226154 -0.8165221175 0.0975339719 -0.538208
chr1:222437062-222437743(+) ENSRNOG00000020206 Ctsd -0.6235290917 0.304732215 -0.3633521581 0.0988581346 -1.15509
chr1:229209248-229210864(+) ENSRNOG00000021150 Plcb3 0.485775811 0.522226726 -0.3516802804 0.0977593436 -1.12512
chr1:245206514-245209217(+) ENSRNOG00000017469 Anxa1 1.2247686954 0.0628253085 0.4531432481 0.0990798605 -1.00017
chr10:40573511-40574610(+) ENSRNOG00000012840 Sparc 0.693080439 0.0309146894 0.5219163833 0.0004593778 -0.972695
chr10:49346229-49346991(-) ENSRNOG00000003338 Pmp22 -0.1177015925 0.7477371661 0.236004643 0.3916407903 -1.19616
chr10:56591574-56650214(+) ENSRNOG00000027037 Alox12 0.1314851106 0.563538108 0.2755623591 0.4643322887 -0.0382499
chr10:56761324-56812677(-) ENSRNOG00000019308 Arrb2 -0.7070928775 0.0629842467 -0.3152262668 0.0469287398 -1.11061
chr10:62857461-62860411(+) ENSRNOG00000003476 Slc6a4 -0.6717379382 0.2842524415 NA NA -0.372492
chr10:81937955-81950750(+) ENSRNOG00000002948 Abcc3 0.6430729974 0.1193131905 0.4573801324 0.0104184609 -0.800468
chr10:81950724-81953548(+) ENSRNOG00000002981 NA 0.1272952672 0.5374914338 -0.0268674599 0.9424883437 -0.575908
chr10:90227150-90682919(-) ENSRNOG00000002753 Adam11 0.073446823 0.6725234564 -1.013439415 0.0001701342 -1.15469
chr10:96310354-96310917(+) ENSRNOG00000003491 Prkca -0.1990222363 0.7690545773 -0.5076312503 0.0053541231 -1.23327
chr11:29078952-29091061(+) ENSRNOG00000001606 NA -0.392644359 0.0227719465 -0.1424088152 0.2832251035 -0.886432
chr11:31735382-31864076(+) ENSRNOG00000001575 Grik1 -1.2187665724 0.0008949842 -1.4425118869 0.0026368395 -0.940265
chr11:36455832-36456560(+) ENSRNOG00000001704 Runx1 1.0564240662 0.0674304349 0.1714696229 0.3626048906 -0.768232
chr11:62764709-62826162(-) ENSRNOG00000001528 Gap43 -0.202150834 0.4350106104 1.1099123845 7.66981630138424E-05 -0.100841
chr11:71932813-71946183(+) ENSRNOG00000002229 Adcy5 -0.3028927596 0.3669153667 0.0050502205 0.9787693274 -1.01178
chr12:1148261-1148984(+) ENSRNOG00000001090 Stard13 0.9088934954 0.0425706885 1.0436792285 0.0002948938 -1.18939
chr12:41201037-41219792(+) ENSRNOG00000001300 P2rx4 0.824750745 0.2159980941 0.259414065 0.3010495352 -0.812486
chr13:52205634-52281411(+) ENSRNOG00000003927 Cd55 -0.7126622392 0.2030060805 -1.2274586192 0.0093133909 0.573113
chr13:95223994-95228919(+) ENSRNOG00000007645 Kcnj9 1.1049036718 6.56002103938819E-05 -1.2226296115 0.0003202419 0.459104
chr14:8191831-8193162(-) ENSRNOG00000002079 Mapk10 0.2401930381 0.7403921646 -0.8442717744 0.0004100803 -1.50245
chr14:34155103-34162352(-) ENSRNOG00000002164 Nmu -0.4489053786 0.1308590754 NA NA -1.06048
chr14:42928354-42928641(+) ENSRNOG00000002343 Uchl1 -0.4731225392 0.1839489513 -0.3091734109 0.1359027758 -1.05083
chr14:71785314-71786402(+) ENSRNOG00000003069 Cd38 -0.6344039521 0.3367613316 0.2377024038 0.5153810696 -1.09667
chr15:91530679-91541466(+) ENSRNOG00000010997 Ednrb -0.0703856724 0.8215235733 -0.0640513458 0.7906606809 -1.1472
chr15:107356568-107361999(+) ENSRNOG00000010064 Abcc4 -0.9388852963 0.0034811028 0.0287800233 0.8511005855 -1.02241
chr16:11585122-11585914(+) ENSRNOG00000020155 Mapk8 0.572410107 0.4302871179 -0.2941889671 0.0097183305 -1.01858
chr16:19636469-19640494(+) ENSRNOG00000016892 Nr2f6 0.2024489197 0.5545590293 0.3143276744 0.0190656913 -1.10719
chr16:37462470-37491708(+) ENSRNOG00000049792 Glra3 0.2838969898 0.7061792884 NA NA -1.5332
chr19:11642610-11644968(+) ENSRNOG00000019482 Gnao1 -0.3340469383 0.5796951191 -0.6652059467 0.0078647986 -0.892065
chr2:41590850-41591127(+) ENSRNOG00000012471 Thbs4 0.9987025993 0.1449421069 0.8050443217 0.0208455771 -1.1965
chr2:63334966-63356823(-) ENSRNOG00000013963 Il6st 0.2337646709 0.7210196331 0.3063017582 0.0126989676 -1.15433
chr2:170727905-170730261(-) ENSRNOG00000014232 P2ry1 -0.1317282099 0.7404354621 -0.3621258376 0.1032307581 -0.738574
chr2:199111645-199115704(+) ENSRNOG00000028589 Gria2 -1.5735337199 8.73053258903914E-05 -1.7163376183 8.44767579830593E-08 -0.97916
chr2:223469266-223471786(+) ENSRNOG00000030019 Atp1a1 -1.5871758913 3.48442041275082E-05 -1.3611462919 0.000031922 -1.14917
chr20:13639959-13659017(-) ENSRNOG00000001216 Trpm2 0.0218240816 0.9655273051 0.6565867731 1.99392721612971E-05 -0.739585
chr20:45787077-45787666(-) ENSRNOG00000000599 Lama4 0.6684365109 0.2970693435 0.7159466344 0.001954655 0.378354
chr20:46160790-46161175(-) ENSRNOG00000000596 Fyn 0.4435010339 0.5537561776 0.4118310479 0.0015142443 -1.01299
chr3:59057403-59276093(+) ENSRNOG00000006639 Scn9a -2.357018731 1.42524585316199E-09 -1.0866688096 1.44524593696598E-05 -0.815863
chr3:69041756-69043454(+) ENSRNOG00000001548 Nfe2l2 0.8870856496 0.1233891464 0.1634197457 0.2048763399 -0.232069
chr3:127260488-127283308(-) ENSRNOG00000014152 Kcnip3 -1.5362755276 0.00000623 -1.6266979042 4.14361222986572E-05 -1.15812
chr4:7251609-7306887(+) ENSRNOG00000008380 Asic3 -0.296239585 0.3378583875 -0.2285426371 0.1836174061 0.353415
chr4:9636853-9646624(-) ENSRNOG00000021441 Reln 1.2405189319 0.0029984059 0.7327351616 0.0018675684 -1.30911
chr4:162569914-162651062(+) ENSRNOG00000005615 Gadd45a 0.9741379114 0.0011496768 1.0547848024 0.0022037369 -0.434463
chr4:224270790-224274242(+) ENSRNOG00000014294 Ptpn6 -0.1183917742 0.8562262094 0.8228388998 0.003274947 -1.54357
chr4:224746318-224747269(-) ENSRNOG00000019219 Vamp1 -0.6141431576 0.2040033788 -1.5285410153 0.0006560966 -0.744079
chr5:3719233-3765605(-) ENSRNOG00000007354 Trpa1 -1.0607031702 0.0005619469 -0.8457661675 0.0203168171 -0.814652
chr5:102448464-102448826(-) ENSRNOG00000029318 Tyrp1 -0.1928496338 0.7902991047 -0.9854320236 0.0236335401 -1.27712
chr5:154402173-154493191(-) ENSRNOG00000013231 Ptafr 0.677320791 0.0271052464 0.6466799012 0.0313546671 -1.52982
chr6:9546755-9553254(-) ENSRNOG00000015603 NA 0.020837421 0.969466824 -0.9300543601 2.49781655973716E-05 -1.11413
chr7:126391081-126394210(-) ENSRNOG00000021463 Ppara -0.0300122855 0.900186327 0.1982840405 0.4581352938 0.680499
chr7:140661997-140671754(-) ENSRNOG00000007346 Grasp 0.3462366023 0.3027295777 0.3944661433 0.1206041916 -1.20061
chr8:2515108-2772995(-) ENSRNOG00000007372 Casp1 0.0935904095 0.8743411701 0.7067930217 0.0098913233 -1.89693
chr8:32323519-32324313(+) ENSRNOG00000047179 Aplp2 -1.6363414407 0.0115691932 -0.7368788555 4.68583620320112E-05 -1.12105
chr8:48034756-48064293(-) ENSRNOG00000016221 Scn2b -0.8096772721 0.0208522022 -0.0207163123 0.9410233127 -0.925869
chr8:57331729-57332065(+) ENSRNOG00000000196 Cyp19a1 0.2466031844 0.7251451474 NA NA -1.29188
chr8:88667082-88711088(+) ENSRNOG00000013042 Htr1b 1.1366503299 5.71176513352015E-05 0.3209479749 0.0322417882 -1.06466
chr8:103496790-103720412(+) ENSRNOG00000011501 Atp1b3 0.0227119781 0.9141564307 -0.7630008751 0.0001102393 -1.72487
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PC1 PC1_symbol PC2 PC2_symbol
1 ENSMUSG00000036395 Glb1l2 ENSMUSG00000023046 Igfbp6
2 ENSMUSG00000110631 NA ENSMUSG00000049134 Nrap
3 ENSMUSG00000024366 Gfra3 ENSMUSG00000017344 Vtn
4 ENSMUSG00000001435 Col18a1 ENSMUSG00000030108 Slc6a13
5 ENSMUSG00000041607 Mbp ENSMUSG00000064387 Snora73a
6 ENSMUSG00000004098 Col5a3 ENSMUSG00000075307 Klhl41
7 ENSMUSG00000045573 Penk ENSMUSG00000019577 Pdk4
8 ENSMUSG00000027273 Snap25 ENSMUSG00000078234 Klhdc7a
9 ENSMUSG00000040152 Thbs1 ENSMUSG00000111340 NA
10 ENSMUSG00000092805 NA ENSMUSG00000008845 Cd163
11 ENSMUSG00000049176 Frmpd4 ENSMUSG00000010122 Slc47a1
12 ENSMUSG00000045589 Frrs1l ENSMUSG00000045039 Megf8
13 ENSMUSG00000026042 Col5a2 ENSMUSG00000024049 Myom1
14 ENSMUSG00000021219 Rgs6 ENSMUSG00000041559 Fmod
15 ENSMUSG00000000223 Drp2 ENSMUSG00000030107 Usp18
16 ENSMUSG00000030108 Slc6a13 ENSMUSG00000026904 Slc4a10
17 ENSMUSG00000042286 Stab1 ENSMUSG00000024529 Lox
18 ENSMUSG00000064945 Rny3 ENSMUSG00000044938 Klhl31
19 ENSMUSG00000095079 NA ENSMUSG00000032589 Bsn
20 ENSMUSG00000056306 Sertm1 ENSMUSG00000031722 Hp
21 ENSMUSG00000074899 NA ENSMUSG00000027737 Slc7a11
22 ENSMUSG00000040690 Col16a1 ENSMUSG00000040055 Gjb6
23 ENSMUSG00000020396 Nefh ENSMUSG00000031765 Mt1
24 ENSMUSG00000031538 Plat ENSMUSG00000045573 Penk
25 ENSMUSG00000033595 Lgi3 ENSMUSG00000025153 Fasn
26 ENSMUSG00000025348 Itga7 ENSMUSG00000056328 Myh1
27 ENSMUSG00000076609 NA ENSMUSG00000001348 Acp5
28 ENSMUSG00000024621 Csf1r ENSMUSG00000038541 Srd5a2
29 ENSMUSG00000064337 NA ENSMUSG00000036814 Slc6a20a
30 ENSMUSG00000015647 Lama5 ENSMUSG00000023993 Treml1
31 ENSMUSG00000044071 Fam19a2 ENSMUSG00000004891 Nes
32 ENSMUSG00000003746 Man1a ENSMUSG00000056174 Col8a2
33 ENSMUSG00000036594 H2-Aa ENSMUSG00000031762 Mt2
34 ENSMUSG00000035202 Lars2 ENSMUSG00000050578 Mmp13
35 ENSMUSG00000041020 Map7d2 ENSMUSG00000034664 Itga2b
36 ENSMUSG00000013584 Aldh1a2 ENSMUSG00000070385 Ampd1
37 ENSMUSG00000090667 Gm765 ENSMUSG00000021390 Ogn
38 ENSMUSG00000073418 C4b ENSMUSG00000035202 Lars2
39 ENSMUSG00000047344 Lancl3 ENSMUSG00000037736 Limch1
40 ENSMUSG00000047216 Cdh19 ENSMUSG00000026051 1500015O10Rik
41 ENSMUSG00000033066 Gas7 ENSMUSG00000032648 Pygm
42 ENSMUSG00000024164 C3 ENSMUSG00000029843 Slc13a4
43 ENSMUSG00000063011 Msln ENSMUSG00000024471 Myot
44 ENSMUSG00000003477 Inmt ENSMUSG00000026697 Myoc
45 ENSMUSG00000026712 Mrc1 ENSMUSG00000016255 Tubb1
46 ENSMUSG00000018217 Pmp22 ENSMUSG00000030116 Mfap5
47 ENSMUSG00000045672 Col27a1 ENSMUSG00000064945 Rny3
48 ENSMUSG00000030218 Mgp ENSMUSG00000013584 Aldh1a2
49 ENSMUSG00000032854 Ugt8a ENSMUSG00000029373 Pf4
50 ENSMUSG00000046157 Tmem229b ENSMUSG00000098178 NA
Table 1: Top 50 genes contributing to PC1 and PC2 for the BALB/c mouse strain
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PC1 PC1_symbol PC2 PC2_symbol
1 ENSMUSG00000032332 Col12a1 ENSMUSG00000061762 Tac1
2 ENSMUSG00000083161 NA ENSMUSG00000024222 Fkbp5
3 ENSMUSG00000109908 NA ENSMUSG00000032496 Ltf
4 ENSMUSG00000094546 NA ENSMUSG00000037868 Egr2
5 ENSMUSG00000086825 NA ENSMUSG00000093843 NA
6 ENSMUSG00000095589 NA ENSMUSG00000026395 Ptprc
7 ENSMUSG00000076940 NA ENSMUSG00000035200 Chrnb4
8 ENSMUSG00000026904 Slc4a10 ENSMUSG00000020849 Ywhae
9 ENSMUSG00000076258 NA ENSMUSG00000032303 Chrna3
10 ENSMUSG00000076672 NA ENSMUSG00000005952 Trpv1
11 ENSMUSG00000019874 Fabp7 ENSMUSG00000051855 Mest
12 ENSMUSG00000037868 Egr2 ENSMUSG00000010154 Spire2
13 ENSMUSG00000019960 Dusp6 ENSMUSG00000083161 NA
14 ENSMUSG00000042644 Itpr3 ENSMUSG00000026904 Slc4a10
15 ENSMUSG00000076617 NA ENSMUSG00000030157 Clec2d
16 ENSMUSG00000059824 Dbp ENSMUSG00000020599 Rgs9
17 ENSMUSG00000093861 NA ENSMUSG00000042942 Greb1l
18 ENSMUSG00000017344 Vtn ENSMUSG00000031667 Aktip
19 ENSMUSG00000100510 LOC102636514 ENSMUSG00000026185 Igfbp5
20 ENSMUSG00000025479 Cyp2e1 ENSMUSG00000069919 Hba-a1
21 ENSMUSG00000094491 NA ENSMUSG00000095130 NA
22 ENSMUSG00000004105 Angptl2 ENSMUSG00000036699 Zcchc12
23 ENSMUSG00000106106 NA ENSMUSG00000094546 NA
24 ENSMUSG00000076563 NA ENSMUSG00000070570 Slc17a7
25 ENSMUSG00000064367 ND5 ENSMUSG00000021647 Cartpt
26 ENSMUSG00000066687 Zbtb16 ENSMUSG00000020483 Dynll2
27 ENSMUSG00000078234 Klhdc7a ENSMUSG00000022054 Nefm
28 ENSMUSG00000032589 Bsn ENSMUSG00000030790 Adm
29 ENSMUSG00000076677 NA ENSMUSG00000061535 C1qtnf7
30 ENSMUSG00000027737 Slc7a11 ENSMUSG00000076652 NA
31 ENSMUSG00000038872 Zfhx3 ENSMUSG00000022123 Scel
32 ENSMUSG00000061762 Tac1 ENSMUSG00000056054 S100a8
33 ENSMUSG00000030730 Atp2a1 ENSMUSG00000050963 Kcns2
34 ENSMUSG00000067786 Nnat ENSMUSG00000006411 Pvrl4
35 ENSMUSG00000053279 Aldh1a1 ENSMUSG00000007682 Dio2
36 ENSMUSG00000035000 Dpp4 ENSMUSG00000019874 Fabp7
37 ENSMUSG00000095889 NA ENSMUSG00000025270 Alas2
38 ENSMUSG00000032657 Fam189b ENSMUSG00000046480 Scn4b
39 ENSMUSG00000039488 Cntn5 ENSMUSG00000056071 S100a9
40 ENSMUSG00000051747 Ttn ENSMUSG00000087382 NA
41 ENSMUSG00000056215 Lrguk ENSMUSG00000096349 NA
42 ENSMUSG00000020483 Dynll2 ENSMUSG00000094075 NA
43 ENSMUSG00000094433 NA ENSMUSG00000041556 Fbxo2
44 ENSMUSG00000038193 Hand2 ENSMUSG00000073940 Hbb-b1
45 ENSMUSG00000102364 NA ENSMUSG00000028369 Svep1
46 ENSMUSG00000044734 Serpinb1a ENSMUSG00000020701 Tmem132e
47 ENSMUSG00000002944 Cd36 ENSMUSG00000020053 Igf1
48 ENSMUSG00000024650 Slc22a6 ENSMUSG00000096833 NA
49 ENSMUSG00000091345 Col6a5 ENSMUSG00000038319 Kcnh2
50 ENSMUSG00000010122 Slc47a1 ENSMUSG00000067149 Jchain
Table 2: Top 50 genes contributing to PC1 and PC2 for the B10.D2 strain
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Table 1: All LncRNAs in mouse DRG antisense of pain genes. Log fold changes and p.values are for 
SNI vs Sham BALB.c strain
LncRNA Genomic Coordinates ENSEMBL ID symbol lnc_lfc lnc_pvalue gene_lfc gene_pvalue cpc
chr1:131263308-131266930(+) ENSMUSG00000042349 Ikbke -0.98520025 0.6592695429 0.3261541797 0.2142890364 -1.16173
chr10:39555935-39560136(-) ENSMUSG00000019843 Fyn -0.277984631 0.3544766412 0.1165577866 0.1207782839 -0.472081
chr11:7213635-7261406(+) ENSMUSG00000020427 Igfbp3 0.3107693246 0.7052722355 0.1947102662 0.5265263297 -1.00746
chr11:55394494-55395613(+) ENSMUSG00000018593 Sparc 0.154481082 0.9317813792 0.3846903375 0.0044242494 -1.05264
chr11:63150892-63151309(-) ENSMUSG00000018217 Pmp22 0.2368154814 0.9104057371 0.0367805138 0.9290005349 -0.886487
chr11:66896676-66931091(-) ENSMUSG00000048070 Pirt -0.201672067 0.772517491 -0.155669631 0.1423672603 0.907072
chr11:70239888-70246096(+) ENSMUSG00000000320 Alox12 0.1813909634 0.9004524871 0.4654956959 0.5374670032 0.125631
chr11:73296005-73300736(-) ENSMUSG00000043029 Trpv3 0.3789321054 0.4348536675 0.052672489 0.9293436747 -0.979906
chr11:81966759-81995840(+) ENSMUSG00000020704 Asic2 -0.343159024 0.2996970344 -0.091843141 0.6553707748 -0.833933
chr11:83526976-83532680(+) ENSMUSG00000035042 Ccl5 1.0110523243 0.6322415666 0.7629876473 0.4298909755 -0.685233
chr11:102739325-102762503(-) ENSMUSG00000020926 Adam11 -0.176744019 0.7599021089 -0.157396544 0.364093453 0.539235
chr11:107935614-107937468(+) ENSMUSG00000050965 Prkca 0.5167625641 0.8478472381 -0.178048418 0.0338701243 -0.893234
chr13:112505712-112508381(-) ENSMUSG00000021756 Il6st 0.1297205562 0.9465674986 0.0612605241 0.4975361924 -1.01211
chr14:74638797-74642453(-) ENSMUSG00000034997 Htr2a 0.4123544967 0.9076411811 0.0251968876 0.9185442832 -1.24073
chr14:103778950-103851424(+) ENSMUSG00000022122 Ednrb 0.4948442126 0.1528368859 0.145793644 0.2528297697 0.298243
chr15:78081606-78108287(+) ENSMUSG00000019146 Cacng2 -0.296514822 0.7374523878 -0.57794508 0.0170050333 -0.615593
chr15:78919895-78928253(-) ENSMUSG00000068220 Lgals1 0.1777692974 0.8991514195 0.6709975096 3.976506E-18 -0.956606
chr15:79071107-79242303(-) ENSMUSG00000068206 Pick1 0.2698762926 0.785038705 -0.065600513 0.6456907014 0.265443
chr15:101214611-101225267(-) ENSMUSG00000000531 Grasp 0.098875379 0.9798524065 0.1195690448 0.6817437262 -0.116895
chr15:102138265-102205121(-) ENSMUSG00000023046 Igfbp6 -0.067812584 0.8698159699 -0.067706189 0.8999149811 0.527199
chr16:85898584-85905300(+) ENSMUSG00000022894 Adamts5 0.3483300083 0.3330813848 0.000848238 0.997377315 -0.949085
chr16:87934064-87936434(+) ENSMUSG00000022935 Grik1 -0.921835283 0.6451204509 -0.17453844 0.1805609643 -1.01687
chr16:92690953-92693516(+) ENSMUSG00000022952 Runx1 0.7466460941 0.5433316449 -0.150059313 0.3051862594 -1.09998
chr16:94752627-94753306(+) ENSMUSG00000043301 Kcnj6 0.8951291087 0.7257449949 0.0464183082 0.9528614695 -1.04139
chr17:86375800-86379306(-) ENSMUSG00000045038 Prkce -0.996940145 0.2785528776 -0.145539461 0.2439022269 -0.899925
chr18:4352995-4368040(+) ENSMUSG00000024235 Map3k8 -0.54220561 0.7196399978 0.0772844548 0.8491287909 -1.1489
chr18:82405614-82406458(+) ENSMUSG00000024553 Galr1 0.1235252513 0.9545689021 -0.034555841 0.9451380866 -0.350143
chr19:6969343-6970896(+) ENSMUSG00000024960 Plcb3 -0.166144246 0.9646489653 -0.161539318 0.3413281225 -0.934247
chr19:22435556-22448608(-) ENSMUSG00000052387 Trpm3 0.1196303319 0.9105345312 -0.054003125 0.7413896245 -0.191057
chr19:58296973-58301066(+) ENSMUSG00000025089 Gfra1 -0.343493397 0.9177484643 0.4468156038 1.675207E-05 -0.786685
chr2:55427442-55436542(-) ENSMUSG00000026824 Kcnj3 -0.580237298 0.6033988923 -0.57447561 4.282814E-08 -1.0562
chr2:66634323-66642309(+) ENSMUSG00000075316 Scn9a 0.0687529985 0.9926893542 -0.145395638 0.2883473421 -1.12072
chr2:68470860-68477044(+) ENSMUSG00000027030 Stk39 0.1226660881 0.9719415755 -0.084965957 0.4156602925 -1.12018
chr2:75671430-75690556(+) ENSMUSG00000015839 Nfe2l2 0.0490989247 0.986018665 0.0838626129 0.5312041689 0.169968
chr2:109674786-109677623(-) ENSMUSG00000048482 Bdnf 0.3293679099 0.8644903084 0.0696616305 0.8775146727 -1.0687
chr2:127481675-127485719(+) ENSMUSG00000079056 Kcnip3 -0.515414154 0.3408899129 -0.298817895 0.0007083523 -1.07449
chr2:135894491-135898147(-) ENSMUSG00000039943 Plcb4 0.7098198145 0.5926860334 -0.104413466 0.3379184765 -0.030264
chr2:181609802-181957990(-) ENSMUSG00000027584 Oprl1 0.0120499059 0.9944177995 -0.505326952 4.921184E-07 0.160446
chr3:60782742-61004319(-) ENSMUSG00000027765 P2ry1 -0.192103558 0.5060442174 -0.109144501 0.5185215467 0.749763
chr3:80800379-80851997(+) ENSMUSG00000033981 Gria2 -1.216555107 0.5745991129 -0.49156506 5.055106E-12 -0.981679
chr3:101592328-101592581(+) ENSMUSG00000033161 Atp1a1 -1.028248102 0.3537633784 -0.233929626 0.0531679513 -1.18998
chr4:46784711-46788504(+) ENSMUSG00000039809 Gabbr2 1.3310521312 0.1609055133 -0.303498634 0.0164962137 -0.450315
chr4:58552293-58555304(+) ENSMUSG00000038668 Lpar1 -0.511973278 0.7274282672 0.1851517195 0.0378675787 -0.819195
chr4:132560740-132604797(-) ENSMUSG00000056529 Ptafr -0.193113244 0.9673261307 0.4313546354 0.0879254679 -0.216132
chr5:15923808-15935945(-) ENSMUSG00000040118 Cacna2d1 0.8450650334 0.1858737873 0.7358847545 2.574299E-09 -1.24297
chr5:30582864-30588672(-) ENSMUSG00000049265 Kcnk3 0.5059393595 0.8181920646 0.1913319969 0.5451568951 -0.75535
chr5:35236149-35279078(-) ENSMUSG00000045318 Adra2c -0.416976374 0.0511192809 -0.368500205 0.0217133551 0.487157
chr5:43867709-43869237(-) ENSMUSG00000029084 Cd38 0.1700508666 0.9356797221 0.3802306283 0.0994113845 -1.12311
chr5:135910531-135911651(+) ENSMUSG00000051391 Ywhag 0.120019824 0.9465674986 -0.156355756 0.4885279085 0.444727
chr6:118163117-118170060(+) ENSMUSG00000030110 Ret -0.252029044 0.9492627383 -0.045756162 0.839797438 -0.98824
chr6:125241923-125242339(-) ENSMUSG00000030337 Vamp1 -2.105684506 0.1835646872 -0.558387229 5.679823E-06 -0.713977
chr6:126636519-126640569(+) ENSMUSG00000047976 Kcna1 -0.198656717 0.9144054087 -0.036102344 0.884347396 -0.67089
chr7:45830846-45838266(+) ENSMUSG00000002771 Grin2d -0.130144969 0.8742402255 -0.19475351 0.6783363649 -1.28868
chr7:51570197-51623188(-) ENSMUSG00000030500 Slc17a6 -0.237515141 0.7052722355 0.0737330654 0.6654869991 0.0645359
chr7:57590158-57591036(-) ENSMUSG00000033676 Gabrb3 -0.398396221 0.7794392377 -0.325063047 0.0024889939 -1.02142
chr7:75308507-75312178(+) ENSMUSG00000053025 Sv2b -0.366418008 0.8105102187 -0.3502195 3.549174E-06 -0.846792
chr7:91253594-91259556(-) ENSMUSG00000052572 Dlg2 -0.314768325 0.8953219043 -0.028026406 0.9033465972 -1.2575
chr7:99263649-99269728(-) ENSMUSG00000055407 Map6 0.1486494885 0.9105345312 -0.127707824 0.5474093107 0.035665
chr7:114635520-114636347(+) ENSMUSG00000030669 Calca -0.308329115 0.4775839761 -0.098255089 0.5129124813 -1.18392
chr9:96345647-96364371(+) ENSMUSG00000032412 Atp1b3 -0.3577547 0.925482472 0.0169311681 0.9194243012 -1.00742
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Table 2:All LncRNAs in mouse DRG antisense of pain genes. Log fold changes and p.values are for SNI vs
Sham B10.D2 strain
LncRNA genomic coordinates ENSEMBL ID symbol lnc_lfc lnc_pvalue gene_lfc gene_pvalue cpc
chr1:131263308-131266930(+) ENSMUSG00000042349 Ikbke -1.078111727 0.397719411 0.2457525415 0.3932158227 -1.16173
chr10:39555935-39560136(-) ENSMUSG00000019843 Fyn -0.243497809 0.5035520725 0.043041668 0.7131938403 -0.472081
chr11:7213635-7261406(+) ENSMUSG00000020427 Igfbp3 0.0167402906 0.989607363 0.3077295865 0.2333603316 -1.00746
chr11:55394494-55395613(+) ENSMUSG00000018593 Sparc 0.1375173714 0.9639834139 0.2174199139 0.1764539804 -1.05264
chr11:63150892-63151309(-) ENSMUSG00000018217 Pmp22 0.8817390532 0.4326273958 0.0345001222 0.9440613212 -0.886487
chr11:66896676-66931091(-) ENSMUSG00000048070 Pirt 0.1938223753 0.8254926541 -0.045968414 0.7875637177 0.907072
chr11:70239888-70246096(+) ENSMUSG00000000320 Alox12 0.0988438932 0.973077453 0.1574883068 0.8897735056 0.125631
chr11:73296005-73300736(-) ENSMUSG00000043029 Trpv3 0.2396813077 0.7521598325 -0.156215714 0.7477299356 -0.979906
chr11:81966759-81995840(+) ENSMUSG00000020704 Asic2 -0.351495815 0.2827416728 3.413768E-05 0.9998413947 -0.833933
chr11:83526976-83532680(+) ENSMUSG00000035042 Ccl5 -0.522655499 0.8903792755 0.5509165533 0.5849996984 -0.685233
chr11:102739325-102762503(-) ENSMUSG00000020926 Adam11 0.2321013698 0.730803581 -0.062294256 0.7998050125 0.539235
chr11:107935614-107937468(+) ENSMUSG00000050965 Prkca -0.199675752 0.9705727865 -0.02859984 0.8628297695 -0.893234
chr13:112505712-112508381(-) ENSMUSG00000021756 Il6st 0.3297431117 0.8820463148 0.0869975911 0.2601859488 -1.01211
chr14:74638797-74642453(-) ENSMUSG00000034997 Htr2a -0.314947033 0.9639834139 0.055837711 0.8127659278 -1.24073
chr14:103778950-103851424(+) ENSMUSG00000022122 Ednrb 0.2321027822 0.7655453131 -0.009434471 0.9702263737 0.298243
chr15:78081606-78108287(+) ENSMUSG00000019146 Cacng2 0.048915626 0.9758352683 -0.305087973 0.3048619151 -0.615593
chr15:78919895-78928253(-) ENSMUSG00000068220 Lgals1 0.222948079 0.8927790233 0.4627870665 7.638229E-10 -0.956606
chr15:79071107-79242303(-) ENSMUSG00000068206 Pick1 0.0813402994 0.973077453 -0.027638256 0.8839176216 0.265443
chr15:101214611-101225267(-) ENSMUSG00000000531 Grasp -0.146283116 0.9743351145 -0.020928561 0.9628442936 -0.116895
chr15:102138265-102205121(-) ENSMUSG00000023046 Igfbp6 -0.048028647 0.9446682396 -0.057296307 0.9303470783 0.527199
chr16:85898584-85905300(+) ENSMUSG00000022894 Adamts5 -0.053506938 0.9705727865 0.0579465468 0.7853077524 -0.949085
chr16:87934064-87936434(+) ENSMUSG00000022935 Grik1 -0.203429573 0.9677930437 -0.020753259 0.9361552775 -1.01687
chr16:92690953-92693516(+) ENSMUSG00000022952 Runx1 0.1342255838 0.9705727865 0.0095130398 0.9728777749 -1.09998
chr16:94752627-94753306(+) ENSMUSG00000043301 Kcnj6 -0.168565844 NA 0.3470856068 0.5279605773 -1.04139
chr17:86375800-86379306(-) ENSMUSG00000045038 Prkce -0.386538769 0.7385394353 0.0071226184 0.9769084578 -0.899925
chr18:4352995-4368040(+) ENSMUSG00000024235 Map3k8 0.1469768665 0.969395687 0.1547033524 0.669227555 -1.1489
chr18:82405614-82406458(+) ENSMUSG00000024553 Galr1 0.4081348311 0.785324861 0.0319199831 0.9562733313 -0.350143
chr19:6969343-6970896(+) ENSMUSG00000024960 Plcb3 -0.715045891 0.8180007522 -0.07246381 0.7605269617 -0.934247
chr19:22435556-22448608(-) ENSMUSG00000052387 Trpm3 -0.122783885 0.9347317631 0.010232127 0.9646533273 -0.191057
chr19:58296973-58301066(+) ENSMUSG00000025089 Gfra1 0.1730403636 0.9732881435 0.457017995 1.317818E-06 -0.786685
chr2:55427442-55436542(-) ENSMUSG00000026824 Kcnj3 -0.20082323 0.9387478423 -0.2065731 0.125599383 -1.0562
chr2:66634323-66642309(+) ENSMUSG00000075316 Scn9a -0.419457319 0.9347317631 -0.022210573 0.9319527903 -1.12072
chr2:68470860-68477044(+) ENSMUSG00000027030 Stk39 -1.042928271 0.4961701849 -0.117325078 0.1881186421 -1.12018
chr2:75671430-75690556(+) ENSMUSG00000015839 Nfe2l2 -0.073928483 0.9758352683 0.0389651017 0.8268121068 0.169968
chr2:109674786-109677623(-) ENSMUSG00000048482 Bdnf -0.23531589 0.9446610926 -0.334250402 0.2424108574 -1.0687
chr2:127481675-127485719(+) ENSMUSG00000079056 Kcnip3 0.178893432 0.9077801239 -0.173585845 0.0845250648 -1.07449
chr2:135894491-135898147(-) ENSMUSG00000039943 Plcb4 0.2382590536 0.9455791355 -0.077405251 0.5346915682 -0.030264
chr2:181609802-181957990(-) ENSMUSG00000027584 Oprl1 0.1658856806 0.9639834139 -0.463996966 6.792654E-07 0.160446
chr3:60782742-61004319(-) ENSMUSG00000027765 P2ry1 -0.04096317 0.96692948 0.0459277354 0.8411258526 0.749763
chr3:80800379-80851997(+) ENSMUSG00000033981 Gria2 0.7836843393 0.8400002197 -0.421306441 3.234753E-10 -0.981679
chr3:101592328-101592581(+) ENSMUSG00000033161 Atp1a1 0.4207641944 0.8608015807 -0.188540584 0.1343371599 -1.18998
chr4:46784711-46788504(+) ENSMUSG00000039809 Gabbr2 0.6713122866 0.7497985037 -0.143473066 0.3963161582 -0.450315
chr4:58552293-58555304(+) ENSMUSG00000038668 Lpar1 0.2387660609 0.9356855468 0.0769427646 0.5500225626 -0.819195
chr4:132560740-132604797(-) ENSMUSG00000056529 Ptafr -0.123339248 0.9801366717 0.3943566257 0.0981170393 -0.216132
chr5:15923808-15935945(-) ENSMUSG00000040118 Cacna2d1 0.8156841762 0.1889214288 0.5091287054 3.342554E-05 -1.24297
chr5:30582864-30588672(-) ENSMUSG00000049265 Kcnk3 -0.466332612 0.8912289083 0.2537765343 0.367209238 -0.75535
chr5:35236149-35279078(-) ENSMUSG00000045318 Adra2c -0.14461118 0.8227140887 -0.228261149 0.2277920785 0.487157
chr5:43867709-43869237(-) ENSMUSG00000029084 Cd38 0.2385900982 0.9282341862 0.1959170178 0.5019581754 -1.12311
chr5:135910531-135911651(+) ENSMUSG00000051391 Ywhag 0.3231610457 0.8496431381 -0.073921932 0.8061803575 0.444727
chr6:118163117-118170060(+) ENSMUSG00000030110 Ret -0.090794894 0.9876321853 -0.016975427 0.9552272304 -0.98824
chr6:125241923-125242339(-) ENSMUSG00000030337 Vamp1 0.1800569004 0.9741855109 -0.481227374 4.078426E-05 -0.713977
chr6:126636519-126640569(+) ENSMUSG00000047976 Kcna1 -0.375754473 0.8275318945 -0.22179362 0.112835847 -0.67089
chr7:45830846-45838266(+) ENSMUSG00000002771 Grin2d -0.311604384 0.5599885511 0.0497896167 0.945800424 -1.28868
chr7:51570197-51623188(-) ENSMUSG00000030500 Slc17a6 -0.136785769 0.9212685871 0.0018376723 0.9930761308 0.0645359
chr7:57590158-57591036(-) ENSMUSG00000033676 Gabrb3 -0.299312546 0.8902636021 -0.160672147 0.2380967932 -1.02142
chr7:75308507-75312178(+) ENSMUSG00000053025 Sv2b -0.33515086 0.8477325228 -0.288171733 7.685535E-05 -0.846792
chr7:91253594-91259556(-) ENSMUSG00000052572 Dlg2 -0.759690261 0.6718182648 -0.049468816 0.8279471735 -1.2575
chr7:99263649-99269728(-) ENSMUSG00000055407 Map6 0.2981164569 0.8275318945 -0.085718388 0.7403051251 0.035665
chr7:114635520-114636347(+) ENSMUSG00000030669 Calca -0.224843222 0.7344297262 -0.182357985 0.1064025309 -1.18392
chr9:96345647-96364371(+) ENSMUSG00000032412 Atp1b3 0.1694189274 0.9743351145 0.0696509475 0.5935400139 -1.00742
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Dim.1 Dim.2 Dim.3 Dim.4
NPSI_BURNING 0.302130884294959 -0.092173940249317 0.067460577339705 -0.235182819896692
NPSI_SQUEEZING 0.279071960504311 0.120954876609237 -0.173248916463105 0.26774479272829
NPSI_PRESSURE 0.326641767992884 0.338419682258165 -0.014151520287947 0.17123647418006
NPSI_SPONTONGOING 0.155558537325615 0.212566272710502 0.727365465007889 0.112105817881556
NPSI_ELECSHOCKS 0.293989883612732 -0.432809669597189 0.005316452827467 0.138388748663079
NPSI_STABBING 0.268144866300825 -0.190792773155487 -0.201114329371849 0.68994373116077
NPSI_SPONTPAROXYSMAL 0.269654548500442 0.018103737843322 0.526469216941567 0.009911282604728
NPSI_BRUSHEVOKED 0.2925672302872 0.340737336154331 -0.22257552676774 -0.078442017879774
NPSI_PRESSUREEVOKED 0.31084911647656 0.344260160957282 -0.126426597535849 0.007225487114492
NPSI_COLDEVOKED 0.24217065751517 0.280162399702034 -0.210739282049941 -0.43108090350353
NPSI_PANDN 0.323321630730991 -0.405789325685545 0.043493563163504 -0.281586549547539
NPSI_TINGLING 0.35141273206 -0.339609784166332 -0.081864149566949 -0.253994100655439
Table 2:Non-varimax rotated loadings for data with all variables. 
Dim.1 Dim.2 Dim.3
NPSI_BURNING 0.314441856707305 -0.092218177377863 -0.267987288773362
NPSI_SQUEEZING 0.296543521593314 0.140966702103109 0.281414737418969
NPSI_PRESSURE 0.334429042260101 0.345642055022025 0.152216617304376
NPSI_ELECSHOCKS 0.307958687532538 -0.430514206181964 0.14233851239341
NPSI_STABBING 0.288211204352699 -0.167543179018359 0.720355822966716
NPSI_BRUSHEVOKED 0.315262282799851 0.358482948487693 -0.077614758503885
NPSI_PRESSUREEVOKED 0.322759914289525 0.369744450168993 0.022252355946422
NPSI_COLDEVOKED 0.255132570163264 0.315931534569473 -0.365751397910472
NPSI_PANDN 0.340095191967857 -0.411221117662129 -0.297072251829438
NPSI_TINGLING 0.372987379836333 -0.323428574750983 -0.24104080625497
Table 1:  Non-varimax rotated loadings for data without the spontaneous pain categorical
variables. It is much more difficult to identify the highest contributing variables.
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